<SEC-DOCUMENT>0001104659-22-104691.txt : 20221003
<SEC-HEADER>0001104659-22-104691.hdr.sgml : 20221003
<ACCEPTANCE-DATETIME>20220930173834
ACCESSION NUMBER:		0001104659-22-104691
CONFORMED SUBMISSION TYPE:	424B3
PUBLIC DOCUMENT COUNT:		12
FILED AS OF DATE:		20221003
DATE AS OF CHANGE:		20220930

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CALAMOS GLOBAL TOTAL RETURN FUND
		CENTRAL INDEX KEY:			0001285650
		IRS NUMBER:				203377281
		FISCAL YEAR END:			1031

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-251787
		FILM NUMBER:		221285157

	BUSINESS ADDRESS:	
		STREET 1:		2020 CALAMOS COURT
		STREET 2:		C/O CALAMOS ADVISORS LLC
		CITY:			NAPERVILLE
		STATE:			IL
		ZIP:			60563
		BUSINESS PHONE:		6302451046

	MAIL ADDRESS:	
		STREET 1:		2020 CALAMOS COURT
		STREET 2:		C/O CALAMOS ADVISORS LLC
		CITY:			NAPERVILLE
		STATE:			IL
		ZIP:			60563
</SEC-HEADER>
<DOCUMENT>
<TYPE>424B3
<SEQUENCE>1
<FILENAME>tm2226808d4_424b3.htm
<DESCRIPTION>424B3
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>
<!--INTEGIX by Ez-XBRL--><html xmlns="http://www.w3.org/1999/xhtml" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2022-02-16" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:cef="http://xbrl.sec.gov/cef/2022" xmlns:ck0001285650="http://www.calamos.com/20220930" xmlns:dei="http://xbrl.sec.gov/dei/2022"  ><head><meta http-equiv="Content-Type" content="text/html; charset=UTF-8"/><title>CALAMOS GLOBAL TOTAL RETURN FUND - 1285650 - 2022</title></head><body>
        <div style="display:none">
        <ix:header><ix:hidden><ix:footnote id="FN20220929132605436" xml:lang="en-US">Represents the estimated commission with respect to the Fund's common shares being sold in this offering. There is no guarantee that there will be any sales of the Fund's common shares pursuant to this prospectus supplement and the accompanying prospectus. Actual sales of the Fund's common shares under this prospectus supplement and the accompanying prospectus, if any, may be less than as set forth under "Capitalization" above. In addition, the price per share of any such sale may be greater or less than the price set forth under "Capitalization" above, depending on the market price of the Fund's common shares at the time of any such sale.</ix:footnote>
<ix:footnote id="FN20220929132653404" xml:lang="en-US">Calamos will pay the expenses of the offering (other than the applicable commissions). However, on a one year lag Calamos may recapture from the Fund previously paid offering expenses at a rate of $6,500 for each $1 million on sales (net of commissions) up to the lesser of $200,000 or actual costs. The Fund would accrue the costs over the following fiscal year. As of the date of this prospectus supplement and the accompanying prospectus, Calamos will pay all of the expenses associated with the offering (other than the applicable commissions). If the recapture provision is triggered in the future, such expenses that will be borne by Fund shareholders will be set forth in the "Shareholder Transaction Expenses" table above.</ix:footnote>
<ix:footnote id="FN20220929132839835" xml:lang="en-US">Shareholders will pay a $15.00 transaction fee plus a $0.02 per share brokerage charge if they direct Computershare Shareowner Services LLC (the "Plan Agent") to sell common shares held in a Plan account. In addition, each participant will pay a pro rata share of brokerage commissions incurred with respect to the Plan Agent's open-market purchases in connection with the reinvestment of dividends or distributions. If a participant elects to have the Plan Agent sell part or all of his or her common shares and remit the proceeds, such participant will be charged his or her pro rata share of brokerage commissions on the shares sold. See "Dividends and Distributions on Common Shares; Automatic Dividend Reinvestment Plan" on page 77 of the accompanying prospectus.</ix:footnote>
<ix:footnote id="FN20220929132913036" xml:lang="en-US">The Fund pays Calamos an annual management fee, payable monthly in arrears, for its investment management services in an amount equal to 1.00% of the Fund's average weekly managed assets. In accordance with the requirements of the Commission, the table above shows the Fund's management fee as a percentage of average net assets attributable to common shareholders. By showing the management fee as a percentage of net assets, the management fee is not expressed as a percentage of all of the assets the Fund intends to invest. For purposes of the table, the management fee has been converted to 1.51% of the Fund's average weekly net assets as of September 6, 2022 by dividing the total dollar amount of the management fee by the Fund's average weekly net assets (managed assets less outstanding leverage).</ix:footnote>
<ix:footnote id="FN20220929133003685" xml:lang="en-US">Reflects interest expense paid on $9 million in average borrowings under the Fund's Amended and Restated Liquidity Agreement with State Street Bank and Trust Company, plus $34.8 million in additional average structural leverage related to certain securities lending programs, as described in the accompanying prospectus under "Leverage."</ix:footnote>
<ix:footnote id="FN20220929172523053" xml:lang="en-US">Reflects estimated dividend expense on $17 million aggregate liquidation preference of mandatory redeemable preferred shares ("MRP Shares" or "MRPS") outstanding. See "Prospectus Summary &#8212; Use of Leverage by the Fund" and "Leverage" in the accompanying prospectus for additional information.</ix:footnote>
<ix:footnote id="FN20220929153237904" xml:lang="en-US">"Other Expenses" are based on estimated amounts for the Fund's current fiscal year.</ix:footnote>
<ix:footnote id="FN20220929133313270" xml:lang="en-US">The example includes sales load and estimated offering costs.</ix:footnote>
<ix:footnote id="FN20220929133639594" xml:lang="en-US">Includes interest expense on the borrowings under the SSB Agreement, accrued at interest rates in effect on September 6, 2022 of 3.12%, and dividend expense on the MRP Shares.</ix:footnote>
<ix:footnote id="FN20221001021751665" xml:lang="en-US">Reflects interest expense paid on $9 million in average borrowings under the Fund's Amended and Restated Liquidity Agreement with State Street Bank and Trust Company, plus $34.8 million in additional average structural leverage related to certain securities lending programs, as described in the accompanying prospectus under "Leverage."</ix:footnote>
<ix:nonNumeric name="dei:EntityCentralIndexKey" contextRef="C_20220930to20220930"  id="Fdei_EntityCentralIndexKey20220929104601661" >0001285650</ix:nonNumeric><ix:nonNumeric name="dei:AmendmentFlag" contextRef="C_20220930to20220930"  id="Fdei_AmendmentFlag20220929104606790" >false</ix:nonNumeric><ix:nonNumeric name="dei:DocumentType" contextRef="C_20220930to20220930"  id="Fdei_DocumentType20220929105659401" >424B3</ix:nonNumeric></ix:hidden>
<ix:references>
        <link:schemaRef xlink:type="simple" xlink:href="ck0001285650-20220930.xsd"/>
        </ix:references><ix:resources><xbrli:context id="C_20220930to20220930"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001285650</xbrli:identifier></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-09-30</xbrli:startDate>
        <xbrli:endDate>2022-09-30</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220930to20220930_cefSecurityAxis_ck0001285650MandatoryRedeemablePreferredSharesSeriesBMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001285650</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cef:SecurityAxis">ck0001285650:MandatoryRedeemablePreferredSharesSeriesBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-09-30</xbrli:startDate>
        <xbrli:endDate>2022-09-30</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220930to20220930_cefSecurityAxis_ck0001285650MandatoryRedeemablePreferredSharesSeriesCMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001285650</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cef:SecurityAxis">ck0001285650:MandatoryRedeemablePreferredSharesSeriesCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-09-30</xbrli:startDate>
        <xbrli:endDate>2022-09-30</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220930to20220930_cefSecurityAxis_ck0001285650MandatoryRedeemablePreferredSharesSeriesDMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001285650</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cef:SecurityAxis">ck0001285650:MandatoryRedeemablePreferredSharesSeriesDMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-09-30</xbrli:startDate>
        <xbrli:endDate>2022-09-30</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220930to20220930_cefSecurityAxis_ck0001285650MandatoryRedeemablePreferredSharesSeriesEMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001285650</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cef:SecurityAxis">ck0001285650:MandatoryRedeemablePreferredSharesSeriesEMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-09-30</xbrli:startDate>
        <xbrli:endDate>2022-09-30</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220930to20220930_cefSecurityAxis_ck0001285650CommonSharesMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001285650</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cef:SecurityAxis">ck0001285650:CommonSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-09-30</xbrli:startDate>
        <xbrli:endDate>2022-09-30</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:unit id="Pure"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit>
<xbrli:unit id="Shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit>
<xbrli:unit id="USD"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit>
<ix:relationship fromRefs="Fxbrl_20220929112500797" toRefs="FN20220929132605436"/><ix:relationship fromRefs="Fxbrl_20220929112617176" toRefs="FN20220929132653404"/><ix:relationship fromRefs="Fxbrl_20220929112636853" toRefs="FN20220929132839835"/><ix:relationship fromRefs="Fxbrl_20220929113617094" toRefs="FN20220929132913036"/><ix:relationship fromRefs="Fxbrl_20220929113717521" toRefs="FN20220929172523053"/><ix:relationship fromRefs="Fxbrl_20220929113811453" toRefs="FN20220929153237904"/><ix:relationship fromRefs="Fxbrl_20220929114522735" toRefs="FN20220929133313270"/><ix:relationship fromRefs="Fxbrl_20220929114620465" toRefs="FN20220929133313270"/><ix:relationship fromRefs="Fxbrl_20220929114644347" toRefs="FN20220929133313270"/><ix:relationship fromRefs="Fxbrl_20220929114705250" toRefs="FN20220929133313270"/><ix:relationship fromRefs="Fxbrl_20220929124540326" toRefs="FN20220929133639594"/><ix:relationship fromRefs="Fxbrl_20220929125453107" toRefs="FN20220929133639594"/><ix:relationship fromRefs="Fxbrl_20220929125525365" toRefs="FN20220929133639594"/><ix:relationship fromRefs="Fxbrl_20220929125550342" toRefs="FN20220929133639594"/><ix:relationship fromRefs="Fxbrl_20220929125703335" toRefs="FN20220929133639594"/><ix:relationship fromRefs="Fxbrl_20221001021619972" toRefs="FN20221001021751665"/></ix:resources></ix:header></div><div>
  <p style="text-align:center;margin-top:20pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong><ix:nonNumeric id="Fxbrl_20220929153115609" name="dei:EntityRegistrantName" contextRef="C_20220930to20220930">Calamos Global Total Return Fund</ix:nonNumeric> (the "Fund")<br />Supplement dated September 30, 2022 to the Fund's Prospectus dated March 1, 2021, and as<br />supplemented from time to time and to the Fund's Statement of Information ("SAI") dated<br />March 1, 2021, and as supplemented from time to time</strong></span></span></span></span></p>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center;background-color:white">&#160;</p>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;background-color:white"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong>I. Recent Developments &#8212; Mandatory Redeemable Preferred Shares</strong></span></span></span></span></p>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;background-color:white">&#160;</p>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;background-color:white"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>On September 6, 2022, the Fund redeemed 100% (160,000) of outstanding Series A mandatory redeemable preferred shares ("MRP Shares") with an aggregate liquidation preference totaling </span><span style="color:#231f20">$4,000,000</span>.</span></span></span></span></p>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;background-color:white">&#160;</p>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;background-color:white"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Additional updated information regarding the Fund's MRP Shares is included in the restated disclosures set forth below.</span></span></span></span></p>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;background-color:white">&#160;</p>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;background-color:white"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong>Revised Disclosure Related to MRP Shares</strong></span></span></span></span></p>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;background-color:white">&#160;</p>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;background-color:white"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>In accordance with the above, the Fund's Prospectus, SAI and Prospectus Supplement are hereby amended as follows:</span></span></span></span></p>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;background-color:white">&#160;</p>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;background-color:white"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><i>The section titled "Capitalization" beginning on page SUP-3 of the Prospectus Supplement is deleted in its entirety and replaced with the following:</i></span></span></span></span></p>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;background-color:white">&#160;</p>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center;background-color:white"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong>CAPITALIZATION</strong></span></span></span></span></p>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center;background-color:white">&#160;</p>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;background-color:white"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The Fund may offer and sell up to 898,864 of our common shares, no par value per share, from time to time through the Sub-Placement Agent as sub-placement agent under this prospectus supplement and the accompanying prospectus. There is no guarantee that there will be any sales of our common shares pursuant to this prospectus supplement and the accompanying prospectus. The table below assumes that we will sell 898,864 common shares (the number of common shares remaining to be sold under the current sales agreement as of September 6, 2022) at a price of $11.96 per share (the last reported sale price per share of our common shares on NASDAQ on September 6, 2022).</span></span></span></span></p>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;background-color:white">&#160;</p>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;background-color:white"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The table below shows our historical capitalization as of April 30, 2022 and the estimated capitalization of the Fund assuming the sale of all 898,864 common shares that are subject to the sales agreement at a price of $11.96 per share, the last reported sales price per share of our common shares on a pro forma, as adjusted basis as of September 6, 2022. Actual sales, if any, of the Fund's common shares under this prospectus supplement and accompanying prospectus may be different than as set forth in the table below. In addition, the price per share of any such sale may be greater or less than $11.96 per share, depending on the market price of the Fund's common shares at the time of any such sale and/or the Fund's net asset value ("NAV") for purposes of calculating the Minimum Price. The Fund and the Distributor will determine whether any sales of the Fund's common shares will be authorized on a particular day; the Fund and the Distributor, however, will not authorize sales of the Fund's common shares if the per share price of the shares is less than the Minimum Price. The Fund and the Distributor may elect not to authorize sales of the Fund's common shares on a particular day even if the per share price of the shares is equal to or greater than the Minimum Price, or may only authorize a fixed number of shares to be sold on any particular day. The Fund and the Distributor will have full discretion regarding whether sales of Fund common shares will be authorized on a particular day and, if so, in what amounts.</span></span></span></span></p>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;background-color:white">&#160;</p>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;background-color:white"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The following table sets forth our capitalization:</span></span></span></span></p>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;background-color:white">&#160;</p>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;background-color:white"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>&#8226;</span><span><span>&#160;&#160;on an actual basis as of April 30, 2022; and</span></span></span></span></p>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;background-color:white">&#160;</p>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;background-color:white"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>&#8226;</span>&#160;&#160;on a pro forma as adjusted basis to reflect (1) the assumed sale of 898,864 common shares at $11.96 per share (the last reported sale price of the Fund's common shares on NASDAQ on September 6, 2022), in an <span style="background-color:white">offering under this prospectus supplement and the accompanying prospectus and the issuance of </span>11,511 <span style="background-color:white">of our common shares through the Fund's dividend reinvestment plan, (2) the investment of net proceeds assumed from such offering in accordance with the Fund's investment objective and policies, after deducting the assumed aggregate commission of $107,504 (representing an estimated commission of 1% of the gross sales price in connection with sale of common shares), </span></span><span style="background-color:white">and (3) the redemption of $</span><span style="color:#231f20">4,000,000</span> <span style="background-color:white">of Series A MRP Shares on September 6, 2022.</span></span></span></span></span></p>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;background-color:white">&#160;</p>
  <div style="break-before:page;margin-top:6pt;margin-bottom:12pt">
    <p style="margin:0pt">&#160;</p>
  </div>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;background-color:white">&#160;</p>
  <table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width:100%;font:10pt Times New Roman, Times, Serif">

      <tr style="vertical-align:bottom">
        <td style="font-size:10pt">&#160;</td>
        <td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt">&#160;</td>
        <td colspan="2" style="font:bold 10pt Times New Roman, Times, Serif;text-align:center;border-bottom:Black 1pt solid"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Actual</span></span></span></span></td>
        <td style="padding-bottom:1pt;font:bold 10pt Times New Roman, Times, Serif">&#160;</td>
        <td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt">&#160;</td>
        <td colspan="2" style="font:bold 10pt Times New Roman, Times, Serif;text-align:center;border-bottom:Black 1pt solid"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>As&#160;Adjusted</span></span></span></span></td>
        <td style="padding-bottom:1pt;font:bold 10pt Times New Roman, Times, Serif">&#160;</td>
      </tr>
      <tr style="vertical-align:bottom;background-color:rgb(204,238,255)">
        <td style="width:70%;font:10pt Times New Roman, Times, Serif;padding-left:0.9pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Loans<sup>(1)</sup></span></span></span></span></span></td>
        <td style="width:1%;font:10pt Times New Roman, Times, Serif">&#160;</td>
        <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>$</span></span></span></span></td>
        <td style="width:12%;font:10pt Times New Roman, Times, Serif;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>11,300,000</span></span></span></span></td>
        <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
        <td style="width:1%;font:10pt Times New Roman, Times, Serif">&#160;</td>
        <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>$</span></span></span></span></td>
        <td style="width:12%;font:10pt Times New Roman, Times, Serif;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>1,500,000</span></span></span></span></td>
        <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
      </tr>
      <tr style="vertical-align:bottom;background-color:White">
        <td style="font:10pt Times New Roman, Times, Serif;padding-left:0.9pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Preferred Shares</span></span></span></span></td>
        <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
        <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
        <td style="font:10pt Times New Roman, Times, Serif;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>17,000,000</span></span></span></span></td>
        <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
        <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
        <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
        <td style="font:10pt Times New Roman, Times, Serif;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>17,000,000</span></span></span></span></td>
        <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
      </tr>
      <tr style="vertical-align:bottom;background-color:rgb(204,238,255)">
        <td style="font:10pt Times New Roman, Times, Serif;padding-left:0.9pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Common shares, no par value per share, unlimited shares authorized, 9,515,845 outstanding (actual) and 10,718,918 shares outstanding (as adjusted)</span></span></span></span></td>
        <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
        <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
        <td style="font:10pt Times New Roman, Times, Serif;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>122,486,204</span></span></span></span></td>
        <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
        <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
        <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
        <td style="font:10pt Times New Roman, Times, Serif;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>136,544,999</span></span></span></span></td>
        <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
      </tr>
      <tr style="vertical-align:bottom;background-color:White">
        <td style="font:10pt Times New Roman, Times, Serif;text-align:left;padding-bottom:1pt;padding-left:0.25pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Accumulated distributable earnings (loss)</span></span></span></span></td>
        <td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt">&#160;</td>
        <td style="border-bottom:Black 1pt solid;font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
        <td style="border-bottom:Black 1pt solid;font:10pt Times New Roman, Times, Serif;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(9,469,472</span></span></span></span></td>
        <td style="padding-bottom:1pt;font:10pt Times New Roman, Times, Serif;text-align:left"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)</span></span></span></span></td>
        <td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt">&#160;</td>
        <td style="border-bottom:Black 1pt solid;font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
        <td style="border-bottom:Black 1pt solid;font:10pt Times New Roman, Times, Serif;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(9,469,472</span></span></span></span></td>
        <td style="padding-bottom:1pt;font:10pt Times New Roman, Times, Serif;text-align:left"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)</span></span></span></span></td>
      </tr>
      <tr style="vertical-align:bottom;background-color:rgb(204,238,255)">
        <td style="font:10pt Times New Roman, Times, Serif;text-align:left;padding-bottom:1pt;padding-left:0.9pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Net assets applicable to common shareholders</span></span></span></span></td>
        <td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt">&#160;</td>
        <td style="border-bottom:Black 1pt solid;font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
        <td style="border-bottom:Black 1pt solid;font:10pt Times New Roman, Times, Serif;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>113,016,732</span></span></span></span></td>
        <td style="padding-bottom:1pt;font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
        <td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt">&#160;</td>
        <td style="border-bottom:Black 1pt solid;font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
        <td style="border-bottom:Black 1pt solid;font:10pt Times New Roman, Times, Serif;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>127,075,527</span></span></span></span></td>
        <td style="padding-bottom:1pt;font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
      </tr>
      <tr style="vertical-align:bottom;background-color:White">
        <td style="font:10pt Times New Roman, Times, Serif;text-align:left;padding-bottom:2.5pt;padding-left:0.25pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Total Capitalization</span></span></span></span></td>
        <td style="font:10pt Times New Roman, Times, Serif;padding-bottom:2.5pt">&#160;</td>
        <td style="border-bottom:Black 2.5pt double;font:10pt Times New Roman, Times, Serif;text-align:left"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>$</span></span></span></span></td>
        <td style="border-bottom:Black 2.5pt double;font:10pt Times New Roman, Times, Serif;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>141,016,732</span></span></span></span></td>
        <td style="padding-bottom:2.5pt;font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
        <td style="font:10pt Times New Roman, Times, Serif;padding-bottom:2.5pt">&#160;</td>
        <td style="border-bottom:Black 2.5pt double;font:10pt Times New Roman, Times, Serif;text-align:left"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>$</span></span></span></span></td>
        <td style="border-bottom:Black 2.5pt double;font:10pt Times New Roman, Times, Serif;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>145,575,527</span></span></span></span></td>
        <td style="padding-bottom:2.5pt;font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
      </tr>

  </table>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 8.75pt 0pt 0;text-align:justify">&#160;</p>
  <div style="margin-top:3pt;margin-bottom:3pt;width:25%">
    <div style="font-size:1pt;border-top:Black 1pt solid">&#160;</div>
  </div>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 8.75pt 0pt 0;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><sup>(1) </sup></span>Figures do not reflect additional structural leverage related to certain securities lending programs, which were $39.2 million and $24.5 million as of April 30, 2022 and September 6, 2022, respectively.</span></span></span></span></p>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;background-color:white">&#160;</p>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;background-color:white"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><i>The section titled "Summary of Fund Expenses" beginning on page SUP-4 of the Prospectus Supplement is deleted in its entirety and replaced with the following:</i></span></span></span></span></p>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;background-color:white">&#160;</p>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center;background-color:white"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong>SUMMARY OF FUND EXPENSES</strong></span></span></span></span></p>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center;background-color:white">&#160;</p>
  <ix:nonNumeric id="Fxbrl_20220929130737894" name="cef:PurposeOfFeeTableNoteTextBlock" contextRef="C_20220930to20220930" escape="true">
    <div>
      <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;background-color:white"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The following table and example contain information about the costs and expenses that common shareholders will bear directly or indirectly. In accordance with Commission requirements, the table below shows our expenses, including interest payments on borrowed funds, as a percentage of our average net assets as of September 6, 2022, and not as a percentage of gross assets or managed assets.</span></span></span></span></p>
      <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;background-color:white">&#160;</p>
      <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;background-color:white"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>By showing expenses as a percentage of average net assets, expenses are not expressed as a percentage of all of the assets we invest. The table and example are based on our capital structure as of September 6, 2022. As of September 6, 2022, we had $1.5 million in borrowings outstanding, $17 million in outstanding preferred shares and additional structural leverage of $25 million, collectively representing 30.3% of managed assets as of that date.</span></span></span></span></p>
    </div>
  </ix:nonNumeric>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;background-color:white">&#160;</p>
  <div style="break-before:page;margin-top:6pt;margin-bottom:12pt">
    <p style="margin:0pt">&#160;</p>
  </div>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
  <ix:nonNumeric id="Fxbrl_20220929114119577" name="cef:ShareholderTransactionExpensesTableTextBlock" contextRef="C_20220930to20220930" escape="true">
    <table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width:90%;font:10pt Times New Roman, Times, Serif" width="90%">

        <tr style="vertical-align:bottom">
          <td style="font:bold 10pt Times New Roman, Times, Serif;text-align:justify;border-bottom:Black 1pt solid"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Shareholder Transaction Expenses</span></span></span></span></td>
          <td style="font-size:10pt;padding-bottom:1pt">&#160;</td>
          <td colspan="2" style="font-size:10pt;text-align:justify">&#160;</td>
          <td style="padding-bottom:1pt;font-size:10pt">&#160;</td>
          <td style="padding-bottom:1pt;font-size:10pt">&#160;</td>
        </tr>
        <tr style="vertical-align:bottom;background-color:rgb(204,238,255)">
          <td style="font:10pt Times New Roman, Times, serif;text-align:justify;width:78%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Sales Load (<ix:nonNumeric id="Fxbrl_20220929113312049" name="cef:BasisOfTransactionFeesNoteTextBlock" contextRef="C_20220930to20220930" escape="true"><span style="font:10pt Times New Roman, Times, serif">as a percentage of offering price</span></ix:nonNumeric>)</span></span></span></span></td>
          <td style="font:10pt Times New Roman, Times, serif;width:1%">&#160;</td>
          <td style="font:10pt Times New Roman, Times, serif;text-align:left;width:1%">&#160;</td>
          <td style="font:10pt Times New Roman, Times, serif;text-align:right;width:18%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20220929112500797" name="cef:SalesLoadPercent" contextRef="C_20220930to20220930" unitRef="Pure" scale="-2" decimals="4" format="ixt:num-dot-decimal">1.00</ix:nonFraction></span></span></span></span></td>
          <td style="font:10pt Times New Roman, Times, serif;text-align:left;width:1%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>%</span></span></span></span></td>
          <td style="font:10pt Times New Roman, Times, serif;text-align:left;width:1%">
            <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Times New Roman, Times, serif"><sup>(1)</sup></span></p>
          </td>
        </tr>
        <tr style="vertical-align:bottom;background-color:White">
          <td style="font:10pt Times New Roman, Times, serif;text-align:justify;width:78%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Offering Expenses Borne by the Fund (<ix:nonNumeric id="Fxbrl_20220929113430396" name="cef:BasisOfTransactionFeesNoteTextBlock" contextRef="C_20220930to20220930" escape="true"><span style="font:10pt Times New Roman, Times, serif">as a percentage of offering price</span></ix:nonNumeric>)</span></span></span></span></td>
          <td style="font:10pt Times New Roman, Times, serif;width:1%">&#160;</td>
          <td style="font:10pt Times New Roman, Times, serif;text-align:left;width:1%">&#160;</td>
          <td style="font:10pt Times New Roman, Times, serif;text-align:right;width:18%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20220929112617176" name="cef:OtherTransactionExpensesPercent" contextRef="C_20220930to20220930" unitRef="Pure" scale="-2" decimals="2" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></span></span></span></td>
          <td style="font:10pt Times New Roman, Times, serif;text-align:left;width:1%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>%</span></span></span></span></td>
          <td style="font:10pt Times New Roman, Times, serif;text-align:left;width:1%">
            <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Times New Roman, Times, serif"><sup>(2)</sup></span></p>
          </td>
        </tr>
        <tr style="vertical-align:bottom;background-color:rgb(204,238,255)">
          <td style="font:10pt Times New Roman, Times, serif;text-align:justify;width:78%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Dividend Reinvestment Plan Fees (per sales transaction fee)<sup>(3)</sup></span></span></span></span></span></td>
          <td style="font:10pt Times New Roman, Times, serif;width:1%">&#160;</td>
          <td style="font:10pt Times New Roman, Times, serif;text-align:left;width:1%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>$</span></span></span></span></td>
          <td style="font:10pt Times New Roman, Times, serif;text-align:right;width:18%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20220929112636853" name="cef:DividendReinvestmentAndCashPurchaseFees" contextRef="C_20220930to20220930" unitRef="USD" scale="0" decimals="2" format="ixt:num-dot-decimal">15.00</ix:nonFraction></span></span></span></span></td>
          <td style="font:10pt Times New Roman, Times, serif;text-align:left;width:1%">&#160;</td>
          <td style="font:10pt Times New Roman, Times, serif;text-align:left;width:1%">&#160;</td>
        </tr>

    </table>
  </ix:nonNumeric>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify">&#160;</p>
  <ix:nonNumeric id="Fxbrl_20220929114148337" name="cef:AnnualExpensesTableTextBlock" contextRef="C_20220930to20220930" escape="true">
    <table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width:90%;font:10pt Times New Roman, Times, Serif">

        <tr style="vertical-align:bottom">
          <td style="white-space:nowrap;font:bold 10pt Times New Roman, Times, Serif;text-align:justify;border-bottom:Black 1pt solid"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Annual Expenses</span></span></span></span></td>
          <td style="white-space:nowrap;font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt">&#160;</td>
          <td colspan="2" style="white-space:nowrap;font:bold 10pt Times New Roman, Times, Serif;text-align:center;border-bottom:Black 1pt solid"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Percentage&#160;of&#160;Average Net<br />Assets Attributable to<br />Common Shareholders</span></span></span></span></td>
          <td style="white-space:nowrap;padding-bottom:1pt;font:bold 10pt Times New Roman, Times, Serif">&#160;</td>
        </tr>
        <tr style="vertical-align:bottom;background-color:rgb(204,238,255)">
          <td style="width:79%;font:10pt Times New Roman, Times, Serif;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Management Fee<sup>(4)</sup></span></span></span></span></span></td>
          <td style="width:1%;font:10pt Times New Roman, Times, Serif">&#160;</td>
          <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
          <td style="width:18%;font:10pt Times New Roman, Times, Serif;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><ix:nonFraction id="Fxbrl_20220929113617094" name="cef:ManagementFeesPercent" contextRef="C_20220930to20220930" unitRef="Pure" scale="-2" decimals="4" format="ixt:num-dot-decimal">1.51</ix:nonFraction></span></span></span></span></span></td>
          <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>%</span></span></span></span></span></td>
        </tr>
        <tr style="vertical-align:bottom;background-color:White">
          <td style="font:10pt Times New Roman, Times, Serif;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Interest Payments on Borrowed Funds<sup>(5)</sup></span></span></span></span></span></td>
          <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
          <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
          <td style="font:10pt Times New Roman, Times, Serif;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><ix:nonFraction id="Fxbrl_20221001021619972" name="cef:InterestExpensesOnBorrowingsPercent" contextRef="C_20220930to20220930" unitRef="Pure" scale="-2" decimals="4" format="ixt:num-dot-decimal">0.35</ix:nonFraction></span></span></span></span></span></td>
          <td style="font:10pt Times New Roman, Times, Serif;text-align:left"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>%</span></span></span></span></span></td>
        </tr>
        <tr style="vertical-align:bottom;background-color:rgb(204,238,255)">
          <td style="font:10pt Times New Roman, Times, Serif;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Preferred Stock Dividend Payments<sup>(6)</sup></span></span></span></span></span></td>
          <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
          <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
          <td style="font:10pt Times New Roman, Times, Serif;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><ix:nonFraction id="Fxbrl_20220929113717521" name="cef:DividendExpenseOnPreferredSharesPercent" contextRef="C_20220930to20220930" unitRef="Pure" scale="-2" decimals="4" format="ixt:num-dot-decimal">0.55</ix:nonFraction></span></span></span></span></span></td>
          <td style="font:10pt Times New Roman, Times, Serif;text-align:left">%</td>
        </tr>
        <tr style="vertical-align:bottom;background-color:White">
          <td style="font:10pt Times New Roman, Times, Serif;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Other Expenses<sup>(7)</sup></span></span></span></span></span></td>
          <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
          <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
          <td style="font:10pt Times New Roman, Times, Serif;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><ix:nonFraction id="Fxbrl_20220929113811453" name="cef:OtherAnnualExpensesPercent" contextRef="C_20220930to20220930" unitRef="Pure" scale="-2" decimals="4" format="ixt:num-dot-decimal">0.32</ix:nonFraction></span></span></span></span></span></td>
          <td style="font:10pt Times New Roman, Times, Serif;text-align:left"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>%</span></span></span></span></span></td>
        </tr>
        <tr style="vertical-align:bottom;background-color:rgb(204,238,255)">
          <td style="font:10pt Times New Roman, Times, Serif;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Total Annual Expenses</span></span></span></span></td>
          <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
          <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
          <td style="font:10pt Times New Roman, Times, Serif;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><ix:nonFraction id="Fxbrl_20220929113907282" name="cef:TotalAnnualExpensesPercent" contextRef="C_20220930to20220930" unitRef="Pure" scale="-2" decimals="4" format="ixt:num-dot-decimal">2.73</ix:nonFraction></span></span></span></span></span></td>
          <td style="font:10pt Times New Roman, Times, Serif;text-align:left"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>%</span></span></span></span></span></td>
        </tr>

    </table>
  </ix:nonNumeric>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify">&#160;</p>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;background-color:white"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong>Example:</strong></span></span></span></span></p>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;background-color:white">&#160;</p>
  <ix:nonNumeric id="Fxbrl_20221001021123702" name="cef:ExpenseExampleTableTextBlock" contextRef="C_20220930to20220930" escape="true">
    <div>
      <div>
        <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;background-color:white"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The following example illustrates the expenses that common shareholders would pay on a $1,000 investment in common shares, assuming (1) net annual expenses of 2.73% of net assets attributable to common shareholders; (2) a 5% annual gross return; and (3) all distributions are reinvested at net asset value:</span></span></span></span></p>
        <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;background-color:white">&#160;</p>
        <table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width:100%;font:10pt Times New Roman, Times, Serif">

            <tr style="vertical-align:bottom">
              <td style="font-size:10pt;text-align:center">&#160;</td>
              <td style="text-align:center;font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt">&#160;</td>
              <td colspan="2" style="border-bottom:Black 1pt solid;font:bold 10pt Times New Roman, Times, Serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>1 Year</span></span></span></span></td>
              <td style="text-align:center;padding-bottom:1pt;font:bold 10pt Times New Roman, Times, Serif">&#160;</td>
              <td style="text-align:center;font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt">&#160;</td>
              <td colspan="2" style="border-bottom:Black 1pt solid;font:bold 10pt Times New Roman, Times, Serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>3 Years</span></span></span></span></td>
              <td style="text-align:center;padding-bottom:1pt;font:bold 10pt Times New Roman, Times, Serif">&#160;</td>
              <td style="text-align:center;font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt">&#160;</td>
              <td colspan="2" style="border-bottom:Black 1pt solid;font:bold 10pt Times New Roman, Times, Serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>5 Years</span></span></span></span></td>
              <td style="text-align:center;padding-bottom:1pt;font:bold 10pt Times New Roman, Times, Serif">&#160;</td>
              <td style="text-align:center;font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt">&#160;</td>
              <td colspan="2" style="border-bottom:Black 1pt solid;font:bold 10pt Times New Roman, Times, Serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>10 Years</span></span></span></span></td>
              <td style="text-align:center;padding-bottom:1pt;font:bold 10pt Times New Roman, Times, Serif">&#160;</td>
            </tr>
            <tr style="vertical-align:bottom;background-color:rgb(204,238,255)">
              <td style="width:48%;font:10pt Times New Roman, Times, Serif;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Total Expenses Paid by Common Shareholders<sup>(8)</sup></span></span></span></span></span></td>
              <td style="width:1%;font:10pt Times New Roman, Times, Serif">&#160;</td>
              <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>$</span></span></span></span></td>
              <td style="width:10%;font:10pt Times New Roman, Times, Serif;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20220929114522735" name="cef:ExpenseExampleYear01" contextRef="C_20220930to20220930" unitRef="USD" scale="0" decimals="0" format="ixt:num-dot-decimal">37</ix:nonFraction></span></span></span></span></td>
              <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
              <td style="width:1%;font:10pt Times New Roman, Times, Serif">&#160;</td>
              <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>$</span></span></span></span></td>
              <td style="width:10%;font:10pt Times New Roman, Times, Serif;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20220929114620465" name="cef:ExpenseExampleYears1to3" contextRef="C_20220930to20220930" unitRef="USD" scale="0" decimals="0" format="ixt:num-dot-decimal">94</ix:nonFraction></span></span></span></span></td>
              <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
              <td style="width:1%;font:10pt Times New Roman, Times, Serif">&#160;</td>
              <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>$</span></span></span></span></td>
              <td style="width:10%;font:10pt Times New Roman, Times, Serif;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20220929114644347" name="cef:ExpenseExampleYears1to5" contextRef="C_20220930to20220930" unitRef="USD" scale="0" decimals="0" format="ixt:num-dot-decimal">153</ix:nonFraction></span></span></span></span></td>
              <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
              <td style="width:1%;font:10pt Times New Roman, Times, Serif">&#160;</td>
              <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>$</span></span></span></span></td>
              <td style="width:10%;font:10pt Times New Roman, Times, Serif;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20220929114705250" name="cef:ExpenseExampleYears1to10" contextRef="C_20220930to20220930" unitRef="USD" scale="0" decimals="0" format="ixt:num-dot-decimal">313</ix:nonFraction></span></span></span></span></td>
              <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
            </tr>

        </table>
      </div>
      <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;background-color:white">&#160;</p>
      <div style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;background-color:white"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong>The example should not be considered a representation of future expenses. Actual expenses may be greater or less than those assumed. Moreover, our actual rate of return may be greater or less than the hypothetical 5% return shown in the example.</strong></span></span></span></span></div>
    </div>
  </ix:nonNumeric>
  <div style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;background-color:white">&#160;</div>
  <div style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;background-color:white"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(1)&#160;&#160;Represents the estimated commission with respect to the Fund's common shares being sold in this offering. There is no guarantee that there will be any sales of the Fund's common shares pursuant to this prospectus supplement and the accompanying prospectus. Actual sales of the Fund's common shares under this prospectus supplement and the accompanying prospectus, if any, may be less than as set forth under "Capitalization" above. In addition, the price per share of any such sale may be greater or less than the price set forth under "Capitalization" above, depending on the market price of the Fund's common shares at the time of any such sale.&#160;</span></span></span></span></div>
  <div style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;background-color:white"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(2)&#160;&#160;<span style="background-color:white">Calamos will pay the expenses of the offering (other than the applicable commissions). However, on a one year lag Calamos may recapture from the Fund previously paid offering expenses at a rate of $6,500 for each $1 million on sales (net of commissions) up to the lesser of $200,000 or actual costs. The Fund would accrue the costs over the following fiscal year. As of the date of this prospectus supplement and the accompanying prospectus, Calamos will pay all of the expenses associated with the offering (other than the applicable commissions). If the recapture provision is triggered in the future, such expenses that will be borne by Fund shareholders will be set forth in the "Shareholder Transaction Expenses" table above.&#160;</span></span></span></span></span></div>
  <div style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;background-color:white"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(3)&#160;&#160;Shareholders will pay a $15.00 transaction fee plus a $0.02 per share brokerage charge if they direct Computershare Shareowner Services LLC (the "Plan Agent") to sell common shares held in a Plan account. In addition, each participant will pay a pro rata share of brokerage commissions incurred with respect to the Plan Agent's open-market purchases in connection with the reinvestment of dividends or distributions. If a participant elects to have the Plan Agent sell part or all of his or her common shares and remit the proceeds, such participant will be charged his or her pro rata share of brokerage commissions on the shares sold. See "Dividends and Distributions on Common Shares; Automatic Dividend Reinvestment Plan" on page 77 of the accompanying prospectus.&#160;</span></span></span></span></div>
  <div style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;background-color:white"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(4)&#160;&#160;</span></span></span></span>
    <ix:nonNumeric id="Fxbrl_20220929114954484" name="cef:ManagementFeeNotBasedOnNetAssetsNoteTextBlock" contextRef="C_20220930to20220930" escape="true"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The Fund pays Calamos an annual management fee, payable monthly in arrears, for its investment management services in an amount equal to 1.00% of the Fund's average weekly managed assets. In accordance with the requirements of the Commission, the table above shows the Fund's management fee as a percentage of average net assets attributable to common shareholders. By showing the management fee as a percentage of net assets, the management fee is not expressed as a percentage of all of the assets the Fund intends to invest. For purposes of the table, the management fee has been converted to 1.51% of the Fund's average weekly net assets as of September 6, 2022 by dividing the total dollar amount of the management fee by the Fund's average weekly net assets (managed assets less outstanding leverage).</span></span></span></span></ix:nonNumeric>
  </div>
  <div style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;background-color:white">&#160;</div>
  <div style="break-before:page;margin-top:6pt;margin-bottom:12pt">
    <div style="margin:0pt">&#160;</div>
  </div>
  <div style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;background-color:white">&#160;</div>
  <div style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;background-color:white"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(5)&#160;&#160;Reflects interest expense paid on $9 million in average borrowings under the Fund's Amended and Restated Liquidity Agreement with State Street Bank and Trust Company, plus $34.8 million in additional average structural leverage related to certain securities lending programs, as described in the accompanying prospectus under "Leverage."&#160;</span></span></span></span></div>
  <div style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;background-color:white"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(6)&#160;&#160;Reflects estimated dividend expense on $17 million aggregate liquidation preference of mandatory redeemable preferred shares ("MRP Shares" or "MRPS") outstanding. See "Prospectus Summary </span></span></span></span>&#8212;<span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span> Use of Leverage by the Fund" and "Leverage" in the accompanying prospectus for additional information.&#160;</span></span></span></span></div>
  <div style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;background-color:white"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(7)&#160;&#160;"Other Expenses" are based on estimated amounts for the Fund's current fiscal year.&#160;</span></span></span></span></div>
  <div style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;background-color:white"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(8)&#160;&#160;The example includes sales load and estimated offering costs.</span></span></span></span></div>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;background-color:white">&#160;</p>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;background-color:white"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><i>The third, fourth and fifth sentences of the first paragraph of the section titled "Prospectus Summary &#8212; The Fund" beginning on page 1 of the Prospectus are deleted in their entirety and replaced with the following:</i></span></span></span></span></p>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;background-color:white">&#160;</p>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;background-color:white"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>As of September 6, 2022, we had $142 million of total managed assets, including $17 million of outstanding mandatory redeemable preferred shares ("MRP Shares" or "MRPS"). As of September 6, 2022 the Fund had utilized $26 million of the $55 million available under the Amended and Restated Liquidity Agreement (the "SSB Agreement") with State Street Bank and Trust Company ("SSB" or "State Street") ($1.5 million in borrowings outstanding, and $24.5 million in structural leverage consisting of collateral received from SSB in connection with securities on loan), representing 18.3% of the Fund's managed assets as of that date, and had $17 million of MRP Shares outstanding, representing 12.0% of the Fund's managed assets. Combined, the borrowings under the SSB Agreement and the outstanding MRP Shares represented 30.3% of the Fund's managed assets.</span></span></span></span></p>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;background-color:white">&#160;</p>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;background-color:white"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><i>The first two paragraphs of the section titled "Use of Leverage by the Fund" beginning on page 6 of the Prospectus are deleted in their entirety and replaced with the following:</i></span></span></span></span></p>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;background-color:white">&#160;</p>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;background-color:white"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong>Use of Leverage by the Fund</strong></span></span></span></span></p>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;background-color:white">&#160;</p>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;background-color:white"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The Fund currently uses, and may in the future use, financial leverage. The Fund has obtained financial leverage (i) under the SSB Agreement that allows the Fund to borrow up to $55 million and (ii) through the issuance of four series of MRP Shares with an aggregate liquidation preference of $17 million, as described in greater detail below. The SSB Agreement provides for securities lending and securities repurchase transactions that may offset some of the interest rate payments that would otherwise be due in respect of the borrowings under the SSB Agreement. The Fund's outstanding MRP Shares include 160,000 Series B MRP Shares, with an aggregate liquidation preference of $4.0 million and a mandatory redemption date of September 6, 2024; and 160,000 Series C MRP Shares, with an aggregate liquidation preference of $4.0 million and a mandatory redemption date of September 6, 2027; 200,000 Series&#160;D MRP Shares, with an aggregate liquidation preference of $5.0 million and a mandatory redemption date of August&#160;24, 2026; and 160,000 Series&#160;E MRP Shares, with an aggregate liquidation preference of $4.0 million and a mandatory redemption date of May&#160;24, 2027. The Series&#160;B, Series&#160;C, Series&#160;D and Series&#160;E MRP Shares are to pay monthly cash dividends initially at rates of 4.00%, 4.24%, 2.45% and 2.68%, respectively, subject to adjustment under certain circumstances. Additional details regarding the SSB Agreement and the MRP Shares are included under "Leverage.&#8221;</span></span></span></span></p>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;background-color:white">&#160;</p>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;background-color:white"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>As of September 6, 2022, the Fund had utilized $26 million of the $55 million available under the SSB Agreement ($1.5 million in borrowings outstanding, and $24.5 million in structural leverage consisting of collateral received from SSB in connection with securities on loan), representing 18.3% of the Fund's managed assets as of that date, and had $17 million of MRP Shares outstanding, representing 12.0% of the Fund's managed assets. Combined, the borrowings under the SSB Agreement and the outstanding MRP Shares represented 30.3% of the Fund's managed assets.</span></span></span></span></p>
  <div style="margin-top:0pt;margin-bottom:6pt">&#160;</div>
  <div style="break-before:page;margin-top:6pt;margin-bottom:12pt">
    <p style="margin:0pt">&#160;</p>
  </div>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;background-color:white">&#160;</p>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;background-color:white"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><i>The second and third paragraphs of the section titled "The Fund" beginning on page 29 of the Prospectus is deleted in its entirety and replaced with the following:</i></span></span></span></span></p>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;background-color:white">&#160;</p>
  <div style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;background-color:white"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>As of September 6, 2022, the Fund had utilized $26 million of the $55 million available under the SSB Agreement ($1.5 million in borrowings outstanding, and $24.5 million in structural leverage consisting of collateral received from SSB in connection with securities on loan), representing 18.3% of the Fund's managed assets as of that date, and had $17 million of MRP Shares outstanding, representing 12.0% of the Fund's managed assets. Combined, the borrowings under the SSB Agreement and the outstanding MRP Shares represented 30.3% of the Fund's managed assets. Structural leverage refers to borrowings under the SSB Agreement in respect of which the Fund's interest payments are reduced or eliminated by the Fund's securities lending activities. See "Leverage." The Fund's common shares are listed on Nasdaq under the symbol "CHI." The Fund's principal office is located at 2020 Calamos Court, Naperville,&#160;Illinois 60563, and its telephone number is 800-582-6959.</span></span></span></span></div>
  <div style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;background-color:white">&#160;</div>
  <ix:nonNumeric id="Fxbrl_20220929131822607" name="cef:OutstandingSecuritiesTableTextBlock" contextRef="C_20220930to20220930" escape="true">
    <div>
      <div style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The following table provides information about our outstanding securities as of September 6, 2022:</span></span></span></span></div>
      <div style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;background-color:white">&#160;</div>
      <table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width:80%;font:10pt Times New Roman, Times, Serif;margin:auto">

          <tr style="vertical-align:bottom">
            <td style="white-space:nowrap;font:bold 10pt Times New Roman, Times, Serif;border-bottom:Black 1pt solid"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Title of Class</span></span></span></span></td>
            <td style="white-space:nowrap;font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt">&#160;</td>
            <td colspan="2" style="white-space:nowrap;font:bold 10pt Times New Roman, Times, Serif;text-align:center;border-bottom:Black 1pt solid"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Amount Authorized</span></span></span></span></td>
            <td style="white-space:nowrap;padding-bottom:1pt;font:bold 10pt Times New Roman, Times, Serif">&#160;</td>
            <td style="white-space:nowrap;font:10pt Times New Roman, Times, Serif;padding-bottom:1pt">&#160;</td>
            <td colspan="2" style="white-space:nowrap;font:10pt Times New Roman, Times, Serif;text-align:center;border-bottom:Black 1pt solid">
              <div style="font:10pt Times New Roman, Times, Serif;margin:0pt 0 0pt 0.9pt;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong>Amount Held by the </strong></span></span></span></span></div>
              <div style="font:10pt Times New Roman, Times, Serif;margin:0pt 0 0pt 0.9pt;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong>Fund for its Account</strong></span></span></span></span></div>
            </td>
            <td style="white-space:nowrap;padding-bottom:1pt;font:10pt Times New Roman, Times, Serif">&#160;</td>
            <td style="white-space:nowrap;font:10pt Times New Roman, Times, Serif;padding-bottom:1pt">&#160;</td>
            <td colspan="2" style="white-space:nowrap;font:10pt Times New Roman, Times, Serif;text-align:center;border-bottom:Black 1pt solid">
              <div style="font:10pt Times New Roman, Times, Serif;margin:0pt 0 0pt 0.9pt;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong>Amount </strong></span></span></span></span></div>
              <div style="font:10pt Times New Roman, Times, Serif;margin:0pt 0 0pt 0.9pt;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong>Outstanding</strong></span></span></span></span></div>
            </td>
            <td style="white-space:nowrap;padding-bottom:1pt;font:10pt Times New Roman, Times, Serif">&#160;</td>
          </tr>
          <tr style="vertical-align:bottom;background-color:rgb(204,238,255)">
            <td style="width:55%;font:10pt Times New Roman, Times, Serif;padding-left:0.9pt"><span style="font-size:10pt"><span><span><ix:nonNumeric id="Fxbrl_20220929131304038" name="cef:OutstandingSecurityTitleTextBlock" contextRef="C_20220930to20220930_cefSecurityAxis_ck0001285650CommonSharesMember" escape="true"><span style="font:10pt Times New Roman, Times, serif">Common Shares</span></ix:nonNumeric></span></span></span></td>
            <td style="width:1%;font:10pt Times New Roman, Times, Serif">&#160;</td>
            <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
            <td style="width:12%;font:10pt Times New Roman, Times, Serif;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Unlimited</span></span></span></span></span></td>
            <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
            <td style="width:1%;font:10pt Times New Roman, Times, Serif">&#160;</td>
            <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
            <td style="width:12%;font:10pt Times New Roman, Times, Serif;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20220929121333381" name="cef:OutstandingSecurityHeldShares" contextRef="C_20220930to20220930_cefSecurityAxis_ck0001285650CommonSharesMember" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal">9,812,054</ix:nonFraction></span></span></span></span></td>
            <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
            <td style="width:1%;font:10pt Times New Roman, Times, Serif">&#160;</td>
            <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
            <td style="width:12%;font:10pt Times New Roman, Times, Serif;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20220929121344952" name="cef:OutstandingSecurityNotHeldShares" contextRef="C_20220930to20220930_cefSecurityAxis_ck0001285650CommonSharesMember" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal">10,710,918</ix:nonFraction></span></span></span></span></td>
            <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
          </tr>
          <tr style="vertical-align:bottom;background-color:White">
            <td style="font:10pt Times New Roman, Times, Serif;text-align:left;padding-left:0.25pt"><span style="font-size:10pt"><span><span><ix:nonNumeric id="Fxbrl_20220929131350718" name="cef:OutstandingSecurityTitleTextBlock" contextRef="C_20220930to20220930_cefSecurityAxis_ck0001285650MandatoryRedeemablePreferredSharesSeriesBMember" escape="true"><span style="font:10pt Times New Roman, Times, serif">MRPS-Series B</span></ix:nonNumeric></span></span></span></td>
            <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
            <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
            <td style="font:10pt Times New Roman, Times, Serif;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20220929121047001" name="cef:OutstandingSecurityAuthorizedShares" contextRef="C_20220930to20220930_cefSecurityAxis_ck0001285650MandatoryRedeemablePreferredSharesSeriesBMember" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal">160,000</ix:nonFraction></span></span></span></span></td>
            <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
            <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
            <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
            <td style="font:10pt Times New Roman, Times, Serif;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20220929121149545" name="cef:OutstandingSecurityHeldShares" contextRef="C_20220930to20220930_cefSecurityAxis_ck0001285650MandatoryRedeemablePreferredSharesSeriesBMember" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal">0</ix:nonFraction></span></span></span></span></td>
            <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
            <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
            <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
            <td style="font:10pt Times New Roman, Times, Serif;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20220929121217818" name="cef:OutstandingSecurityNotHeldShares" contextRef="C_20220930to20220930_cefSecurityAxis_ck0001285650MandatoryRedeemablePreferredSharesSeriesBMember" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal">160,000</ix:nonFraction></span></span></span></span></td>
            <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
          </tr>
          <tr style="vertical-align:bottom;background-color:rgb(204,238,255)">
            <td style="font:10pt Times New Roman, Times, Serif;text-align:left;padding-left:0.9pt"><span style="font-size:10pt"><span><span><ix:nonNumeric id="Fxbrl_20220929131420207" name="cef:OutstandingSecurityTitleTextBlock" contextRef="C_20220930to20220930_cefSecurityAxis_ck0001285650MandatoryRedeemablePreferredSharesSeriesCMember" escape="true"><span style="font:10pt Times New Roman, Times, serif">MRPS-Series C</span></ix:nonNumeric></span></span></span></td>
            <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
            <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
            <td style="font:10pt Times New Roman, Times, Serif;text-align:right"><ix:nonFraction id="Fxbrl_20220929121245938_3_3" name="cef:OutstandingSecurityAuthorizedShares" contextRef="C_20220930to20220930_cefSecurityAxis_ck0001285650MandatoryRedeemablePreferredSharesSeriesCMember" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal">160,000</ix:nonFraction></td>
            <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
            <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
            <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
            <td style="font:10pt Times New Roman, Times, Serif;text-align:right"><ix:nonFraction id="Fxbrl_20220929121245938_7_3" name="cef:OutstandingSecurityHeldShares" contextRef="C_20220930to20220930_cefSecurityAxis_ck0001285650MandatoryRedeemablePreferredSharesSeriesCMember" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal">0</ix:nonFraction></td>
            <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
            <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
            <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
            <td style="font:10pt Times New Roman, Times, Serif;text-align:right"><ix:nonFraction id="Fxbrl_20220929121245938_11_3" name="cef:OutstandingSecurityNotHeldShares" contextRef="C_20220930to20220930_cefSecurityAxis_ck0001285650MandatoryRedeemablePreferredSharesSeriesCMember" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal">160,000</ix:nonFraction></td>
            <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
          </tr>
          <tr style="vertical-align:bottom;background-color:White">
            <td style="font:10pt Times New Roman, Times, Serif;text-align:left;padding-left:0.9pt"><span style="font-size:10pt"><span><span><ix:nonNumeric id="Fxbrl_20220929131444270" name="cef:OutstandingSecurityTitleTextBlock" contextRef="C_20220930to20220930_cefSecurityAxis_ck0001285650MandatoryRedeemablePreferredSharesSeriesDMember" escape="true"><span style="font:10pt Times New Roman, Times, serif">MRPS-Series D</span></ix:nonNumeric></span></span></span></td>
            <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
            <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
            <td style="font:10pt Times New Roman, Times, Serif;text-align:right"><ix:nonFraction id="Fxbrl_20220929121245938_3_4" name="cef:OutstandingSecurityAuthorizedShares" contextRef="C_20220930to20220930_cefSecurityAxis_ck0001285650MandatoryRedeemablePreferredSharesSeriesDMember" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal">200,000</ix:nonFraction></td>
            <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
            <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
            <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
            <td style="font:10pt Times New Roman, Times, Serif;text-align:right"><ix:nonFraction id="Fxbrl_20220929121245938_7_4" name="cef:OutstandingSecurityHeldShares" contextRef="C_20220930to20220930_cefSecurityAxis_ck0001285650MandatoryRedeemablePreferredSharesSeriesDMember" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal">0</ix:nonFraction></td>
            <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
            <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
            <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
            <td style="font:10pt Times New Roman, Times, Serif;text-align:right"><ix:nonFraction id="Fxbrl_20220929121245938_11_4" name="cef:OutstandingSecurityNotHeldShares" contextRef="C_20220930to20220930_cefSecurityAxis_ck0001285650MandatoryRedeemablePreferredSharesSeriesDMember" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal">200,000</ix:nonFraction></td>
            <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
          </tr>
          <tr style="vertical-align:bottom;background-color:rgb(204,238,255)">
            <td style="font:10pt Times New Roman, Times, Serif;text-align:left;padding-left:0.9pt"><span style="font-size:10pt"><span><span><ix:nonNumeric id="Fxbrl_20220929131525264" name="cef:OutstandingSecurityTitleTextBlock" contextRef="C_20220930to20220930_cefSecurityAxis_ck0001285650MandatoryRedeemablePreferredSharesSeriesEMember" escape="true"><span style="font:10pt Times New Roman, Times, serif">MRPS-Series E</span></ix:nonNumeric></span></span></span></td>
            <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
            <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
            <td style="font:10pt Times New Roman, Times, Serif;text-align:right"><ix:nonFraction id="Fxbrl_20220929121245938_3_5" name="cef:OutstandingSecurityAuthorizedShares" contextRef="C_20220930to20220930_cefSecurityAxis_ck0001285650MandatoryRedeemablePreferredSharesSeriesEMember" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal">160,000</ix:nonFraction></td>
            <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
            <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
            <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
            <td style="font:10pt Times New Roman, Times, Serif;text-align:right"><ix:nonFraction id="Fxbrl_20220929121245938_7_5" name="cef:OutstandingSecurityHeldShares" contextRef="C_20220930to20220930_cefSecurityAxis_ck0001285650MandatoryRedeemablePreferredSharesSeriesEMember" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal">0</ix:nonFraction></td>
            <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
            <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
            <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
            <td style="font:10pt Times New Roman, Times, Serif;text-align:right"><ix:nonFraction id="Fxbrl_20220929121245938_11_5" name="cef:OutstandingSecurityNotHeldShares" contextRef="C_20220930to20220930_cefSecurityAxis_ck0001285650MandatoryRedeemablePreferredSharesSeriesEMember" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal">160,000</ix:nonFraction></td>
            <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
          </tr>

      </table>
    </div>
  </ix:nonNumeric>
  <div style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;background-color:white">&#160;</div>
  <div style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;background-color:white"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><i>The first paragraph in the section titled "Leverage" beginning on page 38 of the Prospectus is deleted in its entirety and replaced with the following:</i></span></span></span></span></div>
  <div style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;background-color:white">&#160;</div>
  <div style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;background-color:white"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The Fund may issue preferred shares or debt securities or borrow to increase its assets available for investment. As of September 6, 2022, the Fund had $26 million in borrowings outstanding under the SSB Agreement, MRP Shares outstanding with an aggregate liquidation preference of $17 million and used approximately $1.5 million of collateral obtained through securities lending arrangements as an offset against borrowings under the SSB Agreement, for a total of $43 million of leverage representing 30.3% of managed assets as of that date. The SSB Agreement provides for additional credit availability for the Fund, such that it may borrow up to $55 million. Additional information regarding the Fund's preferred shares is included below under "Mandatory Redeemable Preferred Shares."</span></span></span></span></div>
  <div style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;background-color:white">&#160;</div>
  <div style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;background-color:white"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><i>The section titled "Mandatory Redeemable Preferred Shares" beginning on page 40 of the Prospectus is deleted in its entirety and replaced with the following:</i></span></span></span></span></div>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;background-color:white">&#160;</p>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;background-color:white"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong>Mandatory Redeemable Preferred Shares</strong></span></span></span></span></p>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;background-color:white">&#160;</p>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;background-color:white"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>On September&#160;6, 2017, the Fund completed a private placement of 160,000 Series&#160;B MRP Shares and 160,000 Series&#160;C MRP Shares. On August&#160;24, 2021, the Fund completed a private placement of 200,000 Series&#160;D MRP Shares and 160,000 Series&#160;E MRP Shares.&#160;Each MRP Share has a liquidation preference of $25.00, resulting in an aggregate liquidation preference of $17 million for all MRP Shares.</span></span></span></span></p>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;background-color:white">&#160;</p>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;background-color:white"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The holders of MRP Shares for the Fund ("MRP Shareholders") are entitled to receive monthly cash dividends, payable on the first business day (a "Dividend Payment Date") of each month following issuance.</span></span></span></span></p>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;background-color:white">&#160;</p>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;background-color:white"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Subject to adjustment as described below under "MRP Shares Dividends," the dividend rate per annum (the "Applicable Rate") for each class of MRP Share is as follows:</span></span></span></span></p>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;background-color:white">&#160;</p>
  <table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width:70%;font:10pt Times New Roman, Times, Serif;margin:auto">

      <tr style="vertical-align:bottom">
        <td style="border-bottom:Black 1pt solid;font:bold 10pt Times New Roman, Times, Serif;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>MRP Shares</span></span></span></span></td>
        <td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt">&#160;</td>
        <td colspan="2" style="border-bottom:Black 1pt solid;font:bold 10pt Times New Roman, Times, Serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Applicable Rate</span></span></span></span></td>
        <td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt">&#160;</td>
      </tr>
      <tr style="vertical-align:bottom;background-color:rgb(204,238,255)">
        <td style="font:10pt Times New Roman, Times, Serif;width:82%;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Series B MRP Shares</span></span></span></span></td>
        <td style="font:10pt Times New Roman, Times, Serif;width:1%">&#160;</td>
        <td style="font:10pt Times New Roman, Times, Serif;width:1%;text-align:left">&#160;</td>
        <td style="font:10pt Times New Roman, Times, Serif;width:15%;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>4.00</span></span></span></span></td>
        <td style="font:10pt Times New Roman, Times, Serif;width:1%;text-align:left"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>%</span></span></span></span></td>
      </tr>
      <tr style="vertical-align:bottom;background-color:White">
        <td style="font:10pt Times New Roman, Times, Serif;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Series C MRP Shares</span></span></span></span></td>
        <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
        <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
        <td style="font:10pt Times New Roman, Times, Serif;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>4.24</span></span></span></span></td>
        <td style="font:10pt Times New Roman, Times, Serif;text-align:left"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>%</span></span></span></span></td>
      </tr>
      <tr style="vertical-align:bottom;background-color:rgb(204,238,255)">
        <td style="font:10pt Times New Roman, Times, Serif;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Series D MRP Shares</span></span></span></span></td>
        <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
        <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
        <td style="font:10pt Times New Roman, Times, Serif;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>2.45</span></span></span></span></td>
        <td style="font:10pt Times New Roman, Times, Serif;text-align:left"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>%</span></span></span></span></td>
      </tr>
      <tr style="vertical-align:bottom;background-color:White">
        <td style="font:10pt Times New Roman, Times, Serif;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Series E MRP Shares</span></span></span></span></td>
        <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
        <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
        <td style="font:10pt Times New Roman, Times, Serif;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>2.68</span></span></span></span></td>
        <td style="font:10pt Times New Roman, Times, Serif;text-align:left"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>%</span></span></span></span></td>
      </tr>

  </table>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;background-color:white">&#160;</p>
  <div style="break-before:page;margin-top:6pt;margin-bottom:12pt">
    <p style="margin:0pt">&#160;</p>
  </div>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;background-color:white">&#160;</p>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;background-color:white"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The MRP Shares have a term redemption date of September&#160;6, 2024 for the Series&#160;B MRP Shares, September&#160;6, 2027 for the Series&#160;C MRP Shares, August&#160;24, 2026 for the Series&#160;D MRP Shares and May&#160;24, 2027 for the Series&#160;E MRP Shares.</span></span></span></span></p>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;background-color:white">&#160;</p>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;background-color:white"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Previously, the Series B MRP Shares and the Series C MRP Shares had been assigned a rating of "AA" by Fitch Ratings, Inc. ("Fitch"). As of December 17, 2020, Kroll Bond Rating Agency LLC ("KBRA") replaced Fitch as the rating agency for the Series B MRP Shares and the Series C MRP Shares and each of the Series B MRP Shares and the Series C MRP Shares have been assigned a rating of 'AA-' by KBRA. As of August&#160;24, 2021, the Series&#160;D MRP Shares and Series&#160;E MRP Shares have each been assigned a rating of &#8216;AA-&#8217; by KBRA. If the ratings of the MRP Shares are downgraded, the Fund's dividend expense may increase, as described below.</span></span></span></span></p>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;background-color:white">&#160;</p>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;background-color:white"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><i>Liquidation Preference.</i></span>&#160;In the event of any voluntary or involuntary liquidation, dissolution or winding up of the Fund, the MRP Shareholders will be entitled to receive a preferential liquidating distribution equal to $25.00 per MRP Share plus accrued and unpaid dividends, after satisfaction of claims of creditors of the Fund, but before any distribution of assets is made to common shareholders.</span></span></span></span></p>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;background-color:white">&#160;</p>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;background-color:white"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><i>MRP Shares Dividends.</i></span>&#160;If, on the first day of the monthly dividend period immediately preceding a Dividend Payment Date (each such period a "Dividend Period"), Series B MRP Shares or Series C MRP Shares is rated no less than "A" by Fitch (and no less than the equivalent of such rating by some other NRSRO, if any, other than Fitch, such as KBRA, providing a rating for the MRP Shares pursuant to the request of the Fund) or with respect to Series D MRP Shares or Series E MRP Shares, by KBRA (or lower than the equivalent of such rating by any Other Rating Agency), then the dividend rate for such period (the "Dividend Rate") will be equal to the Applicable Rate for such series.</span></span></span></span></p>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;background-color:white">&#160;</p>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;background-color:white"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>If, on the first day of a Dividend Period, the credit rating assigned on any date to Series B MRP Shares or Series C MRP Shares by Fitch (or some other NRSRO then rating any series of the outstanding MRP Shares pursuant to the request of the Fund, such as KBRA) is lower than a rating of "A" (or lower than the equivalent of such rating by such other rating agency), or with respect to Series D MRP Shares or Series E MRP Shares, are rated lower than the equivalent of "A" by KBRA (or lower than the equivalent of such rating by any Other Rating Agency) the Dividend Rate applicable to such series of outstanding MRP Shares for such Dividend Period shall be the Applicable Rate plus the enhanced dividend amount (which shall not be cumulative) set opposite the lowest of such ratings in the table below:</span></span></span></span></p>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;background-color:white">&#160;</p>
  <table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width:70%;font:10pt Times New Roman, Times, Serif;margin:auto">

      <tr style="vertical-align:bottom">
        <td style="white-space:nowrap;border-bottom:Black 1pt solid;font:bold 10pt Times New Roman, Times, Serif;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Fitch Rating or KBRA Rating (Or Equivalent by an Other Rating Agency)</span></span></span></span></td>
        <td style="white-space:nowrap;padding-bottom:1pt;font:bold 10pt Times New Roman, Times, Serif">&#160;</td>
        <td colspan="2" style="white-space:nowrap;border-bottom:Black 1pt solid;font:bold 10pt Times New Roman, Times, Serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Enhanced<br />Dividend Amount</span></span></span></span></td>
        <td style="white-space:nowrap;padding-bottom:1pt;font:bold 10pt Times New Roman, Times, Serif">&#160;</td>
      </tr>
      <tr style="vertical-align:bottom;background-color:rgb(204,238,255)">
        <td style="width:82%;font:10pt Times New Roman, Times, Serif;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&#8220;A-&#8221;</span></span></span></span></td>
        <td style="width:1%;font:10pt Times New Roman, Times, Serif">&#160;</td>
        <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
        <td style="width:15%;font:10pt Times New Roman, Times, Serif;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>0.5</span></span></span></span></td>
        <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>%</span></span></span></span></td>
      </tr>
      <tr style="vertical-align:bottom;background-color:White">
        <td style="font:10pt Times New Roman, Times, Serif;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&#8220;BBB+&#8221; to &#8220;BBB-&#8221;</span></span></span></span></td>
        <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
        <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
        <td style="font:10pt Times New Roman, Times, Serif;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>2.0</span></span></span></span></td>
        <td style="font:10pt Times New Roman, Times, Serif;text-align:left"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>%</span></span></span></span></td>
      </tr>
      <tr style="vertical-align:bottom;background-color:rgb(204,238,255)">
        <td style="font:10pt Times New Roman, Times, Serif;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&#8220;BB+&#8221; or below</span></span></span></span></td>
        <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
        <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
        <td style="font:10pt Times New Roman, Times, Serif;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>4.0</span></span></span></span></td>
        <td style="font:10pt Times New Roman, Times, Serif;text-align:left"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>%</span></span></span></span></td>
      </tr>

  </table>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;background-color:white"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>A 4.0% premium in addition to the Applicable Rate may apply when the Fund fails to maintain a current credit rating, and a 5.0% premium may apply when the Fund fails to make timely payments with regard to the MRP Shares (subject to cure periods in each case).</span></span></span></span></p>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;background-color:white">&#160;</p>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;background-color:white"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><i>Limitation on Common Share Distributions.</i></span>&#160;With regard to the Series B MRP Shares or Series C MRP Shares, so long as any MRP Shares are outstanding, the Fund will not declare, pay or set apart for payment any dividend or other distribution (other than non-cash distributions) with respect to Fund shares ranking junior to or on parity with the MRP Shares, unless (1) the Fund has satisfied the MRP Shares Overcollateralization Test (as defined below) on at least one "valuation date" in the preceding 65 calendar days, (2) immediately after such transaction the Fund would satisfy the MRP Shares Asset Coverage Test (as defined below), (3) full cumulative dividends on the MRP Shares due on or prior to the date of the transaction have been declared and paid to the holders of MRP Shares and (4) the Fund has redeemed the full number of MRP Shares required to be redeemed by any provision for mandatory redemption or deposited sufficient monies with the Fund's paying agent for that purpose, subject to certain grace periods and exceptions.</span></span></span></span></p>
  <div style="margin-top:0pt;margin-bottom:6pt">&#160;</div>
  <div style="break-before:page;margin-top:6pt;margin-bottom:12pt">
    <p style="margin:0pt">&#160;</p>
  </div>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;background-color:white">&#160;</p>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;background-color:white"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span style="text-decoration:underline">MRP Shares Asset Coverage Test:</span></span>&#160;Asset coverage with respect to all outstanding senior securities and preferred shares, including the MRP Shares, determined in accordance with Section 18(h) of the 1940 Act, on the basis of values calculated as of a time within 48 hours (not including Sundays or holidays) next preceding the time of determination, must be greater than or equal to 225%.</span></span></span></span></p>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;background-color:white">&#160;</p>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;background-color:white"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span style="text-decoration:underline">MRP Shares Overcollateralization Test:</span></span>&#160;So long as Fitch or any other NRSRO, such as KBRA, is then rating any class of the outstanding MRP Shares pursuant to the request of the Fund, satisfaction of only those overcollateralization ratios applicable to closed-end fund issuers with the same rating(s) as the Fund's MRP Shares' then-current rating(s) issued by Fitch or such other NRSRO, such as KBRA, by application of the applicable rating agency guidelines.</span></span></span></span></p>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;background-color:white">&#160;</p>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;background-color:white"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>With regard to Series D MRP Shares or Series E MRP Shares, for so long as any MRP Shares are Outstanding, the Fund will not declare, pay or set apart for payment any dividend or other distribution (other than a dividend or distribution paid in shares of, or options, warrants or rights to subscribe for or purchase, Common Shares or other shares of beneficial interest, if any, ranking junior to the MRP Shares as to dividends or upon liquidation (collectively "non-cash distributions")) with respect to Common Shares or any other shares of the Series or Fund ranking junior to or on a parity with the MRP Shares as to dividends or upon liquidation, or call for redemption, redeem, purchase or otherwise acquire for consideration any Common Shares or any other such junior shares (except by conversion into or exchange for shares of the Fund ranking junior to the MRP Shares as to dividends and upon liquidation) or any such parity shares (except by conversion into or exchange for shares of the Fund ranking junior to or on a parity with the MRP Shares as to dividends and upon liquidation), unless (1) immediately after such transaction the Fund would satisfy the MRP Shares Asset Coverage Test, (2) full cumulative dividends on the MRP Shares due on or prior to the date of the transaction have been declared and paid to the holders of MRP Shares, and (3) the Fund has redeemed the full number of MRP Shares required to be redeemed by any provision for mandatory redemption contained in Section 3(a) or deposited sufficient monies with the Paying Agent for that purpose (without regard to the provisions of the Special Proviso);&#160;<i>provided</i>&#160;that the Fund may make any distributions reasonably necessary for the Fund to continue to qualify as a "regulated investment company" under Subchapter M of the Internal Revenue Code and to avoid excise tax under Section 4982 of the Internal Revenue Code (<i>"Tax Required Payments"</i>). For the avoidance of doubt, any such Tax Required Payments would only be paid to holders of Common Shares after full cumulative dividends due on or prior to the date of the applicable distribution and any mandatory redemptions occurring on or prior to the date of the applicable distribution have been paid to the holders of Preferred Shares.</span></span></span></span></p>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;background-color:white">&#160;</p>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;background-color:white"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The terms of the MRP Shares and rights and preferences of the holders of the MRP Shares are set forth in the Statement of Preferences of Series B Mandatory Redeemable Preferred Shares, Series C Mandatory Redeemable Preferred Shares, Series D Mandatory Redeemable Preferred Shares, and Series E Mandatory Redeemable Preferred Shares of the Fund.</span></span></span></span></p>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;background-color:white">&#160;</p>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;background-color:white"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><i>Redemption.</i></span>&#160;The terms of the MRP Shares provide that: (i) the Fund may redeem the MRP Shares at its option at the liquidation preference plus accrued and unpaid dividends and plus a make-whole premium, subject to notice and other requirements; (ii) the Fund is required to redeem the MRP Shares upon failure to satisfy the MRP Shares Asset Coverage Test (tested monthly) or MRP Shares Overcollateralization Test (tested weekly), subject to cure periods; and (iii) the Fund is required to redeem the MRP Shares on the term redemption date of September 6, 2024 for the Series B MRP Shares, September 6, 2027 for the Series C MRP Shares, August 24, 2026 for the Series D MRP Shares, and May 24, 2027 for the Series E MRP Shares.</span></span></span></span></p>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;background-color:white">&#160;</p>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;background-color:white"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><i>Voting Rights.</i></span>&#160;Except as otherwise required in the prospectus, the governing documents of the Fund, or as otherwise required by applicable law, the Fund's preferred shareholders, including the MRP Shares, have one vote per share and vote together with the Fund's common shareholders as a single class. The 1940 Act grants the holders of preferred stock the right to elect at least two Trustees at all times (the "Preferred Share Trustees") and the remaining Trustees will be elected by the holders of common stock and preferred stock voting as a single class. Except during any time when the Fund has failed to make a dividend or redemption payment in respect of MRP Shares outstanding, the holders of MRP Shares have agreed to vote in accordance with the recommendation of the Board of Trustees on any matter submitted to them for their vote or to the vote of shareholders of the Fund generally.</span></span></span></span></p>
  <div style="margin-top:0pt;margin-bottom:6pt">&#160;</div>
  <div style="break-before:page;margin-top:6pt;margin-bottom:12pt">
    <p style="margin:0pt">&#160;</p>
  </div>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;background-color:white">&#160;</p>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;background-color:white"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>With respect to the MRP Shares, William R. Rybak and Virginia G. Breen were designated by the Board of Trustees as the Preferred Share Trustees of the Fund. As of September 6, 2022, there were five other Trustees of the Fund, Ms. Stuckey and Messrs. Calamos, Neal, Toub and Wennlund. See "Management of the Fund" in the Fund's statement of additional information. The Fund's preferred shareholders, including the MRP Shareholders, are entitled to elect a majority of the Trustees of the Fund during any period when (i) at least two years' accumulated dividends on the preferred stock are due and unpaid or (ii) the preferred shares are otherwise entitled under the 1940 Act to elect a majority of the Trustees of the Fund. The MRP Shareholders have certain additional customary voting rights pursuant to the MRP Shares governing documents and the 1940 Act.</span></span></span></span></p>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;background-color:white">&#160;</p>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;background-color:white"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The summary information regarding the MRP Shares contained herein is qualified in its entirety by reference to the Statement of Preferences and other documents related to the terms and conditions and the offering of the MRP Shares.</span></span></span></span></p>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;background-color:white">&#160;</p>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;background-color:white"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><i>The section titled "Effects of Leverage" beginning on page 42 of the Prospectus is deleted in its entirety and replaced with the following:</i></span></span></span></span></p>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;background-color:white">&#160;</p>
  <ix:nonNumeric id="Fxbrl_20220929125934725" name="cef:EffectsOfLeverageTextBlock" contextRef="C_20220930to20220930" escape="true">
    <div>
      <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;background-color:white"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The SSB Agreement provides for credit availability for the Fund, such that it may borrow up to $55 million. As of September 6, 2022, the Fund had utilized $26 million of the $55 million available under the SSB Agreement ($1.5 million in borrowings outstanding, and $24.5 million in structural leverage consisting of collateral received from SSB in connection with securities on loan), representing 18.3% of the Fund's managed assets as of that date, and had $17 million of MRP Shares outstanding, representing 12.0% of the Fund's managed assets. Combined, the borrowings under the SSB Agreement and the outstanding MRP Shares represented 30.3% of the Fund's managed assets. Interest on the SSB Agreement is charged on the drawn amount at the rate of the Overnight Bank Financing Rate&#160;(&#8220;OBFR&#8221;) plus 0.80%, payable monthly in arrears. Interest on overdue amounts or interest on the drawn amount paid during an event of default will be charged at OBFR plus 2.80%. These rates represent floating rates of interest that may change over time. The SSB Agreement has a commitment fee of 0.10% of any undrawn amount. As of September 6, 2022, the interest rate charged under the SSB Agreement was 3.12%. "Net income" payments related to cash collateral in connection with securities lending were 1.56% of the borrowed amount on an annualized basis as of that date, although this amount can vary based on changes in underlying interest rates.</span></span></span></span></p>
      <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;background-color:white">&#160;</p>
      <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;background-color:white"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The Fund's MRP Shareholders are entitled to receive monthly cash dividends, at a currently effective dividend rate per annum for each series of MRP Shares as follows (subject to adjustment as described above in "Mandatory Redeemable Preferred Shares"): 4.00% for Series B MRP Shares, 4.24% for Series C MRP Shares, 2.45% for Series D MRP Shares, and 2.68% for Series E MRP Shares.</span></span></span></span></p>
      <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;background-color:white">&#160;</p>
      <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;background-color:white"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>To cover the interest expense on the borrowings under the SSB Agreement (including "net income" payments made with respect to borrowings offset by collateral for securities on loan) and the dividend payments associated with the MRP Shares, based on rates in effect on September 6, 2022, the Fund's portfolio would need to experience an annual return of 2.73% (before giving effect to expenses associated with senior securities).</span></span></span></span></p>
      <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;background-color:white">&#160;</p>
      <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;background-color:white"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Leverage is a speculative technique that could adversely affect the returns to common shareholders. Leverage can cause the Fund to lose money and can magnify the effect of any losses. To the extent the income or capital appreciation derived from securities purchased with funds received from leverage exceeds the cost of leverage, the Fund's return will be greater than if leverage had not been used. Conversely, if the income or capital appreciation from the securities purchased with such funds is not sufficient to cover the cost of leverage or if the Fund incurs capital losses, the return of the Fund will be less than if leverage had not been used, and therefore the amount available for distribution to common shareholders as dividends and other distributions will be reduced or potentially eliminated.</span></span></span></span></p>
      <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;background-color:white">&#160;</p>
      <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;background-color:white"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The Fund will pay, and common shareholders will effectively bear, any costs and expenses relating to any borrowings and to the issuance and ongoing maintenance of preferred shares, including the MRP Shares, or debt securities. Such costs and expenses include the higher management fee resulting from the use of any such leverage, offering and/or issuance costs, and interest and/or dividend expense and ongoing maintenance.</span></span></span></span></p>
      <div style="margin-top:0pt;margin-bottom:6pt">&#160;</div>
      <div style="break-before:page;margin-top:6pt;margin-bottom:12pt">
        <p style="margin:0pt">&#160;</p>
      </div>
      <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;background-color:white">&#160;</p>
      <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;background-color:white"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Certain types of borrowings may result in the Fund being subject to covenants in credit agreements, including those relating to asset coverage, borrowing base and portfolio composition requirements and additional covenants that may affect the Fund's ability to pay dividends and distributions on common shares in certain instances. The Fund may also be required to pledge its assets to the lenders in connection with certain types of borrowings. The Fund may be subject to certain restrictions on investments imposed by guidelines of and covenants with rating agencies for the preferred shares or short-term debt instruments issued by the Fund. These guidelines and covenants may impose asset coverage or portfolio composition requirements that are more stringent than those imposed by the 1940 Act.</span></span></span></span></p>
      <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;background-color:white">&#160;</p>
      <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;background-color:white"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Because Calamos' investment management fee is a percentage of the Fund's managed assets, Calamos' fee will be higher if the Fund is leveraged and Calamos will have an incentive to be more aggressive and leverage the Fund. Consequently, the Fund and Calamos may have differing interests in determining whether to leverage the Fund's assets. Any additional use of leverage by the Fund effected through new, additional or increased credit facilities or the issuance of preferred shares would require approval by the Board of Trustees of the Fund.</span></span></span></span></p>
      <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;background-color:white">&#160;</p>
      <ix:nonNumeric id="Fxbrl_20220929124300223" name="cef:EffectsOfLeveragePurposeTextBlock" contextRef="C_20220930to20220930" escape="true">
        <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;background-color:white"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The following table illustrates the hypothetical effect on the return to a holder of the Fund's common shares of the leverage obtained by us (and utilized on September 6, 2022). The purpose of this table is to assist you in understanding the effects of leverage. As the table shows, leverage generally increases the return to common shareholders when portfolio return is positive and greater than the cost of leverage and decreases the return when the portfolio return is negative or less than the cost of leverage. The figures appearing in the table are hypothetical and actual returns may be greater or less than those appearing in the table.</span></span></span></span></p>
      </ix:nonNumeric>
      <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;background-color:white">&#160;</p>
      <ix:nonNumeric id="Fxbrl_20220929124222775" name="cef:EffectsOfLeverageTableTextBlock" contextRef="C_20220930to20220930" escape="true">
        <table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width:100%;font:10pt Times New Roman, Times, Serif">

            <tr style="vertical-align:bottom;background-color:rgb(204,238,255)">
              <td style="width:35%;font:10pt Times New Roman, Times, Serif;text-align:justify;padding-left:2.5pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Assumed Portfolio Return (Net of Expenses)</span></span></span></span></td>
              <td style="width:1%;font:10pt Times New Roman, Times, Serif">&#160;</td>
              <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
              <td style="width:10%;font:10pt Times New Roman, Times, Serif;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(10.00</span></span></span></span></td>
              <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)%</span></span></span></span></td>
              <td style="width:1%;font:10pt Times New Roman, Times, Serif">&#160;</td>
              <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
              <td style="width:10%;font:10pt Times New Roman, Times, Serif;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(5.00</span></span></span></span></td>
              <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)%</span></span></span></span></td>
              <td style="width:1%;font:10pt Times New Roman, Times, Serif">&#160;</td>
              <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
              <td style="width:10%;font:10pt Times New Roman, Times, Serif;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>0.00</span></span></span></span></td>
              <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>%</span></span></span></span></td>
              <td style="width:1%;font:10pt Times New Roman, Times, Serif">&#160;</td>
              <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
              <td style="width:10%;font:10pt Times New Roman, Times, Serif;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>5.00</span></span></span></span></td>
              <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>%</span></span></span></span></td>
              <td style="width:1%;font:10pt Times New Roman, Times, Serif">&#160;</td>
              <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
              <td style="width:10%;font:10pt Times New Roman, Times, Serif;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>10.00</span></span></span></span></td>
              <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>%</span></span></span></span></td>
            </tr>
            <tr style="vertical-align:bottom;background-color:White">
              <td style="font:10pt Times New Roman, Times, Serif;text-align:justify;padding-left:2.5pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Corresponding Common Share Return<sup>(1)</sup></span></span></span></span></td>
              <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
              <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
              <td style="font:10pt Times New Roman, Times, Serif;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(<ix:nonFraction id="Fxbrl_20220929124540326" name="cef:ReturnAtMinusTenPercent" contextRef="C_20220930to20220930" unitRef="Pure" scale="-2" decimals="4" format="ixt:num-dot-decimal" sign="-">18.76</ix:nonFraction></span></span></span></span></td>
              <td style="font:10pt Times New Roman, Times, Serif;text-align:left"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)%</span></span></span></span></td>
              <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
              <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
              <td style="font:10pt Times New Roman, Times, Serif;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(<ix:nonFraction id="Fxbrl_20220929125453107" name="cef:ReturnAtMinusFivePercent" contextRef="C_20220930to20220930" unitRef="Pure" scale="-2" decimals="4" format="ixt:num-dot-decimal" sign="-">10.56</ix:nonFraction></span></span></span></span></td>
              <td style="font:10pt Times New Roman, Times, Serif;text-align:left"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)%</span></span></span></span></td>
              <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
              <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
              <td style="font:10pt Times New Roman, Times, Serif;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(<ix:nonFraction id="Fxbrl_20220929125525365" name="cef:ReturnAtZeroPercent" contextRef="C_20220930to20220930" unitRef="Pure" scale="-2" decimals="4" format="ixt:num-dot-decimal" sign="-">2.36</ix:nonFraction></span></span></span></span></td>
              <td style="font:10pt Times New Roman, Times, Serif;text-align:left"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)%</span></span></span></span></td>
              <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
              <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
              <td style="font:10pt Times New Roman, Times, Serif;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20220929125550342" name="cef:ReturnAtPlusFivePercent" contextRef="C_20220930to20220930" unitRef="Pure" scale="-2" decimals="4" format="ixt:num-dot-decimal">5.84</ix:nonFraction></span></span></span></span></td>
              <td style="font:10pt Times New Roman, Times, Serif;text-align:left"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>%</span></span></span></span></td>
              <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
              <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
              <td style="font:10pt Times New Roman, Times, Serif;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20220929125703335" name="cef:ReturnAtPlusTenPercent" contextRef="C_20220930to20220930" unitRef="Pure" scale="-2" decimals="4" format="ixt:num-dot-decimal">14.04</ix:nonFraction></span></span></span></span></td>
              <td style="font:10pt Times New Roman, Times, Serif;text-align:left"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>%</span></span></span></span></td>
            </tr>

        </table>
      </ix:nonNumeric>
      <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0 0pt 2.5pt;text-align:justify">&#160;</p>
      <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0 0pt 2.5pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(1) Includes interest expense on the borrowings under the SSB Agreement, accrued at interest rates in effect on September 6, 2022 of <ix:nonFraction id="Fxbrl_20220929130131030" name="cef:AnnualInterestRatePercent" contextRef="C_20220930to20220930" unitRef="Pure" scale="-2" decimals="4" format="ixt:num-dot-decimal">3.12</ix:nonFraction>%, and dividend expense on the MRP Shares.</span></span></span></span></p>
    </div>
  </ix:nonNumeric>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>For further information about leveraging, see "Risk Factors &#8212; Fund Risks &#8212; Leverage Risk."</span></span></span></span></p>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;background-color:white">&#160;</p>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;background-color:white"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><i>The second and third paragraphs under the section titled "Description of Securities" beginning on page 82 of the Prospectus is deleted in its entirety and replaced with the following:</i></span></span></span></span></p>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;background-color:white">&#160;</p>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center;background-color:white"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong>DESCRIPTION OF SECURITIES</strong></span></span></span></span></p>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center;background-color:white">&#160;</p>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;background-color:white"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The Fund is authorized to issue an unlimited number of common shares, without par value. The Fund is also authorized to issue preferred shares and debt securities. As of September 6, 2022, the Fund had 9,820,878 common shares outstanding and MRP Shares outstanding in the following amounts: 160,000 Series&#160;B MRP Shares, 160,000 Series&#160;C MRP Shares, 200,000 Series&#160;D MRP Shares and 160,000 Series&#160;E MRP Shares. As of such date, the Fund had not issued any debt securities. Subject to the restrictions under the 1940 Act, the Board of Trustees may, from time to time, establish additional series or classes of Fund shares and set forth the designations, preferences, conversion or other rights, voting powers, restrictions, limitations as to dividends, qualifications or terms or conditions of redemption of such shares and pursuant to such classification or reclassification to increase or decrease the number of authorized shares of any existing class or series but the Board may not change any outstanding shares in a manner materially adverse to such shareholders. The Board of Trustees, without shareholder approval but subject to the governing documents of the Fund and the MRP Shares, is authorized to amend the Agreement and Declaration of Trust and By-Laws to reflect the terms of any such class or series.</span></span></span></span></p>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;background-color:white">&#160;</p>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;background-color:white"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>As of September 6, 2022, the Fund had total leverage of approximately $43 million representing approximately 30.3% of the Fund's managed assets as of that date. The Fund will pay, and common shareholders will effectively bear, any costs and expenses relating to any borrowings by the Fund, including the financial leverage described above, as well as any additional leverage incurred as a result of this offering. Such costs and expenses include the higher management fee resulting from the use of any such leverage, offering and/or issuance costs, and interest and/or dividend expense and ongoing maintenance. Borrowings under the SSB Agreement are secured by assets of the Fund that are held with the Fund's custodian in a separate account. Interest on the SSB Agreement is charged on the drawn amount at the rate of OBFR plus 0.80%, payable monthly in arrears. Interest on overdue amounts or interest on the drawn amount paid during an event of default will be charged at OBFR plus 2.80%. The SSB Agreement has a commitment fee of 0.10% of any undrawn amount. As of September 6, 2022, the interest rate charged under the SSB Agreement was 3.12%.</span></span></span></span></p>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;background-color:white">&#160;</p>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;background-color:white"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong>II. Further Revisions to Disclosure</strong></span></span></span></span></p>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;background-color:white">&#160;</p>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;background-color:white"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>All disclosure in the Fund's Prospectus, SAI and Prospectus Supplement not specifically referenced above is hereby amended to the extent necessary to conform to the information provided in this supplement.</span></span></span></span></p>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;background-color:white">&#160;</p>
  <p style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt;text-align:center;background-color:white"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong>Please retain this supplement for future reference.</strong></span></span></span></span></p>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center;background-color:white">&#160;</p>
  <p style="margin:0">&#160;</p>
</div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>2
<FILENAME>ck0001285650-20220930.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<schema xmlns:ck0001285650="http://www.calamos.com/20220930" xmlns="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:negated="http://www.xbrl.org/2009/role/negated" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:deprecated="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:cef="http://xbrl.sec.gov/cef/2022" targetNamespace="http://www.calamos.com/20220930" elementFormDefault="qualified">
  <!-- INTEGIX by Ez-XBRL -->
  <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <import namespace="http://xbrl.sec.gov/dei/2022" schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd"/>
  <import namespace="http://xbrl.sec.gov/cef/2022" schemaLocation="https://xbrl.sec.gov/cef/2022/cef-2022.xsd"/>
  <import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <annotation>
    <appinfo>
      <link:roleType roleURI="http://www.calamos.com/role/DocumentAndEntityInformation" id="DocumentAndEntityInformation">
        <link:definition>0002 - Disclosure - Document and entity information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.calamos.com/role/FUNDEXPENSES" id="FUNDEXPENSES">
        <link:definition>0004 - Disclosure - FUND EXPENSES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.calamos.com/role/OutstandingSecurities" id="OutstandingSecurities">
        <link:definition>0006 - Disclosure - Outstanding securities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.calamos.com/role/EffectsOfLeverage" id="EffectsOfLeverage">
        <link:definition>0008 - Disclosure - Effects of Leverage</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:linkbaseRef xlink:type="simple" xlink:href="ck0001285650-20220930_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase"/>
      <link:linkbaseRef xlink:type="simple" xlink:href="ck0001285650-20220930_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase"/>
      <link:linkbaseRef xlink:type="simple" xlink:href="ck0001285650-20220930_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase"/>
    </appinfo>
  </annotation>
  <element name="CommonSharesMember" id="ck0001285650_CommonSharesMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="MandatoryRedeemablePreferredSharesSeriesBMember" id="ck0001285650_MandatoryRedeemablePreferredSharesSeriesBMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="MandatoryRedeemablePreferredSharesSeriesCMember" id="ck0001285650_MandatoryRedeemablePreferredSharesSeriesCMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="MandatoryRedeemablePreferredSharesSeriesDMember" id="ck0001285650_MandatoryRedeemablePreferredSharesSeriesDMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="MandatoryRedeemablePreferredSharesSeriesEMember" id="ck0001285650_MandatoryRedeemablePreferredSharesSeriesEMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>3
<FILENAME>ck0001285650-20220930_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<link:linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <!-- INTEGIX by Ez-XBRL -->
  <link:roleRef roleURI="http://xbrl.sec.gov/cef/role/RiskOnly" xlink:type="simple" xlink:href="https://xbrl.sec.gov/cef/2022/cef-2022.xsd#RiskOnly"/>
  <link:roleRef roleURI="http://xbrl.sec.gov/cef/role/SecurityOnly" xlink:type="simple" xlink:href="https://xbrl.sec.gov/cef/2022/cef-2022.xsd#SecurityOnly"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/cef/role/SecurityOnly">
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cef/2022/cef-2022.xsd#cef_AllSecuritiesMember" xlink:label="loc_cef_AllSecuritiesMember_0"/>
    <loc xlink:type="locator" xlink:href="ck0001285650-20220930.xsd#ck0001285650_CommonSharesMember" xlink:label="loc_ck0001285650_CommonSharesMember_1"/>
    <loc xlink:type="locator" xlink:href="ck0001285650-20220930.xsd#ck0001285650_MandatoryRedeemablePreferredSharesSeriesBMember" xlink:label="loc_ck0001285650_MandatoryRedeemablePreferredSharesSeriesBMember_2"/>
    <loc xlink:type="locator" xlink:href="ck0001285650-20220930.xsd#ck0001285650_MandatoryRedeemablePreferredSharesSeriesCMember" xlink:label="loc_ck0001285650_MandatoryRedeemablePreferredSharesSeriesCMember_3"/>
    <loc xlink:type="locator" xlink:href="ck0001285650-20220930.xsd#ck0001285650_MandatoryRedeemablePreferredSharesSeriesDMember" xlink:label="loc_ck0001285650_MandatoryRedeemablePreferredSharesSeriesDMember_4"/>
    <loc xlink:type="locator" xlink:href="ck0001285650-20220930.xsd#ck0001285650_MandatoryRedeemablePreferredSharesSeriesEMember" xlink:label="loc_ck0001285650_MandatoryRedeemablePreferredSharesSeriesEMember_5"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllSecuritiesMember_0" xlink:to="loc_ck0001285650_CommonSharesMember_1" order="1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllSecuritiesMember_0" xlink:to="loc_ck0001285650_MandatoryRedeemablePreferredSharesSeriesBMember_2" order="2"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllSecuritiesMember_0" xlink:to="loc_ck0001285650_MandatoryRedeemablePreferredSharesSeriesCMember_3" order="3"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllSecuritiesMember_0" xlink:to="loc_ck0001285650_MandatoryRedeemablePreferredSharesSeriesDMember_4" order="4"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllSecuritiesMember_0" xlink:to="loc_ck0001285650_MandatoryRedeemablePreferredSharesSeriesEMember_5" order="5"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/cef/role/RiskOnly">
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cef/2022/cef-2022.xsd#cef_AllRisksMember" xlink:label="loc_cef_AllRisksMember_0"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>ck0001285650-20220930_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <!-- INTEGIX by Ez-XBRL -->
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel"/>
  <labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
    <loc xlink:type="locator" xlink:href="ck0001285650-20220930.xsd#ck0001285650_CommonSharesMember" xlink:label="loc_ck0001285650_CommonSharesMember_1"/>
    <loc xlink:type="locator" xlink:href="ck0001285650-20220930.xsd#ck0001285650_CommonSharesMember" xlink:label="loc_ck0001285650_CommonSharesMember_2"/>
    <loc xlink:type="locator" xlink:href="ck0001285650-20220930.xsd#ck0001285650_MandatoryRedeemablePreferredSharesSeriesBMember" xlink:label="loc_ck0001285650_MandatoryRedeemablePreferredSharesSeriesBMember_3"/>
    <loc xlink:type="locator" xlink:href="ck0001285650-20220930.xsd#ck0001285650_MandatoryRedeemablePreferredSharesSeriesBMember" xlink:label="loc_ck0001285650_MandatoryRedeemablePreferredSharesSeriesBMember_4"/>
    <loc xlink:type="locator" xlink:href="ck0001285650-20220930.xsd#ck0001285650_MandatoryRedeemablePreferredSharesSeriesCMember" xlink:label="loc_ck0001285650_MandatoryRedeemablePreferredSharesSeriesCMember_5"/>
    <loc xlink:type="locator" xlink:href="ck0001285650-20220930.xsd#ck0001285650_MandatoryRedeemablePreferredSharesSeriesCMember" xlink:label="loc_ck0001285650_MandatoryRedeemablePreferredSharesSeriesCMember_6"/>
    <loc xlink:type="locator" xlink:href="ck0001285650-20220930.xsd#ck0001285650_MandatoryRedeemablePreferredSharesSeriesDMember" xlink:label="loc_ck0001285650_MandatoryRedeemablePreferredSharesSeriesDMember_7"/>
    <loc xlink:type="locator" xlink:href="ck0001285650-20220930.xsd#ck0001285650_MandatoryRedeemablePreferredSharesSeriesDMember" xlink:label="loc_ck0001285650_MandatoryRedeemablePreferredSharesSeriesDMember_8"/>
    <loc xlink:type="locator" xlink:href="ck0001285650-20220930.xsd#ck0001285650_MandatoryRedeemablePreferredSharesSeriesEMember" xlink:label="loc_ck0001285650_MandatoryRedeemablePreferredSharesSeriesEMember_9"/>
    <loc xlink:type="locator" xlink:href="ck0001285650-20220930.xsd#ck0001285650_MandatoryRedeemablePreferredSharesSeriesEMember" xlink:label="loc_ck0001285650_MandatoryRedeemablePreferredSharesSeriesEMember_10"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001285650_CommonSharesMember_0" xml:lang="en-US">This member stands for Common Shares.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001285650_CommonSharesMember_1" xml:lang="en-US">Common Shares [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001285650_MandatoryRedeemablePreferredSharesSeriesBMember_0" xml:lang="en-US">This member stands for Mandatory Redeemable Preferred Shares Series B.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001285650_MandatoryRedeemablePreferredSharesSeriesBMember_1" xml:lang="en-US">Mandatory Redeemable Preferred Shares Series B [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001285650_MandatoryRedeemablePreferredSharesSeriesCMember_0" xml:lang="en-US">This member stands for Mandatory Redeemable Preferred Shares Series C.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001285650_MandatoryRedeemablePreferredSharesSeriesCMember_1" xml:lang="en-US">Mandatory Redeemable Preferred Shares Series C [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001285650_MandatoryRedeemablePreferredSharesSeriesDMember_0" xml:lang="en-US">This member stands for Mandatory Redeemable Preferred Shares Series D.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001285650_MandatoryRedeemablePreferredSharesSeriesDMember_1" xml:lang="en-US">Mandatory Redeemable Preferred Shares Series D [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001285650_MandatoryRedeemablePreferredSharesSeriesEMember_0" xml:lang="en-US">This member stands for Mandatory Redeemable Preferred Shares Series E.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001285650_MandatoryRedeemablePreferredSharesSeriesEMember_1" xml:lang="en-US">Mandatory Redeemable Preferred Shares Series E [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001285650_CommonSharesMember_1" xlink:to="lab_ck0001285650_CommonSharesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001285650_CommonSharesMember_2" xlink:to="lab_ck0001285650_CommonSharesMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001285650_MandatoryRedeemablePreferredSharesSeriesBMember_3" xlink:to="lab_ck0001285650_MandatoryRedeemablePreferredSharesSeriesBMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001285650_MandatoryRedeemablePreferredSharesSeriesBMember_4" xlink:to="lab_ck0001285650_MandatoryRedeemablePreferredSharesSeriesBMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001285650_MandatoryRedeemablePreferredSharesSeriesCMember_5" xlink:to="lab_ck0001285650_MandatoryRedeemablePreferredSharesSeriesCMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001285650_MandatoryRedeemablePreferredSharesSeriesCMember_6" xlink:to="lab_ck0001285650_MandatoryRedeemablePreferredSharesSeriesCMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001285650_MandatoryRedeemablePreferredSharesSeriesDMember_7" xlink:to="lab_ck0001285650_MandatoryRedeemablePreferredSharesSeriesDMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001285650_MandatoryRedeemablePreferredSharesSeriesDMember_8" xlink:to="lab_ck0001285650_MandatoryRedeemablePreferredSharesSeriesDMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001285650_MandatoryRedeemablePreferredSharesSeriesEMember_9" xlink:to="lab_ck0001285650_MandatoryRedeemablePreferredSharesSeriesEMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001285650_MandatoryRedeemablePreferredSharesSeriesEMember_10" xlink:to="lab_ck0001285650_MandatoryRedeemablePreferredSharesSeriesEMember_1"/>
  </labelLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>ck0001285650-20220930_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<link:linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <!-- INTEGIX by Ez-XBRL -->
  <link:roleRef roleURI="http://xbrl.sec.gov/cef/role/N2" xlink:type="simple" xlink:href="https://xbrl.sec.gov/cef/2022/cef-2022.xsd#N2"/>
  <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/cef/role/N2">
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cef/2022/cef-2022.xsd#cef_AllSecuritiesMember" xlink:label="loc_cef_AllSecuritiesMember_0"/>
    <loc xlink:type="locator" xlink:href="ck0001285650-20220930.xsd#ck0001285650_CommonSharesMember" xlink:label="loc_ck0001285650_CommonSharesMember_1"/>
    <loc xlink:type="locator" xlink:href="ck0001285650-20220930.xsd#ck0001285650_MandatoryRedeemablePreferredSharesSeriesBMember" xlink:label="loc_ck0001285650_MandatoryRedeemablePreferredSharesSeriesBMember_2"/>
    <loc xlink:type="locator" xlink:href="ck0001285650-20220930.xsd#ck0001285650_MandatoryRedeemablePreferredSharesSeriesCMember" xlink:label="loc_ck0001285650_MandatoryRedeemablePreferredSharesSeriesCMember_3"/>
    <loc xlink:type="locator" xlink:href="ck0001285650-20220930.xsd#ck0001285650_MandatoryRedeemablePreferredSharesSeriesDMember" xlink:label="loc_ck0001285650_MandatoryRedeemablePreferredSharesSeriesDMember_4"/>
    <loc xlink:type="locator" xlink:href="ck0001285650-20220930.xsd#ck0001285650_MandatoryRedeemablePreferredSharesSeriesEMember" xlink:label="loc_ck0001285650_MandatoryRedeemablePreferredSharesSeriesEMember_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cef/2022/cef-2022.xsd#cef_AllRisksMember" xlink:label="loc_cef_AllRisksMember_0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllSecuritiesMember_0" xlink:to="loc_ck0001285650_CommonSharesMember_1" order="1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllSecuritiesMember_0" xlink:to="loc_ck0001285650_MandatoryRedeemablePreferredSharesSeriesBMember_2" order="2"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllSecuritiesMember_0" xlink:to="loc_ck0001285650_MandatoryRedeemablePreferredSharesSeriesCMember_3" order="3"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllSecuritiesMember_0" xlink:to="loc_ck0001285650_MandatoryRedeemablePreferredSharesSeriesDMember_4" order="4"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllSecuritiesMember_0" xlink:to="loc_ck0001285650_MandatoryRedeemablePreferredSharesSeriesEMember_5" order="5"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>6
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140521752220608">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>N-2<br></strong></div></th>
<th class="th" colspan="2">
<div>Sep. 30, 2022 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001285650<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">424B3<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Calamos Global Total Return Fund<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_FeeTableAbstract', window );"><strong>Fee Table [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_ShareholderTransactionExpensesTableTextBlock', window );">Shareholder Transaction Expenses [Table Text Block]</a></td>
<td class="text">
    <table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width:90%;font:10pt Times New Roman, Times, Serif" width="90%">

        <tr style="vertical-align:bottom">
          <td style="font:bold 10pt Times New Roman, Times, Serif;text-align:justify;border-bottom:Black 1pt solid"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Shareholder Transaction Expenses</span></span></span></span></td>
          <td style="font-size:10pt;padding-bottom:1pt">&#160;</td>
          <td colspan="2" style="font-size:10pt;text-align:justify">&#160;</td>
          <td style="padding-bottom:1pt;font-size:10pt">&#160;</td>
          <td style="padding-bottom:1pt;font-size:10pt">&#160;</td>
        </tr>
        <tr style="vertical-align:bottom;background-color:rgb(204,238,255)">
          <td style="font:10pt Times New Roman, Times, serif;text-align:justify;width:78%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Sales Load (<span style="font:10pt Times New Roman, Times, serif">as a percentage of offering price</span>)</span></span></span></span></td>
          <td style="font:10pt Times New Roman, Times, serif;width:1%">&#160;</td>
          <td style="font:10pt Times New Roman, Times, serif;text-align:left;width:1%">&#160;</td>
          <td style="font:10pt Times New Roman, Times, serif;text-align:right;width:18%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>1.00</span></span></span></span></td>
          <td style="font:10pt Times New Roman, Times, serif;text-align:left;width:1%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>%</span></span></span></span></td>
          <td style="font:10pt Times New Roman, Times, serif;text-align:left;width:1%">
            <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Times New Roman, Times, serif"><sup>(1)</sup></span></p>
          </td>
        </tr>
        <tr style="vertical-align:bottom;background-color:White">
          <td style="font:10pt Times New Roman, Times, serif;text-align:justify;width:78%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Offering Expenses Borne by the Fund (<span style="font:10pt Times New Roman, Times, serif">as a percentage of offering price</span>)</span></span></span></span></td>
          <td style="font:10pt Times New Roman, Times, serif;width:1%">&#160;</td>
          <td style="font:10pt Times New Roman, Times, serif;text-align:left;width:1%">&#160;</td>
          <td style="font:10pt Times New Roman, Times, serif;text-align:right;width:18%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&#8212;</span></span></span></span></td>
          <td style="font:10pt Times New Roman, Times, serif;text-align:left;width:1%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>%</span></span></span></span></td>
          <td style="font:10pt Times New Roman, Times, serif;text-align:left;width:1%">
            <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Times New Roman, Times, serif"><sup>(2)</sup></span></p>
          </td>
        </tr>
        <tr style="vertical-align:bottom;background-color:rgb(204,238,255)">
          <td style="font:10pt Times New Roman, Times, serif;text-align:justify;width:78%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Dividend Reinvestment Plan Fees (per sales transaction fee)<sup>(3)</sup></span></span></span></span></span></td>
          <td style="font:10pt Times New Roman, Times, serif;width:1%">&#160;</td>
          <td style="font:10pt Times New Roman, Times, serif;text-align:left;width:1%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>$</span></span></span></span></td>
          <td style="font:10pt Times New Roman, Times, serif;text-align:right;width:18%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>15.00</span></span></span></span></td>
          <td style="font:10pt Times New Roman, Times, serif;text-align:left;width:1%">&#160;</td>
          <td style="font:10pt Times New Roman, Times, serif;text-align:left;width:1%">&#160;</td>
        </tr>

    </table>
  <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_SalesLoadPercent', window );">Sales Load [Percent]</a></td>
<td class="nump">1.00%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_DividendReinvestmentAndCashPurchaseFees', window );">Dividend Reinvestment and Cash Purchase Fees | $</a></td>
<td class="nump">$ 15<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_OtherTransactionExpensesAbstract', window );"><strong>Other Transaction Expenses [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_OtherTransactionExpensesPercent', window );">Other Transaction Expenses [Percent]</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_AnnualExpensesTableTextBlock', window );">Annual Expenses [Table Text Block]</a></td>
<td class="text">
    <table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width:90%;font:10pt Times New Roman, Times, Serif">

        <tr style="vertical-align:bottom">
          <td style="white-space:nowrap;font:bold 10pt Times New Roman, Times, Serif;text-align:justify;border-bottom:Black 1pt solid"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Annual Expenses</span></span></span></span></td>
          <td style="white-space:nowrap;font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt">&#160;</td>
          <td colspan="2" style="white-space:nowrap;font:bold 10pt Times New Roman, Times, Serif;text-align:center;border-bottom:Black 1pt solid"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Percentage&#160;of&#160;Average Net<br/>Assets Attributable to<br/>Common Shareholders</span></span></span></span></td>
          <td style="white-space:nowrap;padding-bottom:1pt;font:bold 10pt Times New Roman, Times, Serif">&#160;</td>
        </tr>
        <tr style="vertical-align:bottom;background-color:rgb(204,238,255)">
          <td style="width:79%;font:10pt Times New Roman, Times, Serif;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Management Fee<sup>(4)</sup></span></span></span></span></span></td>
          <td style="width:1%;font:10pt Times New Roman, Times, Serif">&#160;</td>
          <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
          <td style="width:18%;font:10pt Times New Roman, Times, Serif;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>1.51</span></span></span></span></span></td>
          <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>%</span></span></span></span></span></td>
        </tr>
        <tr style="vertical-align:bottom;background-color:White">
          <td style="font:10pt Times New Roman, Times, Serif;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Interest Payments on Borrowed Funds<sup>(5)</sup></span></span></span></span></span></td>
          <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
          <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
          <td style="font:10pt Times New Roman, Times, Serif;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>0.35</span></span></span></span></span></td>
          <td style="font:10pt Times New Roman, Times, Serif;text-align:left"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>%</span></span></span></span></span></td>
        </tr>
        <tr style="vertical-align:bottom;background-color:rgb(204,238,255)">
          <td style="font:10pt Times New Roman, Times, Serif;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Preferred Stock Dividend Payments<sup>(6)</sup></span></span></span></span></span></td>
          <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
          <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
          <td style="font:10pt Times New Roman, Times, Serif;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>0.55</span></span></span></span></span></td>
          <td style="font:10pt Times New Roman, Times, Serif;text-align:left">%</td>
        </tr>
        <tr style="vertical-align:bottom;background-color:White">
          <td style="font:10pt Times New Roman, Times, Serif;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Other Expenses<sup>(7)</sup></span></span></span></span></span></td>
          <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
          <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
          <td style="font:10pt Times New Roman, Times, Serif;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>0.32</span></span></span></span></span></td>
          <td style="font:10pt Times New Roman, Times, Serif;text-align:left"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>%</span></span></span></span></span></td>
        </tr>
        <tr style="vertical-align:bottom;background-color:rgb(204,238,255)">
          <td style="font:10pt Times New Roman, Times, Serif;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Total Annual Expenses</span></span></span></span></td>
          <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
          <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
          <td style="font:10pt Times New Roman, Times, Serif;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>2.73</span></span></span></span></span></td>
          <td style="font:10pt Times New Roman, Times, Serif;text-align:left"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>%</span></span></span></span></span></td>
        </tr>

    </table>
  <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_ManagementFeesPercent', window );">Management Fees [Percent]</a></td>
<td class="nump">1.51%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_InterestExpensesOnBorrowingsPercent', window );">Interest Expenses on Borrowings [Percent]</a></td>
<td class="nump">0.35%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_DividendExpenseOnPreferredSharesPercent', window );">Dividend Expenses on Preferred Shares [Percent]</a></td>
<td class="nump">0.55%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[6]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_OtherAnnualExpensesAbstract', window );"><strong>Other Annual Expenses [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_OtherAnnualExpensesPercent', window );">Other Annual Expenses [Percent]</a></td>
<td class="nump">0.32%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[7]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_TotalAnnualExpensesPercent', window );">Total Annual Expenses [Percent]</a></td>
<td class="nump">2.73%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_ExpenseExampleTableTextBlock', window );">Expense Example [Table Text Block]</a></td>
<td class="text">
    <div>
      <div>
        <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;background-color:white"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The following example illustrates the expenses that common shareholders would pay on a $1,000 investment in common shares, assuming (1) net annual expenses of 2.73% of net assets attributable to common shareholders; (2) a 5% annual gross return; and (3) all distributions are reinvested at net asset value:</span></span></span></span></p>
        <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;background-color:white">&#160;</p>
        <table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width:100%;font:10pt Times New Roman, Times, Serif">

            <tr style="vertical-align:bottom">
              <td style="font-size:10pt;text-align:center">&#160;</td>
              <td style="text-align:center;font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt">&#160;</td>
              <td colspan="2" style="border-bottom:Black 1pt solid;font:bold 10pt Times New Roman, Times, Serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>1 Year</span></span></span></span></td>
              <td style="text-align:center;padding-bottom:1pt;font:bold 10pt Times New Roman, Times, Serif">&#160;</td>
              <td style="text-align:center;font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt">&#160;</td>
              <td colspan="2" style="border-bottom:Black 1pt solid;font:bold 10pt Times New Roman, Times, Serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>3 Years</span></span></span></span></td>
              <td style="text-align:center;padding-bottom:1pt;font:bold 10pt Times New Roman, Times, Serif">&#160;</td>
              <td style="text-align:center;font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt">&#160;</td>
              <td colspan="2" style="border-bottom:Black 1pt solid;font:bold 10pt Times New Roman, Times, Serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>5 Years</span></span></span></span></td>
              <td style="text-align:center;padding-bottom:1pt;font:bold 10pt Times New Roman, Times, Serif">&#160;</td>
              <td style="text-align:center;font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt">&#160;</td>
              <td colspan="2" style="border-bottom:Black 1pt solid;font:bold 10pt Times New Roman, Times, Serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>10 Years</span></span></span></span></td>
              <td style="text-align:center;padding-bottom:1pt;font:bold 10pt Times New Roman, Times, Serif">&#160;</td>
            </tr>
            <tr style="vertical-align:bottom;background-color:rgb(204,238,255)">
              <td style="width:48%;font:10pt Times New Roman, Times, Serif;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Total Expenses Paid by Common Shareholders<sup>(8)</sup></span></span></span></span></span></td>
              <td style="width:1%;font:10pt Times New Roman, Times, Serif">&#160;</td>
              <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>$</span></span></span></span></td>
              <td style="width:10%;font:10pt Times New Roman, Times, Serif;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>37</span></span></span></span></td>
              <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
              <td style="width:1%;font:10pt Times New Roman, Times, Serif">&#160;</td>
              <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>$</span></span></span></span></td>
              <td style="width:10%;font:10pt Times New Roman, Times, Serif;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>94</span></span></span></span></td>
              <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
              <td style="width:1%;font:10pt Times New Roman, Times, Serif">&#160;</td>
              <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>$</span></span></span></span></td>
              <td style="width:10%;font:10pt Times New Roman, Times, Serif;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>153</span></span></span></span></td>
              <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
              <td style="width:1%;font:10pt Times New Roman, Times, Serif">&#160;</td>
              <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>$</span></span></span></span></td>
              <td style="width:10%;font:10pt Times New Roman, Times, Serif;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>313</span></span></span></span></td>
              <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
            </tr>

        </table>
      </div>
      <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;background-color:white">&#160;</p>
      <div style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;background-color:white"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong>The example should not be considered a representation of future expenses. Actual expenses may be greater or less than those assumed. Moreover, our actual rate of return may be greater or less than the hypothetical 5% return shown in the example.</strong></span></span></span></span></div>
    </div>
  <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_ExpenseExampleYear01', window );">Expense Example, Year 01 | $</a></td>
<td class="nump">$ 37<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[8]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_ExpenseExampleYears1to3', window );">Expense Example, Years 1 to 3 | $</a></td>
<td class="nump">94<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[8]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_ExpenseExampleYears1to5', window );">Expense Example, Years 1 to 5 | $</a></td>
<td class="nump">153<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[8]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_ExpenseExampleYears1to10', window );">Expense Example, Years 1 to 10 | $</a></td>
<td class="nump">$ 313<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[8]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_PurposeOfFeeTableNoteTextBlock', window );">Purpose of Fee Table , Note [Text Block]</a></td>
<td class="text">
    <div>
      <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;background-color:white"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The following table and example contain information about the costs and expenses that common shareholders will bear directly or indirectly. In accordance with Commission requirements, the table below shows our expenses, including interest payments on borrowed funds, as a percentage of our average net assets as of September 6, 2022, and not as a percentage of gross assets or managed assets.</span></span></span></span></p>
      <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;background-color:white">&#160;</p>
      <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;background-color:white"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>By showing expenses as a percentage of average net assets, expenses are not expressed as a percentage of all of the assets we invest. The table and example are based on our capital structure as of September 6, 2022. As of September 6, 2022, we had $1.5 million in borrowings outstanding, $17 million in outstanding preferred shares and additional structural leverage of $25 million, collectively representing 30.3% of managed assets as of that date.</span></span></span></span></p>
    </div>
  <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_BasisOfTransactionFeesNoteTextBlock', window );">Basis of Transaction Fees, Note [Text Block]</a></td>
<td class="text"><span style="font:10pt Times New Roman, Times, serif">as a percentage of offering price</span><span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_ManagementFeeNotBasedOnNetAssetsNoteTextBlock', window );">Management Fee not based on Net Assets, Note [Text Block]</a></td>
<td class="text"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The Fund pays Calamos an annual management fee, payable monthly in arrears, for its investment management services in an amount equal to 1.00% of the Fund's average weekly managed assets. In accordance with the requirements of the Commission, the table above shows the Fund's management fee as a percentage of average net assets attributable to common shareholders. By showing the management fee as a percentage of net assets, the management fee is not expressed as a percentage of all of the assets the Fund intends to invest. For purposes of the table, the management fee has been converted to 1.51% of the Fund's average weekly net assets as of September 6, 2022 by dividing the total dollar amount of the management fee by the Fund's average weekly net assets (managed assets less outstanding leverage).</span></span></span></span><span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_GeneralDescriptionOfRegistrantAbstract', window );"><strong>General Description of Registrant [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_EffectsOfLeverageTextBlock', window );">Effects of Leverage [Text Block]</a></td>
<td class="text">
    <div>
      <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;background-color:white"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The SSB Agreement provides for credit availability for the Fund, such that it may borrow up to $55 million. As of September 6, 2022, the Fund had utilized $26 million of the $55 million available under the SSB Agreement ($1.5 million in borrowings outstanding, and $24.5 million in structural leverage consisting of collateral received from SSB in connection with securities on loan), representing 18.3% of the Fund's managed assets as of that date, and had $17 million of MRP Shares outstanding, representing 12.0% of the Fund's managed assets. Combined, the borrowings under the SSB Agreement and the outstanding MRP Shares represented 30.3% of the Fund's managed assets. Interest on the SSB Agreement is charged on the drawn amount at the rate of the Overnight Bank Financing Rate&#160;(&#8220;OBFR&#8221;) plus 0.80%, payable monthly in arrears. Interest on overdue amounts or interest on the drawn amount paid during an event of default will be charged at OBFR plus 2.80%. These rates represent floating rates of interest that may change over time. The SSB Agreement has a commitment fee of 0.10% of any undrawn amount. As of September 6, 2022, the interest rate charged under the SSB Agreement was 3.12%. "Net income" payments related to cash collateral in connection with securities lending were 1.56% of the borrowed amount on an annualized basis as of that date, although this amount can vary based on changes in underlying interest rates.</span></span></span></span></p>
      <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;background-color:white">&#160;</p>
      <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;background-color:white"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The Fund's MRP Shareholders are entitled to receive monthly cash dividends, at a currently effective dividend rate per annum for each series of MRP Shares as follows (subject to adjustment as described above in "Mandatory Redeemable Preferred Shares"): 4.00% for Series B MRP Shares, 4.24% for Series C MRP Shares, 2.45% for Series D MRP Shares, and 2.68% for Series E MRP Shares.</span></span></span></span></p>
      <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;background-color:white">&#160;</p>
      <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;background-color:white"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>To cover the interest expense on the borrowings under the SSB Agreement (including "net income" payments made with respect to borrowings offset by collateral for securities on loan) and the dividend payments associated with the MRP Shares, based on rates in effect on September 6, 2022, the Fund's portfolio would need to experience an annual return of 2.73% (before giving effect to expenses associated with senior securities).</span></span></span></span></p>
      <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;background-color:white">&#160;</p>
      <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;background-color:white"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Leverage is a speculative technique that could adversely affect the returns to common shareholders. Leverage can cause the Fund to lose money and can magnify the effect of any losses. To the extent the income or capital appreciation derived from securities purchased with funds received from leverage exceeds the cost of leverage, the Fund's return will be greater than if leverage had not been used. Conversely, if the income or capital appreciation from the securities purchased with such funds is not sufficient to cover the cost of leverage or if the Fund incurs capital losses, the return of the Fund will be less than if leverage had not been used, and therefore the amount available for distribution to common shareholders as dividends and other distributions will be reduced or potentially eliminated.</span></span></span></span></p>
      <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;background-color:white">&#160;</p>
      <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;background-color:white"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The Fund will pay, and common shareholders will effectively bear, any costs and expenses relating to any borrowings and to the issuance and ongoing maintenance of preferred shares, including the MRP Shares, or debt securities. Such costs and expenses include the higher management fee resulting from the use of any such leverage, offering and/or issuance costs, and interest and/or dividend expense and ongoing maintenance.</span></span></span></span></p>
      <div style="margin-top:0pt;margin-bottom:6pt">&#160;</div>
      <div style="break-before:page;margin-top:6pt;margin-bottom:12pt">
        <p style="margin:0pt">&#160;</p>
      </div>
      <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;background-color:white">&#160;</p>
      <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;background-color:white"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Certain types of borrowings may result in the Fund being subject to covenants in credit agreements, including those relating to asset coverage, borrowing base and portfolio composition requirements and additional covenants that may affect the Fund's ability to pay dividends and distributions on common shares in certain instances. The Fund may also be required to pledge its assets to the lenders in connection with certain types of borrowings. The Fund may be subject to certain restrictions on investments imposed by guidelines of and covenants with rating agencies for the preferred shares or short-term debt instruments issued by the Fund. These guidelines and covenants may impose asset coverage or portfolio composition requirements that are more stringent than those imposed by the 1940 Act.</span></span></span></span></p>
      <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;background-color:white">&#160;</p>
      <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;background-color:white"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Because Calamos' investment management fee is a percentage of the Fund's managed assets, Calamos' fee will be higher if the Fund is leveraged and Calamos will have an incentive to be more aggressive and leverage the Fund. Consequently, the Fund and Calamos may have differing interests in determining whether to leverage the Fund's assets. Any additional use of leverage by the Fund effected through new, additional or increased credit facilities or the issuance of preferred shares would require approval by the Board of Trustees of the Fund.</span></span></span></span></p>
      <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;background-color:white">&#160;</p>

        <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;background-color:white"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The following table illustrates the hypothetical effect on the return to a holder of the Fund's common shares of the leverage obtained by us (and utilized on September 6, 2022). The purpose of this table is to assist you in understanding the effects of leverage. As the table shows, leverage generally increases the return to common shareholders when portfolio return is positive and greater than the cost of leverage and decreases the return when the portfolio return is negative or less than the cost of leverage. The figures appearing in the table are hypothetical and actual returns may be greater or less than those appearing in the table.</span></span></span></span></p>

      <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;background-color:white">&#160;</p>

        <table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width:100%;font:10pt Times New Roman, Times, Serif">

            <tr style="vertical-align:bottom;background-color:rgb(204,238,255)">
              <td style="width:35%;font:10pt Times New Roman, Times, Serif;text-align:justify;padding-left:2.5pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Assumed Portfolio Return (Net of Expenses)</span></span></span></span></td>
              <td style="width:1%;font:10pt Times New Roman, Times, Serif">&#160;</td>
              <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
              <td style="width:10%;font:10pt Times New Roman, Times, Serif;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(10.00</span></span></span></span></td>
              <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)%</span></span></span></span></td>
              <td style="width:1%;font:10pt Times New Roman, Times, Serif">&#160;</td>
              <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
              <td style="width:10%;font:10pt Times New Roman, Times, Serif;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(5.00</span></span></span></span></td>
              <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)%</span></span></span></span></td>
              <td style="width:1%;font:10pt Times New Roman, Times, Serif">&#160;</td>
              <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
              <td style="width:10%;font:10pt Times New Roman, Times, Serif;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>0.00</span></span></span></span></td>
              <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>%</span></span></span></span></td>
              <td style="width:1%;font:10pt Times New Roman, Times, Serif">&#160;</td>
              <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
              <td style="width:10%;font:10pt Times New Roman, Times, Serif;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>5.00</span></span></span></span></td>
              <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>%</span></span></span></span></td>
              <td style="width:1%;font:10pt Times New Roman, Times, Serif">&#160;</td>
              <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
              <td style="width:10%;font:10pt Times New Roman, Times, Serif;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>10.00</span></span></span></span></td>
              <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>%</span></span></span></span></td>
            </tr>
            <tr style="vertical-align:bottom;background-color:White">
              <td style="font:10pt Times New Roman, Times, Serif;text-align:justify;padding-left:2.5pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Corresponding Common Share Return<sup>(1)</sup></span></span></span></span></td>
              <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
              <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
              <td style="font:10pt Times New Roman, Times, Serif;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(18.76</span></span></span></span></td>
              <td style="font:10pt Times New Roman, Times, Serif;text-align:left"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)%</span></span></span></span></td>
              <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
              <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
              <td style="font:10pt Times New Roman, Times, Serif;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(10.56</span></span></span></span></td>
              <td style="font:10pt Times New Roman, Times, Serif;text-align:left"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)%</span></span></span></span></td>
              <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
              <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
              <td style="font:10pt Times New Roman, Times, Serif;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(2.36</span></span></span></span></td>
              <td style="font:10pt Times New Roman, Times, Serif;text-align:left"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)%</span></span></span></span></td>
              <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
              <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
              <td style="font:10pt Times New Roman, Times, Serif;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>5.84</span></span></span></span></td>
              <td style="font:10pt Times New Roman, Times, Serif;text-align:left"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>%</span></span></span></span></td>
              <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
              <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
              <td style="font:10pt Times New Roman, Times, Serif;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>14.04</span></span></span></span></td>
              <td style="font:10pt Times New Roman, Times, Serif;text-align:left"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>%</span></span></span></span></td>
            </tr>

        </table>

      <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0 0pt 2.5pt;text-align:justify">&#160;</p>
      <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0 0pt 2.5pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(1) Includes interest expense on the borrowings under the SSB Agreement, accrued at interest rates in effect on September 6, 2022 of 3.12%, and dividend expense on the MRP Shares.</span></span></span></span></p>
    </div>
  <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_AnnualInterestRatePercent', window );">Annual Interest Rate [Percent]</a></td>
<td class="nump">3.12%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_EffectsOfLeverageTableTextBlock', window );">Effects of Leverage [Table Text Block]</a></td>
<td class="text">
        <table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width:100%;font:10pt Times New Roman, Times, Serif">

            <tr style="vertical-align:bottom;background-color:rgb(204,238,255)">
              <td style="width:35%;font:10pt Times New Roman, Times, Serif;text-align:justify;padding-left:2.5pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Assumed Portfolio Return (Net of Expenses)</span></span></span></span></td>
              <td style="width:1%;font:10pt Times New Roman, Times, Serif">&#160;</td>
              <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
              <td style="width:10%;font:10pt Times New Roman, Times, Serif;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(10.00</span></span></span></span></td>
              <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)%</span></span></span></span></td>
              <td style="width:1%;font:10pt Times New Roman, Times, Serif">&#160;</td>
              <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
              <td style="width:10%;font:10pt Times New Roman, Times, Serif;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(5.00</span></span></span></span></td>
              <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)%</span></span></span></span></td>
              <td style="width:1%;font:10pt Times New Roman, Times, Serif">&#160;</td>
              <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
              <td style="width:10%;font:10pt Times New Roman, Times, Serif;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>0.00</span></span></span></span></td>
              <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>%</span></span></span></span></td>
              <td style="width:1%;font:10pt Times New Roman, Times, Serif">&#160;</td>
              <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
              <td style="width:10%;font:10pt Times New Roman, Times, Serif;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>5.00</span></span></span></span></td>
              <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>%</span></span></span></span></td>
              <td style="width:1%;font:10pt Times New Roman, Times, Serif">&#160;</td>
              <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
              <td style="width:10%;font:10pt Times New Roman, Times, Serif;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>10.00</span></span></span></span></td>
              <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>%</span></span></span></span></td>
            </tr>
            <tr style="vertical-align:bottom;background-color:White">
              <td style="font:10pt Times New Roman, Times, Serif;text-align:justify;padding-left:2.5pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Corresponding Common Share Return<sup>(1)</sup></span></span></span></span></td>
              <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
              <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
              <td style="font:10pt Times New Roman, Times, Serif;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(18.76</span></span></span></span></td>
              <td style="font:10pt Times New Roman, Times, Serif;text-align:left"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)%</span></span></span></span></td>
              <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
              <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
              <td style="font:10pt Times New Roman, Times, Serif;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(10.56</span></span></span></span></td>
              <td style="font:10pt Times New Roman, Times, Serif;text-align:left"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)%</span></span></span></span></td>
              <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
              <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
              <td style="font:10pt Times New Roman, Times, Serif;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(2.36</span></span></span></span></td>
              <td style="font:10pt Times New Roman, Times, Serif;text-align:left"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)%</span></span></span></span></td>
              <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
              <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
              <td style="font:10pt Times New Roman, Times, Serif;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>5.84</span></span></span></span></td>
              <td style="font:10pt Times New Roman, Times, Serif;text-align:left"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>%</span></span></span></span></td>
              <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
              <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
              <td style="font:10pt Times New Roman, Times, Serif;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>14.04</span></span></span></span></td>
              <td style="font:10pt Times New Roman, Times, Serif;text-align:left"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>%</span></span></span></span></td>
            </tr>

        </table>
      <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_ReturnAtMinusTenPercent', window );">Return at Minus Ten [Percent]</a></td>
<td class="num">(18.76%)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[9]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_ReturnAtMinusFivePercent', window );">Return at Minus Five [Percent]</a></td>
<td class="num">(10.56%)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[9]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_ReturnAtZeroPercent', window );">Return at Zero [Percent]</a></td>
<td class="num">(2.36%)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[9]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_ReturnAtPlusFivePercent', window );">Return at Plus Five [Percent]</a></td>
<td class="nump">5.84%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[9]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_ReturnAtPlusTenPercent', window );">Return at Plus Ten [Percent]</a></td>
<td class="nump">14.04%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[9]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_EffectsOfLeveragePurposeTextBlock', window );">Effects of Leverage, Purpose [Text Block]</a></td>
<td class="text">
        <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;background-color:white"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The following table illustrates the hypothetical effect on the return to a holder of the Fund's common shares of the leverage obtained by us (and utilized on September 6, 2022). The purpose of this table is to assist you in understanding the effects of leverage. As the table shows, leverage generally increases the return to common shareholders when portfolio return is positive and greater than the cost of leverage and decreases the return when the portfolio return is negative or less than the cost of leverage. The figures appearing in the table are hypothetical and actual returns may be greater or less than those appearing in the table.</span></span></span></span></p>
      <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_CapitalStockLongTermDebtAndOtherSecuritiesAbstract', window );"><strong>Capital Stock, Long-Term Debt, and Other Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_OutstandingSecuritiesTableTextBlock', window );">Outstanding Securities [Table Text Block]</a></td>
<td class="text">
    <div>
      <div style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The following table provides information about our outstanding securities as of September 6, 2022:</span></span></span></span></div>
      <div style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;background-color:white">&#160;</div>
      <table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width:80%;font:10pt Times New Roman, Times, Serif;margin:auto">

          <tr style="vertical-align:bottom">
            <td style="white-space:nowrap;font:bold 10pt Times New Roman, Times, Serif;border-bottom:Black 1pt solid"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Title of Class</span></span></span></span></td>
            <td style="white-space:nowrap;font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt">&#160;</td>
            <td colspan="2" style="white-space:nowrap;font:bold 10pt Times New Roman, Times, Serif;text-align:center;border-bottom:Black 1pt solid"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Amount Authorized</span></span></span></span></td>
            <td style="white-space:nowrap;padding-bottom:1pt;font:bold 10pt Times New Roman, Times, Serif">&#160;</td>
            <td style="white-space:nowrap;font:10pt Times New Roman, Times, Serif;padding-bottom:1pt">&#160;</td>
            <td colspan="2" style="white-space:nowrap;font:10pt Times New Roman, Times, Serif;text-align:center;border-bottom:Black 1pt solid">
              <div style="font:10pt Times New Roman, Times, Serif;margin:0pt 0 0pt 0.9pt;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong>Amount Held by the </strong></span></span></span></span></div>
              <div style="font:10pt Times New Roman, Times, Serif;margin:0pt 0 0pt 0.9pt;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong>Fund for its Account</strong></span></span></span></span></div>
            </td>
            <td style="white-space:nowrap;padding-bottom:1pt;font:10pt Times New Roman, Times, Serif">&#160;</td>
            <td style="white-space:nowrap;font:10pt Times New Roman, Times, Serif;padding-bottom:1pt">&#160;</td>
            <td colspan="2" style="white-space:nowrap;font:10pt Times New Roman, Times, Serif;text-align:center;border-bottom:Black 1pt solid">
              <div style="font:10pt Times New Roman, Times, Serif;margin:0pt 0 0pt 0.9pt;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong>Amount </strong></span></span></span></span></div>
              <div style="font:10pt Times New Roman, Times, Serif;margin:0pt 0 0pt 0.9pt;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong>Outstanding</strong></span></span></span></span></div>
            </td>
            <td style="white-space:nowrap;padding-bottom:1pt;font:10pt Times New Roman, Times, Serif">&#160;</td>
          </tr>
          <tr style="vertical-align:bottom;background-color:rgb(204,238,255)">
            <td style="width:55%;font:10pt Times New Roman, Times, Serif;padding-left:0.9pt"><span style="font-size:10pt"><span><span><span style="font:10pt Times New Roman, Times, serif">Common Shares</span></span></span></span></td>
            <td style="width:1%;font:10pt Times New Roman, Times, Serif">&#160;</td>
            <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
            <td style="width:12%;font:10pt Times New Roman, Times, Serif;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Unlimited</span></span></span></span></span></td>
            <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
            <td style="width:1%;font:10pt Times New Roman, Times, Serif">&#160;</td>
            <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
            <td style="width:12%;font:10pt Times New Roman, Times, Serif;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>9,812,054</span></span></span></span></td>
            <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
            <td style="width:1%;font:10pt Times New Roman, Times, Serif">&#160;</td>
            <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
            <td style="width:12%;font:10pt Times New Roman, Times, Serif;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>10,710,918</span></span></span></span></td>
            <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
          </tr>
          <tr style="vertical-align:bottom;background-color:White">
            <td style="font:10pt Times New Roman, Times, Serif;text-align:left;padding-left:0.25pt"><span style="font-size:10pt"><span><span><span style="font:10pt Times New Roman, Times, serif">MRPS-Series B</span></span></span></span></td>
            <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
            <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
            <td style="font:10pt Times New Roman, Times, Serif;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>160,000</span></span></span></span></td>
            <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
            <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
            <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
            <td style="font:10pt Times New Roman, Times, Serif;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>0</span></span></span></span></td>
            <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
            <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
            <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
            <td style="font:10pt Times New Roman, Times, Serif;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>160,000</span></span></span></span></td>
            <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
          </tr>
          <tr style="vertical-align:bottom;background-color:rgb(204,238,255)">
            <td style="font:10pt Times New Roman, Times, Serif;text-align:left;padding-left:0.9pt"><span style="font-size:10pt"><span><span><span style="font:10pt Times New Roman, Times, serif">MRPS-Series C</span></span></span></span></td>
            <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
            <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
            <td style="font:10pt Times New Roman, Times, Serif;text-align:right">160,000</td>
            <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
            <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
            <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
            <td style="font:10pt Times New Roman, Times, Serif;text-align:right">0</td>
            <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
            <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
            <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
            <td style="font:10pt Times New Roman, Times, Serif;text-align:right">160,000</td>
            <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
          </tr>
          <tr style="vertical-align:bottom;background-color:White">
            <td style="font:10pt Times New Roman, Times, Serif;text-align:left;padding-left:0.9pt"><span style="font-size:10pt"><span><span><span style="font:10pt Times New Roman, Times, serif">MRPS-Series D</span></span></span></span></td>
            <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
            <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
            <td style="font:10pt Times New Roman, Times, Serif;text-align:right">200,000</td>
            <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
            <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
            <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
            <td style="font:10pt Times New Roman, Times, Serif;text-align:right">0</td>
            <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
            <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
            <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
            <td style="font:10pt Times New Roman, Times, Serif;text-align:right">200,000</td>
            <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
          </tr>
          <tr style="vertical-align:bottom;background-color:rgb(204,238,255)">
            <td style="font:10pt Times New Roman, Times, Serif;text-align:left;padding-left:0.9pt"><span style="font-size:10pt"><span><span><span style="font:10pt Times New Roman, Times, serif">MRPS-Series E</span></span></span></span></td>
            <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
            <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
            <td style="font:10pt Times New Roman, Times, Serif;text-align:right">160,000</td>
            <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
            <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
            <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
            <td style="font:10pt Times New Roman, Times, Serif;text-align:right">0</td>
            <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
            <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
            <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
            <td style="font:10pt Times New Roman, Times, Serif;text-align:right">160,000</td>
            <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
          </tr>

      </table>
    </div>
  <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_SecurityAxis=ck0001285650_CommonSharesMember', window );">Common Shares [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_CapitalStockLongTermDebtAndOtherSecuritiesAbstract', window );"><strong>Capital Stock, Long-Term Debt, and Other Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_OutstandingSecurityTitleTextBlock', window );">Outstanding Security, Title [Text Block]</a></td>
<td class="text"><span style="font:10pt Times New Roman, Times, serif">Common Shares</span><span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_OutstandingSecurityHeldShares', window );">Outstanding Security, Held [Shares]</a></td>
<td class="nump">9,812,054<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_OutstandingSecurityNotHeldShares', window );">Outstanding Security, Not Held [Shares]</a></td>
<td class="nump">10,710,918<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_SecurityAxis=ck0001285650_MandatoryRedeemablePreferredSharesSeriesBMember', window );">Mandatory Redeemable Preferred Shares Series B [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_CapitalStockLongTermDebtAndOtherSecuritiesAbstract', window );"><strong>Capital Stock, Long-Term Debt, and Other Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_OutstandingSecurityTitleTextBlock', window );">Outstanding Security, Title [Text Block]</a></td>
<td class="text"><span style="font:10pt Times New Roman, Times, serif">MRPS-Series B</span><span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_OutstandingSecurityAuthorizedShares', window );">Outstanding Security, Authorized [Shares]</a></td>
<td class="nump">160,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_OutstandingSecurityHeldShares', window );">Outstanding Security, Held [Shares]</a></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_OutstandingSecurityNotHeldShares', window );">Outstanding Security, Not Held [Shares]</a></td>
<td class="nump">160,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_SecurityAxis=ck0001285650_MandatoryRedeemablePreferredSharesSeriesCMember', window );">Mandatory Redeemable Preferred Shares Series C [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_CapitalStockLongTermDebtAndOtherSecuritiesAbstract', window );"><strong>Capital Stock, Long-Term Debt, and Other Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_OutstandingSecurityTitleTextBlock', window );">Outstanding Security, Title [Text Block]</a></td>
<td class="text"><span style="font:10pt Times New Roman, Times, serif">MRPS-Series C</span><span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_OutstandingSecurityAuthorizedShares', window );">Outstanding Security, Authorized [Shares]</a></td>
<td class="nump">160,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_OutstandingSecurityHeldShares', window );">Outstanding Security, Held [Shares]</a></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_OutstandingSecurityNotHeldShares', window );">Outstanding Security, Not Held [Shares]</a></td>
<td class="nump">160,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_SecurityAxis=ck0001285650_MandatoryRedeemablePreferredSharesSeriesDMember', window );">Mandatory Redeemable Preferred Shares Series D [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_CapitalStockLongTermDebtAndOtherSecuritiesAbstract', window );"><strong>Capital Stock, Long-Term Debt, and Other Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_OutstandingSecurityTitleTextBlock', window );">Outstanding Security, Title [Text Block]</a></td>
<td class="text"><span style="font:10pt Times New Roman, Times, serif">MRPS-Series D</span><span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_OutstandingSecurityAuthorizedShares', window );">Outstanding Security, Authorized [Shares]</a></td>
<td class="nump">200,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_OutstandingSecurityHeldShares', window );">Outstanding Security, Held [Shares]</a></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_OutstandingSecurityNotHeldShares', window );">Outstanding Security, Not Held [Shares]</a></td>
<td class="nump">200,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_SecurityAxis=ck0001285650_MandatoryRedeemablePreferredSharesSeriesEMember', window );">Mandatory Redeemable Preferred Shares Series E [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_CapitalStockLongTermDebtAndOtherSecuritiesAbstract', window );"><strong>Capital Stock, Long-Term Debt, and Other Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_OutstandingSecurityTitleTextBlock', window );">Outstanding Security, Title [Text Block]</a></td>
<td class="text"><span style="font:10pt Times New Roman, Times, serif">MRPS-Series E</span><span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_OutstandingSecurityAuthorizedShares', window );">Outstanding Security, Authorized [Shares]</a></td>
<td class="nump">160,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_OutstandingSecurityHeldShares', window );">Outstanding Security, Held [Shares]</a></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_OutstandingSecurityNotHeldShares', window );">Outstanding Security, Not Held [Shares]</a></td>
<td class="nump">160,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr><td colspan="3"></td></tr>
<tr><td colspan="3"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Represents the estimated commission with respect to the Fund's common shares being sold in this offering. There is no guarantee that there will be any sales of the Fund's common shares pursuant to this prospectus supplement and the accompanying prospectus. Actual sales of the Fund's common shares under this prospectus supplement and the accompanying prospectus, if any, may be less than as set forth under "Capitalization" above. In addition, the price per share of any such sale may be greater or less than the price set forth under "Capitalization" above, depending on the market price of the Fund's common shares at the time of any such sale.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">Shareholders will pay a $15.00 transaction fee plus a $0.02 per share brokerage charge if they direct Computershare Shareowner Services LLC (the "Plan Agent") to sell common shares held in a Plan account. In addition, each participant will pay a pro rata share of brokerage commissions incurred with respect to the Plan Agent's open-market purchases in connection with the reinvestment of dividends or distributions. If a participant elects to have the Plan Agent sell part or all of his or her common shares and remit the proceeds, such participant will be charged his or her pro rata share of brokerage commissions on the shares sold. See "Dividends and Distributions on Common Shares; Automatic Dividend Reinvestment Plan" on page 77 of the accompanying prospectus.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[3]</td>
<td style="vertical-align: top;" valign="top">Calamos will pay the expenses of the offering (other than the applicable commissions). However, on a one year lag Calamos may recapture from the Fund previously paid offering expenses at a rate of $6,500 for each $1 million on sales (net of commissions) up to the lesser of $200,000 or actual costs. The Fund would accrue the costs over the following fiscal year. As of the date of this prospectus supplement and the accompanying prospectus, Calamos will pay all of the expenses associated with the offering (other than the applicable commissions). If the recapture provision is triggered in the future, such expenses that will be borne by Fund shareholders will be set forth in the "Shareholder Transaction Expenses" table above.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[4]</td>
<td style="vertical-align: top;" valign="top">The Fund pays Calamos an annual management fee, payable monthly in arrears, for its investment management services in an amount equal to 1.00% of the Fund's average weekly managed assets. In accordance with the requirements of the Commission, the table above shows the Fund's management fee as a percentage of average net assets attributable to common shareholders. By showing the management fee as a percentage of net assets, the management fee is not expressed as a percentage of all of the assets the Fund intends to invest. For purposes of the table, the management fee has been converted to 1.51% of the Fund's average weekly net assets as of September 6, 2022 by dividing the total dollar amount of the management fee by the Fund's average weekly net assets (managed assets less outstanding leverage).</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[5]</td>
<td style="vertical-align: top;" valign="top">Reflects interest expense paid on $9 million in average borrowings under the Fund's Amended and Restated Liquidity Agreement with State Street Bank and Trust Company, plus $34.8 million in additional average structural leverage related to certain securities lending programs, as described in the accompanying prospectus under "Leverage."</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[6]</td>
<td style="vertical-align: top;" valign="top">Reflects estimated dividend expense on $17 million aggregate liquidation preference of mandatory redeemable preferred shares ("MRP Shares" or "MRPS") outstanding. See "Prospectus Summary &#8212; Use of Leverage by the Fund" and "Leverage" in the accompanying prospectus for additional information.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[7]</td>
<td style="vertical-align: top;" valign="top">"Other Expenses" are based on estimated amounts for the Fund's current fiscal year.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[8]</td>
<td style="vertical-align: top;" valign="top">The example includes sales load and estimated offering costs.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[9]</td>
<td style="vertical-align: top;" valign="top">Includes interest expense on the borrowings under the SSB Agreement, accrued at interest rates in effect on September 6, 2022 of 3.12%, and dividend expense on the MRP Shares.</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_AnnualExpensesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br> -Paragraph Instruction 6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_AnnualExpensesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_AnnualInterestRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 8<br> -Subsection 3<br> -Paragraph b<br> -Subparagraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_AnnualInterestRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_BasisOfTransactionFeesNoteTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br> -Paragraph Instruction 4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_BasisOfTransactionFeesNoteTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_CapitalStockLongTermDebtAndOtherSecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_CapitalStockLongTermDebtAndOtherSecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_DividendExpenseOnPreferredSharesPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br> -Paragraph Instruction 9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_DividendExpenseOnPreferredSharesPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_DividendReinvestmentAndCashPurchaseFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_DividendReinvestmentAndCashPurchaseFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_EffectsOfLeveragePurposeTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 8<br> -Subsection 3<br> -Paragraph b<br> -Subparagraph 3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_EffectsOfLeveragePurposeTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_EffectsOfLeverageTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 8<br> -Subsection 3<br> -Paragraph b<br> -Subparagraph 3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_EffectsOfLeverageTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_EffectsOfLeverageTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 8<br> -Subsection 3<br> -Paragraph b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_EffectsOfLeverageTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_ExpenseExampleTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_ExpenseExampleTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_ExpenseExampleYear01">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br> -Paragraph Instruction 11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_ExpenseExampleYear01</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_ExpenseExampleYears1to10">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br> -Paragraph Instruction 11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_ExpenseExampleYears1to10</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_ExpenseExampleYears1to3">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br> -Paragraph Instruction 11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_ExpenseExampleYears1to3</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_ExpenseExampleYears1to5">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br> -Paragraph Instruction 11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_ExpenseExampleYears1to5</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_FeeTableAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_FeeTableAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_GeneralDescriptionOfRegistrantAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_GeneralDescriptionOfRegistrantAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_InterestExpensesOnBorrowingsPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br> -Paragraph Instruction 8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_InterestExpensesOnBorrowingsPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_ManagementFeeNotBasedOnNetAssetsNoteTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br> -Paragraph Instruction 7<br> -Subparagraph b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_ManagementFeeNotBasedOnNetAssetsNoteTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_ManagementFeesPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br> -Paragraph Instruction 7<br> -Subparagraph a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_ManagementFeesPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_OtherAnnualExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br> -Paragraph Instruction 9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_OtherAnnualExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_OtherAnnualExpensesPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br> -Paragraph Instruction 9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_OtherAnnualExpensesPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_OtherTransactionExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br> -Paragraph Instruction 5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_OtherTransactionExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_OtherTransactionExpensesPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br> -Paragraph Instruction 5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_OtherTransactionExpensesPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_OutstandingSecuritiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 10<br> -Subsection 5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_OutstandingSecuritiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_OutstandingSecurityAuthorizedShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 10<br> -Subsection 5<br> -Paragraph 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_OutstandingSecurityAuthorizedShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_OutstandingSecurityHeldShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 10<br> -Subsection 5<br> -Paragraph 3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_OutstandingSecurityHeldShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_OutstandingSecurityNotHeldShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 10<br> -Subsection 5<br> -Paragraph 4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_OutstandingSecurityNotHeldShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_OutstandingSecurityTitleTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 10<br> -Subsection 5<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_OutstandingSecurityTitleTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_PurposeOfFeeTableNoteTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br> -Paragraph Instruction 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_PurposeOfFeeTableNoteTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_ReturnAtMinusFivePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 8<br> -Subsection 3<br> -Paragraph b<br> -Subparagraph 3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_ReturnAtMinusFivePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_ReturnAtMinusTenPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 8<br> -Subsection 3<br> -Paragraph b<br> -Subparagraph 3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_ReturnAtMinusTenPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_ReturnAtPlusFivePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 8<br> -Subsection 3<br> -Paragraph b<br> -Subparagraph 3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_ReturnAtPlusFivePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_ReturnAtPlusTenPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 8<br> -Subsection 3<br> -Paragraph b<br> -Subparagraph 3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_ReturnAtPlusTenPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_ReturnAtZeroPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 8<br> -Subsection 3<br> -Paragraph b<br> -Subparagraph 3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_ReturnAtZeroPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_SalesLoadPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_SalesLoadPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_ShareholderTransactionExpensesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_ShareholderTransactionExpensesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_TotalAnnualExpensesPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br> -Paragraph Instruction 8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_TotalAnnualExpensesPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_SecurityAxis=ck0001285650_CommonSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_SecurityAxis=ck0001285650_CommonSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_SecurityAxis=ck0001285650_MandatoryRedeemablePreferredSharesSeriesBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_SecurityAxis=ck0001285650_MandatoryRedeemablePreferredSharesSeriesBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_SecurityAxis=ck0001285650_MandatoryRedeemablePreferredSharesSeriesCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_SecurityAxis=ck0001285650_MandatoryRedeemablePreferredSharesSeriesCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_SecurityAxis=ck0001285650_MandatoryRedeemablePreferredSharesSeriesDMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_SecurityAxis=ck0001285650_MandatoryRedeemablePreferredSharesSeriesDMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_SecurityAxis=ck0001285650_MandatoryRedeemablePreferredSharesSeriesEMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_SecurityAxis=ck0001285650_MandatoryRedeemablePreferredSharesSeriesEMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>tm2226808d4_424b3_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:cef="http://xbrl.sec.gov/cef/2022"
  xmlns:ck0001285650="http://www.calamos.com/20220930"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="ck0001285650-20220930.xsd" xlink:type="simple"/>
    <context id="C_20220930to20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001285650</identifier>
        </entity>
        <period>
            <startDate>2022-09-30</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="C_20220930to20220930_cefSecurityAxis_ck0001285650MandatoryRedeemablePreferredSharesSeriesBMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001285650</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:SecurityAxis">ck0001285650:MandatoryRedeemablePreferredSharesSeriesBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-30</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="C_20220930to20220930_cefSecurityAxis_ck0001285650MandatoryRedeemablePreferredSharesSeriesCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001285650</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:SecurityAxis">ck0001285650:MandatoryRedeemablePreferredSharesSeriesCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-30</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="C_20220930to20220930_cefSecurityAxis_ck0001285650MandatoryRedeemablePreferredSharesSeriesDMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001285650</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:SecurityAxis">ck0001285650:MandatoryRedeemablePreferredSharesSeriesDMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-30</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="C_20220930to20220930_cefSecurityAxis_ck0001285650MandatoryRedeemablePreferredSharesSeriesEMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001285650</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:SecurityAxis">ck0001285650:MandatoryRedeemablePreferredSharesSeriesEMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-30</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="C_20220930to20220930_cefSecurityAxis_ck0001285650CommonSharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001285650</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:SecurityAxis">ck0001285650:CommonSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-30</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <unit id="Pure">
        <measure>pure</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <dei:EntityCentralIndexKey
      contextRef="C_20220930to20220930"
      id="Fdei_EntityCentralIndexKey20220929104601661">0001285650</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag
      contextRef="C_20220930to20220930"
      id="Fdei_AmendmentFlag20220929104606790">false</dei:AmendmentFlag>
    <dei:DocumentType
      contextRef="C_20220930to20220930"
      id="Fdei_DocumentType20220929105659401">424B3</dei:DocumentType>
    <dei:EntityRegistrantName
      contextRef="C_20220930to20220930"
      id="Fxbrl_20220929153115609">Calamos Global Total Return Fund</dei:EntityRegistrantName>
    <cef:PurposeOfFeeTableNoteTextBlock
      contextRef="C_20220930to20220930"
      id="Fxbrl_20220929130737894">
    &lt;div&gt;
      &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;background-color:white"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;The following table and example contain information about the costs and expenses that common shareholders will bear directly or indirectly. In accordance with Commission requirements, the table below shows our expenses, including interest payments on borrowed funds, as a percentage of our average net assets as of September 6, 2022, and not as a percentage of gross assets or managed assets.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
      &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;background-color:white"&gt;&#160;&lt;/p&gt;
      &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;background-color:white"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;By showing expenses as a percentage of average net assets, expenses are not expressed as a percentage of all of the assets we invest. The table and example are based on our capital structure as of September 6, 2022. As of September 6, 2022, we had $1.5 million in borrowings outstanding, $17 million in outstanding preferred shares and additional structural leverage of $25 million, collectively representing 30.3% of managed assets as of that date.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;/div&gt;
  </cef:PurposeOfFeeTableNoteTextBlock>
    <cef:ShareholderTransactionExpensesTableTextBlock
      contextRef="C_20220930to20220930"
      id="Fxbrl_20220929114119577">
    &lt;table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width:90%;font:10pt Times New Roman, Times, Serif" width="90%"&gt;

        &lt;tr style="vertical-align:bottom"&gt;
          &lt;td style="font:bold 10pt Times New Roman, Times, Serif;text-align:justify;border-bottom:Black 1pt solid"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Shareholder Transaction Expenses&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
          &lt;td style="font-size:10pt;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
          &lt;td colspan="2" style="font-size:10pt;text-align:justify"&gt;&#160;&lt;/td&gt;
          &lt;td style="padding-bottom:1pt;font-size:10pt"&gt;&#160;&lt;/td&gt;
          &lt;td style="padding-bottom:1pt;font-size:10pt"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="vertical-align:bottom;background-color:rgb(204,238,255)"&gt;
          &lt;td style="font:10pt Times New Roman, Times, serif;text-align:justify;width:78%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Sales Load (&lt;span style="font:10pt Times New Roman, Times, serif"&gt;as a percentage of offering price&lt;/span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
          &lt;td style="font:10pt Times New Roman, Times, serif;width:1%"&gt;&#160;&lt;/td&gt;
          &lt;td style="font:10pt Times New Roman, Times, serif;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
          &lt;td style="font:10pt Times New Roman, Times, serif;text-align:right;width:18%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;1.00&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
          &lt;td style="font:10pt Times New Roman, Times, serif;text-align:left;width:1%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;%&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
          &lt;td style="font:10pt Times New Roman, Times, serif;text-align:left;width:1%"&gt;
            &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;sup&gt;(1)&lt;/sup&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="vertical-align:bottom;background-color:White"&gt;
          &lt;td style="font:10pt Times New Roman, Times, serif;text-align:justify;width:78%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Offering Expenses Borne by the Fund (&lt;span style="font:10pt Times New Roman, Times, serif"&gt;as a percentage of offering price&lt;/span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
          &lt;td style="font:10pt Times New Roman, Times, serif;width:1%"&gt;&#160;&lt;/td&gt;
          &lt;td style="font:10pt Times New Roman, Times, serif;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
          &lt;td style="font:10pt Times New Roman, Times, serif;text-align:right;width:18%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
          &lt;td style="font:10pt Times New Roman, Times, serif;text-align:left;width:1%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;%&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
          &lt;td style="font:10pt Times New Roman, Times, serif;text-align:left;width:1%"&gt;
            &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;sup&gt;(2)&lt;/sup&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="vertical-align:bottom;background-color:rgb(204,238,255)"&gt;
          &lt;td style="font:10pt Times New Roman, Times, serif;text-align:justify;width:78%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Dividend Reinvestment Plan Fees (per sales transaction fee)&lt;sup&gt;(3)&lt;/sup&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
          &lt;td style="font:10pt Times New Roman, Times, serif;width:1%"&gt;&#160;&lt;/td&gt;
          &lt;td style="font:10pt Times New Roman, Times, serif;text-align:left;width:1%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
          &lt;td style="font:10pt Times New Roman, Times, serif;text-align:right;width:18%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;15.00&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
          &lt;td style="font:10pt Times New Roman, Times, serif;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
          &lt;td style="font:10pt Times New Roman, Times, serif;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;

    &lt;/table&gt;
  </cef:ShareholderTransactionExpensesTableTextBlock>
    <cef:BasisOfTransactionFeesNoteTextBlock
      contextRef="C_20220930to20220930"
      id="Fxbrl_20220929113312049">&lt;span style="font:10pt Times New Roman, Times, serif"&gt;as a percentage of offering price&lt;/span&gt;</cef:BasisOfTransactionFeesNoteTextBlock>
    <cef:SalesLoadPercent
      contextRef="C_20220930to20220930"
      decimals="4"
      id="Fxbrl_20220929112500797"
      unitRef="Pure">0.01</cef:SalesLoadPercent>
    <cef:BasisOfTransactionFeesNoteTextBlock
      contextRef="C_20220930to20220930"
      id="Fxbrl_20220929113430396">&lt;span style="font:10pt Times New Roman, Times, serif"&gt;as a percentage of offering price&lt;/span&gt;</cef:BasisOfTransactionFeesNoteTextBlock>
    <cef:OtherTransactionExpensesPercent
      contextRef="C_20220930to20220930"
      decimals="2"
      id="Fxbrl_20220929112617176"
      unitRef="Pure">0</cef:OtherTransactionExpensesPercent>
    <cef:DividendReinvestmentAndCashPurchaseFees
      contextRef="C_20220930to20220930"
      decimals="2"
      id="Fxbrl_20220929112636853"
      unitRef="USD">15</cef:DividendReinvestmentAndCashPurchaseFees>
    <cef:AnnualExpensesTableTextBlock
      contextRef="C_20220930to20220930"
      id="Fxbrl_20220929114148337">
    &lt;table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width:90%;font:10pt Times New Roman, Times, Serif"&gt;

        &lt;tr style="vertical-align:bottom"&gt;
          &lt;td style="white-space:nowrap;font:bold 10pt Times New Roman, Times, Serif;text-align:justify;border-bottom:Black 1pt solid"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Annual Expenses&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
          &lt;td style="white-space:nowrap;font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
          &lt;td colspan="2" style="white-space:nowrap;font:bold 10pt Times New Roman, Times, Serif;text-align:center;border-bottom:Black 1pt solid"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Percentage&#160;of&#160;Average Net&lt;br/&gt;Assets Attributable to&lt;br/&gt;Common Shareholders&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
          &lt;td style="white-space:nowrap;padding-bottom:1pt;font:bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="vertical-align:bottom;background-color:rgb(204,238,255)"&gt;
          &lt;td style="width:79%;font:10pt Times New Roman, Times, Serif;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Management Fee&lt;sup&gt;(4)&lt;/sup&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
          &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
          &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
          &lt;td style="width:18%;font:10pt Times New Roman, Times, Serif;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;1.51&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
          &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;%&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="vertical-align:bottom;background-color:White"&gt;
          &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Interest Payments on Borrowed Funds&lt;sup&gt;(5)&lt;/sup&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
          &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
          &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
          &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;0.35&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
          &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;%&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="vertical-align:bottom;background-color:rgb(204,238,255)"&gt;
          &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Preferred Stock Dividend Payments&lt;sup&gt;(6)&lt;/sup&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
          &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
          &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
          &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;0.55&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
          &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;%&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="vertical-align:bottom;background-color:White"&gt;
          &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Other Expenses&lt;sup&gt;(7)&lt;/sup&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
          &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
          &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
          &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;0.32&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
          &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;%&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="vertical-align:bottom;background-color:rgb(204,238,255)"&gt;
          &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Total Annual Expenses&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
          &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
          &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
          &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;2.73&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
          &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;%&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
        &lt;/tr&gt;

    &lt;/table&gt;
  </cef:AnnualExpensesTableTextBlock>
    <cef:ManagementFeesPercent
      contextRef="C_20220930to20220930"
      decimals="4"
      id="Fxbrl_20220929113617094"
      unitRef="Pure">0.0151</cef:ManagementFeesPercent>
    <cef:InterestExpensesOnBorrowingsPercent
      contextRef="C_20220930to20220930"
      decimals="4"
      id="Fxbrl_20221001021619972"
      unitRef="Pure">0.0035</cef:InterestExpensesOnBorrowingsPercent>
    <cef:DividendExpenseOnPreferredSharesPercent
      contextRef="C_20220930to20220930"
      decimals="4"
      id="Fxbrl_20220929113717521"
      unitRef="Pure">0.0055</cef:DividendExpenseOnPreferredSharesPercent>
    <cef:OtherAnnualExpensesPercent
      contextRef="C_20220930to20220930"
      decimals="4"
      id="Fxbrl_20220929113811453"
      unitRef="Pure">0.0032</cef:OtherAnnualExpensesPercent>
    <cef:TotalAnnualExpensesPercent
      contextRef="C_20220930to20220930"
      decimals="4"
      id="Fxbrl_20220929113907282"
      unitRef="Pure">0.0273</cef:TotalAnnualExpensesPercent>
    <cef:ExpenseExampleTableTextBlock
      contextRef="C_20220930to20220930"
      id="Fxbrl_20221001021123702">
    &lt;div&gt;
      &lt;div&gt;
        &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;background-color:white"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;The following example illustrates the expenses that common shareholders would pay on a $1,000 investment in common shares, assuming (1) net annual expenses of 2.73% of net assets attributable to common shareholders; (2) a 5% annual gross return; and (3) all distributions are reinvested at net asset value:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;background-color:white"&gt;&#160;&lt;/p&gt;
        &lt;table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width:100%;font:10pt Times New Roman, Times, Serif"&gt;

            &lt;tr style="vertical-align:bottom"&gt;
              &lt;td style="font-size:10pt;text-align:center"&gt;&#160;&lt;/td&gt;
              &lt;td style="text-align:center;font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
              &lt;td colspan="2" style="border-bottom:Black 1pt solid;font:bold 10pt Times New Roman, Times, Serif;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;1 Year&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="text-align:center;padding-bottom:1pt;font:bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
              &lt;td style="text-align:center;font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
              &lt;td colspan="2" style="border-bottom:Black 1pt solid;font:bold 10pt Times New Roman, Times, Serif;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;3 Years&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="text-align:center;padding-bottom:1pt;font:bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
              &lt;td style="text-align:center;font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
              &lt;td colspan="2" style="border-bottom:Black 1pt solid;font:bold 10pt Times New Roman, Times, Serif;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;5 Years&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="text-align:center;padding-bottom:1pt;font:bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
              &lt;td style="text-align:center;font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
              &lt;td colspan="2" style="border-bottom:Black 1pt solid;font:bold 10pt Times New Roman, Times, Serif;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;10 Years&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="text-align:center;padding-bottom:1pt;font:bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr style="vertical-align:bottom;background-color:rgb(204,238,255)"&gt;
              &lt;td style="width:48%;font:10pt Times New Roman, Times, Serif;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Total Expenses Paid by Common Shareholders&lt;sup&gt;(8)&lt;/sup&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
              &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:10%;font:10pt Times New Roman, Times, Serif;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;37&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
              &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
              &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:10%;font:10pt Times New Roman, Times, Serif;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;94&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
              &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
              &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:10%;font:10pt Times New Roman, Times, Serif;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;153&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
              &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
              &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:10%;font:10pt Times New Roman, Times, Serif;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;313&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;

        &lt;/table&gt;
      &lt;/div&gt;
      &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;background-color:white"&gt;&#160;&lt;/p&gt;
      &lt;div style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;background-color:white"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;The example should not be considered a representation of future expenses. Actual expenses may be greater or less than those assumed. Moreover, our actual rate of return may be greater or less than the hypothetical 5% return shown in the example.&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
    &lt;/div&gt;
  </cef:ExpenseExampleTableTextBlock>
    <cef:ExpenseExampleYear01
      contextRef="C_20220930to20220930"
      decimals="0"
      id="Fxbrl_20220929114522735"
      unitRef="USD">37</cef:ExpenseExampleYear01>
    <cef:ExpenseExampleYears1to3
      contextRef="C_20220930to20220930"
      decimals="0"
      id="Fxbrl_20220929114620465"
      unitRef="USD">94</cef:ExpenseExampleYears1to3>
    <cef:ExpenseExampleYears1to5
      contextRef="C_20220930to20220930"
      decimals="0"
      id="Fxbrl_20220929114644347"
      unitRef="USD">153</cef:ExpenseExampleYears1to5>
    <cef:ExpenseExampleYears1to10
      contextRef="C_20220930to20220930"
      decimals="0"
      id="Fxbrl_20220929114705250"
      unitRef="USD">313</cef:ExpenseExampleYears1to10>
    <cef:ManagementFeeNotBasedOnNetAssetsNoteTextBlock
      contextRef="C_20220930to20220930"
      id="Fxbrl_20220929114954484">&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;The Fund pays Calamos an annual management fee, payable monthly in arrears, for its investment management services in an amount equal to 1.00% of the Fund's average weekly managed assets. In accordance with the requirements of the Commission, the table above shows the Fund's management fee as a percentage of average net assets attributable to common shareholders. By showing the management fee as a percentage of net assets, the management fee is not expressed as a percentage of all of the assets the Fund intends to invest. For purposes of the table, the management fee has been converted to 1.51% of the Fund's average weekly net assets as of September 6, 2022 by dividing the total dollar amount of the management fee by the Fund's average weekly net assets (managed assets less outstanding leverage).&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;</cef:ManagementFeeNotBasedOnNetAssetsNoteTextBlock>
    <cef:OutstandingSecuritiesTableTextBlock
      contextRef="C_20220930to20220930"
      id="Fxbrl_20220929131822607">
    &lt;div&gt;
      &lt;div style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;The following table provides information about our outstanding securities as of September 6, 2022:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
      &lt;div style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;background-color:white"&gt;&#160;&lt;/div&gt;
      &lt;table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width:80%;font:10pt Times New Roman, Times, Serif;margin:auto"&gt;

          &lt;tr style="vertical-align:bottom"&gt;
            &lt;td style="white-space:nowrap;font:bold 10pt Times New Roman, Times, Serif;border-bottom:Black 1pt solid"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Title of Class&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
            &lt;td style="white-space:nowrap;font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
            &lt;td colspan="2" style="white-space:nowrap;font:bold 10pt Times New Roman, Times, Serif;text-align:center;border-bottom:Black 1pt solid"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Amount Authorized&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
            &lt;td style="white-space:nowrap;padding-bottom:1pt;font:bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
            &lt;td style="white-space:nowrap;font:10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
            &lt;td colspan="2" style="white-space:nowrap;font:10pt Times New Roman, Times, Serif;text-align:center;border-bottom:Black 1pt solid"&gt;
              &lt;div style="font:10pt Times New Roman, Times, Serif;margin:0pt 0 0pt 0.9pt;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;Amount Held by the &lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;div style="font:10pt Times New Roman, Times, Serif;margin:0pt 0 0pt 0.9pt;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;Fund for its Account&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td style="white-space:nowrap;padding-bottom:1pt;font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
            &lt;td style="white-space:nowrap;font:10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
            &lt;td colspan="2" style="white-space:nowrap;font:10pt Times New Roman, Times, Serif;text-align:center;border-bottom:Black 1pt solid"&gt;
              &lt;div style="font:10pt Times New Roman, Times, Serif;margin:0pt 0 0pt 0.9pt;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;Amount &lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;div style="font:10pt Times New Roman, Times, Serif;margin:0pt 0 0pt 0.9pt;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;Outstanding&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td style="white-space:nowrap;padding-bottom:1pt;font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="vertical-align:bottom;background-color:rgb(204,238,255)"&gt;
            &lt;td style="width:55%;font:10pt Times New Roman, Times, Serif;padding-left:0.9pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font:10pt Times New Roman, Times, serif"&gt;Common Shares&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
            &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
            &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
            &lt;td style="width:12%;font:10pt Times New Roman, Times, Serif;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Unlimited&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
            &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
            &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
            &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
            &lt;td style="width:12%;font:10pt Times New Roman, Times, Serif;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;9,812,054&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
            &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
            &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
            &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
            &lt;td style="width:12%;font:10pt Times New Roman, Times, Serif;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;10,710,918&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
            &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="vertical-align:bottom;background-color:White"&gt;
            &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left;padding-left:0.25pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font:10pt Times New Roman, Times, serif"&gt;MRPS-Series B&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
            &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
            &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
            &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;160,000&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
            &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
            &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
            &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
            &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;0&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
            &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
            &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
            &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
            &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;160,000&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
            &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="vertical-align:bottom;background-color:rgb(204,238,255)"&gt;
            &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left;padding-left:0.9pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font:10pt Times New Roman, Times, serif"&gt;MRPS-Series C&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
            &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
            &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
            &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;160,000&lt;/td&gt;
            &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
            &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
            &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
            &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;0&lt;/td&gt;
            &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
            &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
            &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
            &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;160,000&lt;/td&gt;
            &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="vertical-align:bottom;background-color:White"&gt;
            &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left;padding-left:0.9pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font:10pt Times New Roman, Times, serif"&gt;MRPS-Series D&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
            &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
            &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
            &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;200,000&lt;/td&gt;
            &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
            &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
            &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
            &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;0&lt;/td&gt;
            &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
            &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
            &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
            &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;200,000&lt;/td&gt;
            &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="vertical-align:bottom;background-color:rgb(204,238,255)"&gt;
            &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left;padding-left:0.9pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font:10pt Times New Roman, Times, serif"&gt;MRPS-Series E&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
            &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
            &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
            &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;160,000&lt;/td&gt;
            &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
            &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
            &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
            &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;0&lt;/td&gt;
            &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
            &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
            &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
            &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;160,000&lt;/td&gt;
            &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
          &lt;/tr&gt;

      &lt;/table&gt;
    &lt;/div&gt;
  </cef:OutstandingSecuritiesTableTextBlock>
    <cef:OutstandingSecurityTitleTextBlock
      contextRef="C_20220930to20220930_cefSecurityAxis_ck0001285650CommonSharesMember"
      id="Fxbrl_20220929131304038">&lt;span style="font:10pt Times New Roman, Times, serif"&gt;Common Shares&lt;/span&gt;</cef:OutstandingSecurityTitleTextBlock>
    <cef:OutstandingSecurityHeldShares
      contextRef="C_20220930to20220930_cefSecurityAxis_ck0001285650CommonSharesMember"
      decimals="INF"
      id="Fxbrl_20220929121333381"
      unitRef="Shares">9812054</cef:OutstandingSecurityHeldShares>
    <cef:OutstandingSecurityNotHeldShares
      contextRef="C_20220930to20220930_cefSecurityAxis_ck0001285650CommonSharesMember"
      decimals="INF"
      id="Fxbrl_20220929121344952"
      unitRef="Shares">10710918</cef:OutstandingSecurityNotHeldShares>
    <cef:OutstandingSecurityTitleTextBlock
      contextRef="C_20220930to20220930_cefSecurityAxis_ck0001285650MandatoryRedeemablePreferredSharesSeriesBMember"
      id="Fxbrl_20220929131350718">&lt;span style="font:10pt Times New Roman, Times, serif"&gt;MRPS-Series B&lt;/span&gt;</cef:OutstandingSecurityTitleTextBlock>
    <cef:OutstandingSecurityAuthorizedShares
      contextRef="C_20220930to20220930_cefSecurityAxis_ck0001285650MandatoryRedeemablePreferredSharesSeriesBMember"
      decimals="INF"
      id="Fxbrl_20220929121047001"
      unitRef="Shares">160000</cef:OutstandingSecurityAuthorizedShares>
    <cef:OutstandingSecurityHeldShares
      contextRef="C_20220930to20220930_cefSecurityAxis_ck0001285650MandatoryRedeemablePreferredSharesSeriesBMember"
      decimals="INF"
      id="Fxbrl_20220929121149545"
      unitRef="Shares">0</cef:OutstandingSecurityHeldShares>
    <cef:OutstandingSecurityNotHeldShares
      contextRef="C_20220930to20220930_cefSecurityAxis_ck0001285650MandatoryRedeemablePreferredSharesSeriesBMember"
      decimals="INF"
      id="Fxbrl_20220929121217818"
      unitRef="Shares">160000</cef:OutstandingSecurityNotHeldShares>
    <cef:OutstandingSecurityTitleTextBlock
      contextRef="C_20220930to20220930_cefSecurityAxis_ck0001285650MandatoryRedeemablePreferredSharesSeriesCMember"
      id="Fxbrl_20220929131420207">&lt;span style="font:10pt Times New Roman, Times, serif"&gt;MRPS-Series C&lt;/span&gt;</cef:OutstandingSecurityTitleTextBlock>
    <cef:OutstandingSecurityAuthorizedShares
      contextRef="C_20220930to20220930_cefSecurityAxis_ck0001285650MandatoryRedeemablePreferredSharesSeriesCMember"
      decimals="INF"
      id="Fxbrl_20220929121245938_3_3"
      unitRef="Shares">160000</cef:OutstandingSecurityAuthorizedShares>
    <cef:OutstandingSecurityHeldShares
      contextRef="C_20220930to20220930_cefSecurityAxis_ck0001285650MandatoryRedeemablePreferredSharesSeriesCMember"
      decimals="INF"
      id="Fxbrl_20220929121245938_7_3"
      unitRef="Shares">0</cef:OutstandingSecurityHeldShares>
    <cef:OutstandingSecurityNotHeldShares
      contextRef="C_20220930to20220930_cefSecurityAxis_ck0001285650MandatoryRedeemablePreferredSharesSeriesCMember"
      decimals="INF"
      id="Fxbrl_20220929121245938_11_3"
      unitRef="Shares">160000</cef:OutstandingSecurityNotHeldShares>
    <cef:OutstandingSecurityTitleTextBlock
      contextRef="C_20220930to20220930_cefSecurityAxis_ck0001285650MandatoryRedeemablePreferredSharesSeriesDMember"
      id="Fxbrl_20220929131444270">&lt;span style="font:10pt Times New Roman, Times, serif"&gt;MRPS-Series D&lt;/span&gt;</cef:OutstandingSecurityTitleTextBlock>
    <cef:OutstandingSecurityAuthorizedShares
      contextRef="C_20220930to20220930_cefSecurityAxis_ck0001285650MandatoryRedeemablePreferredSharesSeriesDMember"
      decimals="INF"
      id="Fxbrl_20220929121245938_3_4"
      unitRef="Shares">200000</cef:OutstandingSecurityAuthorizedShares>
    <cef:OutstandingSecurityHeldShares
      contextRef="C_20220930to20220930_cefSecurityAxis_ck0001285650MandatoryRedeemablePreferredSharesSeriesDMember"
      decimals="INF"
      id="Fxbrl_20220929121245938_7_4"
      unitRef="Shares">0</cef:OutstandingSecurityHeldShares>
    <cef:OutstandingSecurityNotHeldShares
      contextRef="C_20220930to20220930_cefSecurityAxis_ck0001285650MandatoryRedeemablePreferredSharesSeriesDMember"
      decimals="INF"
      id="Fxbrl_20220929121245938_11_4"
      unitRef="Shares">200000</cef:OutstandingSecurityNotHeldShares>
    <cef:OutstandingSecurityTitleTextBlock
      contextRef="C_20220930to20220930_cefSecurityAxis_ck0001285650MandatoryRedeemablePreferredSharesSeriesEMember"
      id="Fxbrl_20220929131525264">&lt;span style="font:10pt Times New Roman, Times, serif"&gt;MRPS-Series E&lt;/span&gt;</cef:OutstandingSecurityTitleTextBlock>
    <cef:OutstandingSecurityAuthorizedShares
      contextRef="C_20220930to20220930_cefSecurityAxis_ck0001285650MandatoryRedeemablePreferredSharesSeriesEMember"
      decimals="INF"
      id="Fxbrl_20220929121245938_3_5"
      unitRef="Shares">160000</cef:OutstandingSecurityAuthorizedShares>
    <cef:OutstandingSecurityHeldShares
      contextRef="C_20220930to20220930_cefSecurityAxis_ck0001285650MandatoryRedeemablePreferredSharesSeriesEMember"
      decimals="INF"
      id="Fxbrl_20220929121245938_7_5"
      unitRef="Shares">0</cef:OutstandingSecurityHeldShares>
    <cef:OutstandingSecurityNotHeldShares
      contextRef="C_20220930to20220930_cefSecurityAxis_ck0001285650MandatoryRedeemablePreferredSharesSeriesEMember"
      decimals="INF"
      id="Fxbrl_20220929121245938_11_5"
      unitRef="Shares">160000</cef:OutstandingSecurityNotHeldShares>
    <cef:EffectsOfLeverageTextBlock
      contextRef="C_20220930to20220930"
      id="Fxbrl_20220929125934725">
    &lt;div&gt;
      &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;background-color:white"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;The SSB Agreement provides for credit availability for the Fund, such that it may borrow up to $55 million. As of September 6, 2022, the Fund had utilized $26 million of the $55 million available under the SSB Agreement ($1.5 million in borrowings outstanding, and $24.5 million in structural leverage consisting of collateral received from SSB in connection with securities on loan), representing 18.3% of the Fund's managed assets as of that date, and had $17 million of MRP Shares outstanding, representing 12.0% of the Fund's managed assets. Combined, the borrowings under the SSB Agreement and the outstanding MRP Shares represented 30.3% of the Fund's managed assets. Interest on the SSB Agreement is charged on the drawn amount at the rate of the Overnight Bank Financing Rate&#160;(&#x201c;OBFR&#x201d;) plus 0.80%, payable monthly in arrears. Interest on overdue amounts or interest on the drawn amount paid during an event of default will be charged at OBFR plus 2.80%. These rates represent floating rates of interest that may change over time. The SSB Agreement has a commitment fee of 0.10% of any undrawn amount. As of September 6, 2022, the interest rate charged under the SSB Agreement was 3.12%. "Net income" payments related to cash collateral in connection with securities lending were 1.56% of the borrowed amount on an annualized basis as of that date, although this amount can vary based on changes in underlying interest rates.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
      &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;background-color:white"&gt;&#160;&lt;/p&gt;
      &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;background-color:white"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;The Fund's MRP Shareholders are entitled to receive monthly cash dividends, at a currently effective dividend rate per annum for each series of MRP Shares as follows (subject to adjustment as described above in "Mandatory Redeemable Preferred Shares"): 4.00% for Series B MRP Shares, 4.24% for Series C MRP Shares, 2.45% for Series D MRP Shares, and 2.68% for Series E MRP Shares.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
      &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;background-color:white"&gt;&#160;&lt;/p&gt;
      &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;background-color:white"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;To cover the interest expense on the borrowings under the SSB Agreement (including "net income" payments made with respect to borrowings offset by collateral for securities on loan) and the dividend payments associated with the MRP Shares, based on rates in effect on September 6, 2022, the Fund's portfolio would need to experience an annual return of 2.73% (before giving effect to expenses associated with senior securities).&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
      &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;background-color:white"&gt;&#160;&lt;/p&gt;
      &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;background-color:white"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Leverage is a speculative technique that could adversely affect the returns to common shareholders. Leverage can cause the Fund to lose money and can magnify the effect of any losses. To the extent the income or capital appreciation derived from securities purchased with funds received from leverage exceeds the cost of leverage, the Fund's return will be greater than if leverage had not been used. Conversely, if the income or capital appreciation from the securities purchased with such funds is not sufficient to cover the cost of leverage or if the Fund incurs capital losses, the return of the Fund will be less than if leverage had not been used, and therefore the amount available for distribution to common shareholders as dividends and other distributions will be reduced or potentially eliminated.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
      &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;background-color:white"&gt;&#160;&lt;/p&gt;
      &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;background-color:white"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;The Fund will pay, and common shareholders will effectively bear, any costs and expenses relating to any borrowings and to the issuance and ongoing maintenance of preferred shares, including the MRP Shares, or debt securities. Such costs and expenses include the higher management fee resulting from the use of any such leverage, offering and/or issuance costs, and interest and/or dividend expense and ongoing maintenance.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
      &lt;div style="margin-top:0pt;margin-bottom:6pt"&gt;&#160;&lt;/div&gt;
      &lt;div style="break-before:page;margin-top:6pt;margin-bottom:12pt"&gt;
        &lt;p style="margin:0pt"&gt;&#160;&lt;/p&gt;
      &lt;/div&gt;
      &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;background-color:white"&gt;&#160;&lt;/p&gt;
      &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;background-color:white"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Certain types of borrowings may result in the Fund being subject to covenants in credit agreements, including those relating to asset coverage, borrowing base and portfolio composition requirements and additional covenants that may affect the Fund's ability to pay dividends and distributions on common shares in certain instances. The Fund may also be required to pledge its assets to the lenders in connection with certain types of borrowings. The Fund may be subject to certain restrictions on investments imposed by guidelines of and covenants with rating agencies for the preferred shares or short-term debt instruments issued by the Fund. These guidelines and covenants may impose asset coverage or portfolio composition requirements that are more stringent than those imposed by the 1940 Act.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
      &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;background-color:white"&gt;&#160;&lt;/p&gt;
      &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;background-color:white"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Because Calamos' investment management fee is a percentage of the Fund's managed assets, Calamos' fee will be higher if the Fund is leveraged and Calamos will have an incentive to be more aggressive and leverage the Fund. Consequently, the Fund and Calamos may have differing interests in determining whether to leverage the Fund's assets. Any additional use of leverage by the Fund effected through new, additional or increased credit facilities or the issuance of preferred shares would require approval by the Board of Trustees of the Fund.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
      &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;background-color:white"&gt;&#160;&lt;/p&gt;

        &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;background-color:white"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;The following table illustrates the hypothetical effect on the return to a holder of the Fund's common shares of the leverage obtained by us (and utilized on September 6, 2022). The purpose of this table is to assist you in understanding the effects of leverage. As the table shows, leverage generally increases the return to common shareholders when portfolio return is positive and greater than the cost of leverage and decreases the return when the portfolio return is negative or less than the cost of leverage. The figures appearing in the table are hypothetical and actual returns may be greater or less than those appearing in the table.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

      &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;background-color:white"&gt;&#160;&lt;/p&gt;

        &lt;table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width:100%;font:10pt Times New Roman, Times, Serif"&gt;

            &lt;tr style="vertical-align:bottom;background-color:rgb(204,238,255)"&gt;
              &lt;td style="width:35%;font:10pt Times New Roman, Times, Serif;text-align:justify;padding-left:2.5pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Assumed Portfolio Return (Net of Expenses)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
              &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
              &lt;td style="width:10%;font:10pt Times New Roman, Times, Serif;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;(10.00&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;)%&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
              &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
              &lt;td style="width:10%;font:10pt Times New Roman, Times, Serif;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;(5.00&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;)%&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
              &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
              &lt;td style="width:10%;font:10pt Times New Roman, Times, Serif;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;0.00&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;%&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
              &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
              &lt;td style="width:10%;font:10pt Times New Roman, Times, Serif;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;5.00&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;%&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
              &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
              &lt;td style="width:10%;font:10pt Times New Roman, Times, Serif;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;10.00&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;%&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr style="vertical-align:bottom;background-color:White"&gt;
              &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:justify;padding-left:2.5pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Corresponding Common Share Return&lt;sup&gt;(1)&lt;/sup&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
              &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
              &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;(18.76&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;)%&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
              &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
              &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;(10.56&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;)%&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
              &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
              &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;(2.36&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;)%&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
              &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
              &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;5.84&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;%&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
              &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
              &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;14.04&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;%&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
            &lt;/tr&gt;

        &lt;/table&gt;

      &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0 0pt 2.5pt;text-align:justify"&gt;&#160;&lt;/p&gt;
      &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0 0pt 2.5pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;(1) Includes interest expense on the borrowings under the SSB Agreement, accrued at interest rates in effect on September 6, 2022 of 3.12%, and dividend expense on the MRP Shares.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;/div&gt;
  </cef:EffectsOfLeverageTextBlock>
    <cef:EffectsOfLeveragePurposeTextBlock
      contextRef="C_20220930to20220930"
      id="Fxbrl_20220929124300223">
        &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;background-color:white"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;The following table illustrates the hypothetical effect on the return to a holder of the Fund's common shares of the leverage obtained by us (and utilized on September 6, 2022). The purpose of this table is to assist you in understanding the effects of leverage. As the table shows, leverage generally increases the return to common shareholders when portfolio return is positive and greater than the cost of leverage and decreases the return when the portfolio return is negative or less than the cost of leverage. The figures appearing in the table are hypothetical and actual returns may be greater or less than those appearing in the table.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
      </cef:EffectsOfLeveragePurposeTextBlock>
    <cef:EffectsOfLeverageTableTextBlock
      contextRef="C_20220930to20220930"
      id="Fxbrl_20220929124222775">
        &lt;table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width:100%;font:10pt Times New Roman, Times, Serif"&gt;

            &lt;tr style="vertical-align:bottom;background-color:rgb(204,238,255)"&gt;
              &lt;td style="width:35%;font:10pt Times New Roman, Times, Serif;text-align:justify;padding-left:2.5pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Assumed Portfolio Return (Net of Expenses)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
              &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
              &lt;td style="width:10%;font:10pt Times New Roman, Times, Serif;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;(10.00&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;)%&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
              &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
              &lt;td style="width:10%;font:10pt Times New Roman, Times, Serif;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;(5.00&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;)%&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
              &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
              &lt;td style="width:10%;font:10pt Times New Roman, Times, Serif;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;0.00&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;%&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
              &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
              &lt;td style="width:10%;font:10pt Times New Roman, Times, Serif;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;5.00&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;%&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
              &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
              &lt;td style="width:10%;font:10pt Times New Roman, Times, Serif;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;10.00&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;%&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr style="vertical-align:bottom;background-color:White"&gt;
              &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:justify;padding-left:2.5pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Corresponding Common Share Return&lt;sup&gt;(1)&lt;/sup&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
              &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
              &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;(18.76&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;)%&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
              &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
              &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;(10.56&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;)%&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
              &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
              &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;(2.36&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;)%&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
              &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
              &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;5.84&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;%&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
              &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
              &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;14.04&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;%&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
            &lt;/tr&gt;

        &lt;/table&gt;
      </cef:EffectsOfLeverageTableTextBlock>
    <cef:ReturnAtMinusTenPercent
      contextRef="C_20220930to20220930"
      decimals="4"
      id="Fxbrl_20220929124540326"
      unitRef="Pure">-0.1876</cef:ReturnAtMinusTenPercent>
    <cef:ReturnAtMinusFivePercent
      contextRef="C_20220930to20220930"
      decimals="4"
      id="Fxbrl_20220929125453107"
      unitRef="Pure">-0.1056</cef:ReturnAtMinusFivePercent>
    <cef:ReturnAtZeroPercent
      contextRef="C_20220930to20220930"
      decimals="4"
      id="Fxbrl_20220929125525365"
      unitRef="Pure">-0.0236</cef:ReturnAtZeroPercent>
    <cef:ReturnAtPlusFivePercent
      contextRef="C_20220930to20220930"
      decimals="4"
      id="Fxbrl_20220929125550342"
      unitRef="Pure">0.0584</cef:ReturnAtPlusFivePercent>
    <cef:ReturnAtPlusTenPercent
      contextRef="C_20220930to20220930"
      decimals="4"
      id="Fxbrl_20220929125703335"
      unitRef="Pure">0.1404</cef:ReturnAtPlusTenPercent>
    <cef:AnnualInterestRatePercent
      contextRef="C_20220930to20220930"
      decimals="4"
      id="Fxbrl_20220929130131030"
      unitRef="Pure">0.0312</cef:AnnualInterestRatePercent>
    <link:footnoteLink
      xlink:role="http://www.xbrl.org/2003/role/link"
      xlink:type="extended">
        <link:loc
          xlink:href="#Fxbrl_20220929112500797"
          xlink:label="Fxbrl_20220929112500797"
          xlink:type="locator"/>
        <link:footnote id="FN20220929132605436" xlink:label="FN20220929132605436" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Represents the estimated commission with respect to the Fund's common shares being sold in this offering. There is no guarantee that there will be any sales of the Fund's common shares pursuant to this prospectus supplement and the accompanying prospectus. Actual sales of the Fund's common shares under this prospectus supplement and the accompanying prospectus, if any, may be less than as set forth under "Capitalization" above. In addition, the price per share of any such sale may be greater or less than the price set forth under "Capitalization" above, depending on the market price of the Fund's common shares at the time of any such sale.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20220929112500797"
          xlink:to="FN20220929132605436"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20220929112617176"
          xlink:label="Fxbrl_20220929112617176"
          xlink:type="locator"/>
        <link:footnote id="FN20220929132653404" xlink:label="FN20220929132653404" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Calamos will pay the expenses of the offering (other than the applicable commissions). However, on a one year lag Calamos may recapture from the Fund previously paid offering expenses at a rate of $6,500 for each $1 million on sales (net of commissions) up to the lesser of $200,000 or actual costs. The Fund would accrue the costs over the following fiscal year. As of the date of this prospectus supplement and the accompanying prospectus, Calamos will pay all of the expenses associated with the offering (other than the applicable commissions). If the recapture provision is triggered in the future, such expenses that will be borne by Fund shareholders will be set forth in the "Shareholder Transaction Expenses" table above.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20220929112617176"
          xlink:to="FN20220929132653404"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20220929112636853"
          xlink:label="Fxbrl_20220929112636853"
          xlink:type="locator"/>
        <link:footnote id="FN20220929132839835" xlink:label="FN20220929132839835" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Shareholders will pay a $15.00 transaction fee plus a $0.02 per share brokerage charge if they direct Computershare Shareowner Services LLC (the "Plan Agent") to sell common shares held in a Plan account. In addition, each participant will pay a pro rata share of brokerage commissions incurred with respect to the Plan Agent's open-market purchases in connection with the reinvestment of dividends or distributions. If a participant elects to have the Plan Agent sell part or all of his or her common shares and remit the proceeds, such participant will be charged his or her pro rata share of brokerage commissions on the shares sold. See "Dividends and Distributions on Common Shares; Automatic Dividend Reinvestment Plan" on page 77 of the accompanying prospectus.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20220929112636853"
          xlink:to="FN20220929132839835"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20220929113617094"
          xlink:label="Fxbrl_20220929113617094"
          xlink:type="locator"/>
        <link:footnote id="FN20220929132913036" xlink:label="FN20220929132913036" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The Fund pays Calamos an annual management fee, payable monthly in arrears, for its investment management services in an amount equal to 1.00% of the Fund's average weekly managed assets. In accordance with the requirements of the Commission, the table above shows the Fund's management fee as a percentage of average net assets attributable to common shareholders. By showing the management fee as a percentage of net assets, the management fee is not expressed as a percentage of all of the assets the Fund intends to invest. For purposes of the table, the management fee has been converted to 1.51% of the Fund's average weekly net assets as of September 6, 2022 by dividing the total dollar amount of the management fee by the Fund's average weekly net assets (managed assets less outstanding leverage).</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20220929113617094"
          xlink:to="FN20220929132913036"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20220929113717521"
          xlink:label="Fxbrl_20220929113717521"
          xlink:type="locator"/>
        <link:footnote id="FN20220929172523053" xlink:label="FN20220929172523053" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Reflects estimated dividend expense on $17 million aggregate liquidation preference of mandatory redeemable preferred shares ("MRP Shares" or "MRPS") outstanding. See "Prospectus Summary &#x2014; Use of Leverage by the Fund" and "Leverage" in the accompanying prospectus for additional information.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20220929113717521"
          xlink:to="FN20220929172523053"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20220929113811453"
          xlink:label="Fxbrl_20220929113811453"
          xlink:type="locator"/>
        <link:footnote id="FN20220929153237904" xlink:label="FN20220929153237904" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">"Other Expenses" are based on estimated amounts for the Fund's current fiscal year.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20220929113811453"
          xlink:to="FN20220929153237904"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20220929114522735"
          xlink:label="Fxbrl_20220929114522735"
          xlink:type="locator"/>
        <link:footnote id="FN20220929133313270" xlink:label="FN20220929133313270" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The example includes sales load and estimated offering costs.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20220929114522735"
          xlink:to="FN20220929133313270"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20220929114620465"
          xlink:label="Fxbrl_20220929114620465"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20220929114620465"
          xlink:to="FN20220929133313270"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20220929114644347"
          xlink:label="Fxbrl_20220929114644347"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20220929114644347"
          xlink:to="FN20220929133313270"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20220929114705250"
          xlink:label="Fxbrl_20220929114705250"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20220929114705250"
          xlink:to="FN20220929133313270"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20220929124540326"
          xlink:label="Fxbrl_20220929124540326"
          xlink:type="locator"/>
        <link:footnote id="FN20220929133639594" xlink:label="FN20220929133639594" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Includes interest expense on the borrowings under the SSB Agreement, accrued at interest rates in effect on September 6, 2022 of 3.12%, and dividend expense on the MRP Shares.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20220929124540326"
          xlink:to="FN20220929133639594"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20220929125453107"
          xlink:label="Fxbrl_20220929125453107"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20220929125453107"
          xlink:to="FN20220929133639594"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20220929125525365"
          xlink:label="Fxbrl_20220929125525365"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20220929125525365"
          xlink:to="FN20220929133639594"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20220929125550342"
          xlink:label="Fxbrl_20220929125550342"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20220929125550342"
          xlink:to="FN20220929133639594"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20220929125703335"
          xlink:label="Fxbrl_20220929125703335"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20220929125703335"
          xlink:to="FN20220929133639594"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20221001021619972"
          xlink:label="Fxbrl_20221001021619972"
          xlink:type="locator"/>
        <link:footnote id="FN20221001021751665" xlink:label="FN20221001021751665" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Reflects interest expense paid on $9 million in average borrowings under the Fund's Amended and Restated Liquidity Agreement with State Street Bank and Trust Company, plus $34.8 million in additional average structural leverage related to certain securities lending programs, as described in the accompanying prospectus under "Leverage."</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20221001021619972"
          xlink:to="FN20221001021751665"
          xlink:type="arc"/>
    </link:footnoteLink>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.2.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>6</ContextCount>
  <ElementCount>36</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>true</FootnotesReported>
  <SegmentCount>5</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="tm2226808d4_424b3.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>995470 - Disclosure - N-2</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/cef/role/N2</Role>
      <ShortName>N-2</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="424B3" original="tm2226808d4_424b3.htm">tm2226808d4_424b3.htm</File>
    <File>ck0001285650-20220930.xsd</File>
    <File>ck0001285650-20220930_def.xml</File>
    <File>ck0001285650-20220930_lab.xml</File>
    <File>ck0001285650-20220930_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="48">http://xbrl.sec.gov/cef/2022</BaseTaxonomy>
    <BaseTaxonomy items="4">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>12
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "tm2226808d4_424b3.htm": {
   "axisCustom": 0,
   "axisStandard": 1,
   "contextCount": 6,
   "dts": {
    "definitionLink": {
     "local": [
      "ck0001285650-20220930_def.xml"
     ]
    },
    "inline": {
     "local": [
      "tm2226808d4_424b3.htm"
     ]
    },
    "labelLink": {
     "local": [
      "ck0001285650-20220930_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "ck0001285650-20220930_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "ck0001285650-20220930.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/2006/xbrldi-2006.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.sec.gov/cef/2022/cef-2022.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022_lab.xsd"
     ]
    }
   },
   "elementCount": 194,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2022": 3,
    "total": 3
   },
   "keyCustom": 0,
   "keyStandard": 36,
   "memberCustom": 5,
   "memberStandard": 0,
   "nsprefix": "ck0001285650",
   "nsuri": "http://www.calamos.com/20220930",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "strong",
       "span",
       "span",
       "span",
       "span",
       "p",
       "div",
       "body",
       "html"
      ],
      "baseRef": "tm2226808d4_424b3.htm",
      "contextRef": "C_20220930to20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:EntityRegistrantName",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "true",
     "longName": "995470 - Disclosure - N-2",
     "role": "http://xbrl.sec.gov/cef/role/N2",
     "shortName": "N-2",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "strong",
       "span",
       "span",
       "span",
       "span",
       "p",
       "div",
       "body",
       "html"
      ],
      "baseRef": "tm2226808d4_424b3.htm",
      "contextRef": "C_20220930to20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:EntityRegistrantName",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 5,
   "tag": {
    "cef_AcquiredFundFeesAndExpensesNoteTextBlock": {
     "auth_ref": [
      "r32"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Acquired Fund Fees and Expenses, Note [Text Block]"
       }
      }
     },
     "localname": "AcquiredFundFeesAndExpensesNoteTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_AcquiredFundFeesAndExpensesPercent": {
     "auth_ref": [
      "r33"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Acquired Fund Fees and Expenses [Percent]"
       }
      }
     },
     "localname": "AcquiredFundFeesAndExpensesPercent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_AcquiredFundFeesEstimatedNoteTextBlock": {
     "auth_ref": [
      "r34"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Acquired Fund Fees Estimated, Note [Text Block]"
       }
      }
     },
     "localname": "AcquiredFundFeesEstimatedNoteTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_AcquiredFundIncentiveAllocationNoteTextBlock": {
     "auth_ref": [
      "r35"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Acquired Fund Incentive Allocation, Note [Text Block]"
       }
      }
     },
     "localname": "AcquiredFundIncentiveAllocationNoteTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_AcquiredFundTotalAnnualExpensesNoteTextBlock": {
     "auth_ref": [
      "r36"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Acquired Fund Total Annual Expenses, Note [Text Block]"
       }
      }
     },
     "localname": "AcquiredFundTotalAnnualExpensesNoteTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_AllRisksMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Risks:"
       }
      }
     },
     "localname": "AllRisksMember",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "domainItemType"
    },
    "cef_AllSecuritiesMember": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Securities:"
       }
      }
     },
     "localname": "AllSecuritiesMember",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "domainItemType"
    },
    "cef_AnnualCoverageReturnRatePercent": {
     "auth_ref": [
      "r62"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Coverage Return Rate [Percent]"
       }
      }
     },
     "localname": "AnnualCoverageReturnRatePercent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_AnnualDividendPayment": {
     "auth_ref": [
      "r61"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Dividend Payment"
       }
      }
     },
     "localname": "AnnualDividendPayment",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "perShareItemType"
    },
    "cef_AnnualDividendPaymentCurrent": {
     "auth_ref": [
      "r61"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Dividend Payment, Current"
       }
      }
     },
     "localname": "AnnualDividendPaymentCurrent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "perShareItemType"
    },
    "cef_AnnualDividendPaymentInitial": {
     "auth_ref": [
      "r61"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Dividend Payment, Initial"
       }
      }
     },
     "localname": "AnnualDividendPaymentInitial",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "perShareItemType"
    },
    "cef_AnnualExpensesTableTextBlock": {
     "auth_ref": [
      "r40"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Expenses [Table Text Block]"
       }
      }
     },
     "localname": "AnnualExpensesTableTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_AnnualInterestRateCurrentPercent": {
     "auth_ref": [
      "r61"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Interest Rate, Current [Percent]"
       }
      }
     },
     "localname": "AnnualInterestRateCurrentPercent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_AnnualInterestRateInitialPercent": {
     "auth_ref": [
      "r61"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Interest Rate, Initial [Percent]"
       }
      }
     },
     "localname": "AnnualInterestRateInitialPercent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_AnnualInterestRatePercent": {
     "auth_ref": [
      "r61"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Interest Rate [Percent]"
       }
      }
     },
     "localname": "AnnualInterestRatePercent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_BasisOfTransactionFeesNoteTextBlock": {
     "auth_ref": [
      "r38"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Basis of Transaction Fees, Note [Text Block]"
       }
      }
     },
     "localname": "BasisOfTransactionFeesNoteTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_BdcFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "BDC File Number"
       }
      }
     },
     "localname": "BdcFileNumber",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "cef_BusinessDevelopmentCompanyFlag": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Development Company [Flag]"
       }
      }
     },
     "localname": "BusinessDevelopmentCompanyFlag",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "booleanItemType"
    },
    "cef_CapitalStockLongTermDebtAndOtherSecuritiesAbstract": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Capital Stock, Long-Term Debt, and Other Securities [Abstract]"
       }
      }
     },
     "localname": "CapitalStockLongTermDebtAndOtherSecuritiesAbstract",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "stringItemType"
    },
    "cef_CapitalStockTableTextBlock": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Capital Stock [Table Text Block]"
       }
      }
     },
     "localname": "CapitalStockTableTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_DistributionServicingFeesPercent": {
     "auth_ref": [
      "r44"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Distribution/Servicing Fees [Percent]"
       }
      }
     },
     "localname": "DistributionServicingFeesPercent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_DistributionsMayReducePrincipalTextBlock": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Distributions May Reduce Principal [Text Block]"
       }
      }
     },
     "localname": "DistributionsMayReducePrincipalTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_DividendAndInterestExpensesOnShortSalesPercent": {
     "auth_ref": [
      "r44"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividend and Interest Expenses on Short Sales [Percent]"
       }
      }
     },
     "localname": "DividendAndInterestExpensesOnShortSalesPercent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_DividendExpenseOnPreferredSharesPercent": {
     "auth_ref": [
      "r44"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividend Expenses on Preferred Shares [Percent]"
       }
      }
     },
     "localname": "DividendExpenseOnPreferredSharesPercent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_DividendReinvestmentAndCashPurchaseFees": {
     "auth_ref": [
      "r30"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividend Reinvestment and Cash Purchase Fees"
       }
      }
     },
     "localname": "DividendReinvestmentAndCashPurchaseFees",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cef_EffectsOfLeveragePurposeTextBlock": {
     "auth_ref": [
      "r63"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effects of Leverage, Purpose [Text Block]"
       }
      }
     },
     "localname": "EffectsOfLeveragePurposeTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_EffectsOfLeverageTableTextBlock": {
     "auth_ref": [
      "r63"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effects of Leverage [Table Text Block]"
       }
      }
     },
     "localname": "EffectsOfLeverageTableTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_EffectsOfLeverageTextBlock": {
     "auth_ref": [
      "r60"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effects of Leverage [Text Block]"
       }
      }
     },
     "localname": "EffectsOfLeverageTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_ExpenseExampleTableTextBlock": {
     "auth_ref": [
      "r30"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expense Example [Table Text Block]"
       }
      }
     },
     "localname": "ExpenseExampleTableTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_ExpenseExampleYear01": {
     "auth_ref": [
      "r37"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expense Example, Year 01"
       }
      }
     },
     "localname": "ExpenseExampleYear01",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cef_ExpenseExampleYears1to10": {
     "auth_ref": [
      "r37"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expense Example, Years 1 to 10"
       }
      }
     },
     "localname": "ExpenseExampleYears1to10",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cef_ExpenseExampleYears1to3": {
     "auth_ref": [
      "r37"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expense Example, Years 1 to 3"
       }
      }
     },
     "localname": "ExpenseExampleYears1to3",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cef_ExpenseExampleYears1to5": {
     "auth_ref": [
      "r37"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expense Example, Years 1 to 5"
       }
      }
     },
     "localname": "ExpenseExampleYears1to5",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cef_FeeTableAbstract": {
     "auth_ref": [
      "r30"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Table [Abstract]"
       }
      }
     },
     "localname": "FeeTableAbstract",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "stringItemType"
    },
    "cef_FinancialHighlightsAbstract": {
     "auth_ref": [
      "r45"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial Highlights [Abstract]"
       }
      }
     },
     "localname": "FinancialHighlightsAbstract",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "stringItemType"
    },
    "cef_GeneralDescriptionOfRegistrantAbstract": {
     "auth_ref": [
      "r57"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "General Description of Registrant [Abstract]"
       }
      }
     },
     "localname": "GeneralDescriptionOfRegistrantAbstract",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "stringItemType"
    },
    "cef_HighestPriceOrBid": {
     "auth_ref": [
      "r64"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Highest Price or Bid"
       }
      }
     },
     "localname": "HighestPriceOrBid",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "perShareItemType"
    },
    "cef_HighestPriceOrBidNav": {
     "auth_ref": [
      "r68"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Highest Price or Bid, NAV"
       }
      }
     },
     "localname": "HighestPriceOrBidNav",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "perShareItemType"
    },
    "cef_HighestPriceOrBidPremiumDiscountToNavPercent": {
     "auth_ref": [
      "r69"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Highest Price or Bid, Premium (Discount) to NAV [Percent]"
       }
      }
     },
     "localname": "HighestPriceOrBidPremiumDiscountToNavPercent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_IncentiveAllocationMaximumPercent": {
     "auth_ref": [
      "r35"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Incentive Allocation Maximum [Percent]"
       }
      }
     },
     "localname": "IncentiveAllocationMaximumPercent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_IncentiveAllocationMinimumPercent": {
     "auth_ref": [
      "r35"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Incentive Allocation Minimum [Percent]"
       }
      }
     },
     "localname": "IncentiveAllocationMinimumPercent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_IncentiveAllocationPercent": {
     "auth_ref": [
      "r35"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Incentive Allocation [Percent]"
       }
      }
     },
     "localname": "IncentiveAllocationPercent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_IncentiveFeesPercent": {
     "auth_ref": [
      "r44"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Incentive Fees [Percent]"
       }
      }
     },
     "localname": "IncentiveFeesPercent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_InterestExpensesOnBorrowingsPercent": {
     "auth_ref": [
      "r43"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest Expenses on Borrowings [Percent]"
       }
      }
     },
     "localname": "InterestExpensesOnBorrowingsPercent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_IntervalFundFlag": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interval Fund [Flag]"
       }
      }
     },
     "localname": "IntervalFundFlag",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "booleanItemType"
    },
    "cef_InvestmentObjectivesAndPracticesTextBlock": {
     "auth_ref": [
      "r58"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Objectives and Practices [Text Block]"
       }
      }
     },
     "localname": "InvestmentObjectivesAndPracticesTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_LatestNav": {
     "auth_ref": [
      "r70"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Latest NAV"
       }
      }
     },
     "localname": "LatestNav",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "perShareItemType"
    },
    "cef_LatestPremiumDiscountToNavPercent": {
     "auth_ref": [
      "r70"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Latest Premium (Discount) to NAV [Percent]"
       }
      }
     },
     "localname": "LatestPremiumDiscountToNavPercent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_LatestSharePrice": {
     "auth_ref": [
      "r70"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Latest Share Price"
       }
      }
     },
     "localname": "LatestSharePrice",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "perShareItemType"
    },
    "cef_LoanServicingFeesPercent": {
     "auth_ref": [
      "r44"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Loan Servicing Fees [Percent]"
       }
      }
     },
     "localname": "LoanServicingFeesPercent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_LongTermDebtDividendsAndCovenantsTextBlock": {
     "auth_ref": [
      "r21"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long Term Debt, Dividends and Covenants [Text Block]"
       }
      }
     },
     "localname": "LongTermDebtDividendsAndCovenantsTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_LongTermDebtIssuanceAndSubstitutionTextBlock": {
     "auth_ref": [
      "r22"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long Term Debt, Issuance and Substitution [Text Block]"
       }
      }
     },
     "localname": "LongTermDebtIssuanceAndSubstitutionTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_LongTermDebtPrincipal": {
     "auth_ref": [
      "r19"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long Term Debt, Principal"
       }
      }
     },
     "localname": "LongTermDebtPrincipal",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cef_LongTermDebtRightsLimitedByOtherSecuritiesTextBlock": {
     "auth_ref": [
      "r23"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long Term Debt, Rights Limited by Other Securities [Text Block]"
       }
      }
     },
     "localname": "LongTermDebtRightsLimitedByOtherSecuritiesTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_LongTermDebtStructuringTextBlock": {
     "auth_ref": [
      "r20"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long Term Debt, Structuring [Text Block]"
       }
      }
     },
     "localname": "LongTermDebtStructuringTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_LongTermDebtTableTextBlock": {
     "auth_ref": [
      "r19"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long Term Debt [Table Text Block]"
       }
      }
     },
     "localname": "LongTermDebtTableTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_LongTermDebtTitleTextBlock": {
     "auth_ref": [
      "r19"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long Term Debt, Title [Text Block]"
       }
      }
     },
     "localname": "LongTermDebtTitleTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_LowestPriceOrBid": {
     "auth_ref": [
      "r64"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lowest Price or Bid"
       }
      }
     },
     "localname": "LowestPriceOrBid",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "perShareItemType"
    },
    "cef_LowestPriceOrBidNav": {
     "auth_ref": [
      "r68"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lowest Price or Bid, NAV"
       }
      }
     },
     "localname": "LowestPriceOrBidNav",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "perShareItemType"
    },
    "cef_LowestPriceOrBidPremiumDiscountToNavPercent": {
     "auth_ref": [
      "r69"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lowest Price or Bid, Premium (Discount) to NAV [Percent]"
       }
      }
     },
     "localname": "LowestPriceOrBidPremiumDiscountToNavPercent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_ManagementFeeNotBasedOnNetAssetsNoteTextBlock": {
     "auth_ref": [
      "r42"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Management Fee not based on Net Assets, Note [Text Block]"
       }
      }
     },
     "localname": "ManagementFeeNotBasedOnNetAssetsNoteTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_ManagementFeesPercent": {
     "auth_ref": [
      "r41"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Management Fees [Percent]"
       }
      }
     },
     "localname": "ManagementFeesPercent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_NetExpenseOverAssetsPercent": {
     "auth_ref": [
      "r44"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Expense over Assets [Percent]"
       }
      }
     },
     "localname": "NetExpenseOverAssetsPercent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_NewCefOrBdcRegistrantFlag": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "New CEF or BDC Registrant [Flag]"
       }
      }
     },
     "localname": "NewCefOrBdcRegistrantFlag",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "booleanItemType"
    },
    "cef_NoPublicTradingTextBlock": {
     "auth_ref": [
      "r67"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Public Trading [Text Block]"
       }
      }
     },
     "localname": "NoPublicTradingTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_NoTradingHistoryTextBlock": {
     "auth_ref": [
      "r71"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading History [Text Block]"
       }
      }
     },
     "localname": "NoTradingHistoryTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_OtherAnnualExpense1Percent": {
     "auth_ref": [
      "r44"
     ],
     "calculation": {
      "http://xbrl.sec.gov/cef/role/Item3Ae": {
       "order": 1.0,
       "parentTag": "cef_OtherAnnualExpensesPercent",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Annual Expense 1 [Percent]"
       }
      }
     },
     "localname": "OtherAnnualExpense1Percent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_OtherAnnualExpense2Percent": {
     "auth_ref": [
      "r44"
     ],
     "calculation": {
      "http://xbrl.sec.gov/cef/role/Item3Ae": {
       "order": 2.0,
       "parentTag": "cef_OtherAnnualExpensesPercent",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Annual Expense 2 [Percent]"
       }
      }
     },
     "localname": "OtherAnnualExpense2Percent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_OtherAnnualExpense3Percent": {
     "auth_ref": [
      "r44"
     ],
     "calculation": {
      "http://xbrl.sec.gov/cef/role/Item3Ae": {
       "order": 3.0,
       "parentTag": "cef_OtherAnnualExpensesPercent",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Annual Expense 3 [Percent]"
       }
      }
     },
     "localname": "OtherAnnualExpense3Percent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_OtherAnnualExpensesAbstract": {
     "auth_ref": [
      "r44"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Annual Expenses [Abstract]"
       }
      }
     },
     "localname": "OtherAnnualExpensesAbstract",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "stringItemType"
    },
    "cef_OtherAnnualExpensesPercent": {
     "auth_ref": [
      "r44"
     ],
     "calculation": {
      "http://xbrl.sec.gov/cef/role/Item3Ae": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Annual Expenses [Percent]"
       }
      }
     },
     "localname": "OtherAnnualExpensesPercent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_OtherExpensesNoteTextBlock": {
     "auth_ref": [
      "r40"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Expenses, Note [Text Block]"
       }
      }
     },
     "localname": "OtherExpensesNoteTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_OtherFeederFundExpensesPercent": {
     "auth_ref": [
      "r44"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Feeder Fund Expenses [Percent]"
       }
      }
     },
     "localname": "OtherFeederFundExpensesPercent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_OtherMasterFundExpensesPercent": {
     "auth_ref": [
      "r44"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Master Fund Expenses [Percent]"
       }
      }
     },
     "localname": "OtherMasterFundExpensesPercent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_OtherSecuritiesTableTextBlock": {
     "auth_ref": [
      "r24"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Securities [Table Text Block]"
       }
      }
     },
     "localname": "OtherSecuritiesTableTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_OtherSecurityDescriptionTextBlock": {
     "auth_ref": [
      "r24"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Security, Description [Text Block]"
       }
      }
     },
     "localname": "OtherSecurityDescriptionTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_OtherSecurityTitleTextBlock": {
     "auth_ref": [
      "r24"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Security, Title [Text Block]"
       }
      }
     },
     "localname": "OtherSecurityTitleTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_OtherTransactionExpense1Percent": {
     "auth_ref": [
      "r39"
     ],
     "calculation": {
      "http://xbrl.sec.gov/cef/role/Item3Te": {
       "order": 1.0,
       "parentTag": "cef_OtherTransactionExpensesPercent",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Transaction Expense 1 [Percent]"
       }
      }
     },
     "localname": "OtherTransactionExpense1Percent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_OtherTransactionExpense2Percent": {
     "auth_ref": [
      "r39"
     ],
     "calculation": {
      "http://xbrl.sec.gov/cef/role/Item3Te": {
       "order": 2.0,
       "parentTag": "cef_OtherTransactionExpensesPercent",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Transaction Expense 2 [Percent]"
       }
      }
     },
     "localname": "OtherTransactionExpense2Percent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_OtherTransactionExpense3Percent": {
     "auth_ref": [
      "r39"
     ],
     "calculation": {
      "http://xbrl.sec.gov/cef/role/Item3Te": {
       "order": 3.0,
       "parentTag": "cef_OtherTransactionExpensesPercent",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Transaction Expense 3 [Percent]"
       }
      }
     },
     "localname": "OtherTransactionExpense3Percent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_OtherTransactionExpensesAbstract": {
     "auth_ref": [
      "r39"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Transaction Expenses [Abstract]"
       }
      }
     },
     "localname": "OtherTransactionExpensesAbstract",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "stringItemType"
    },
    "cef_OtherTransactionExpensesPercent": {
     "auth_ref": [
      "r39"
     ],
     "calculation": {
      "http://xbrl.sec.gov/cef/role/Item3Te": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Transaction Expenses [Percent]"
       }
      }
     },
     "localname": "OtherTransactionExpensesPercent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_OtherTransactionFeesBasisMaximum": {
     "auth_ref": [
      "r39"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Transaction Fees Basis, Maximum"
       }
      }
     },
     "localname": "OtherTransactionFeesBasisMaximum",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cef_OtherTransactionFeesBasisMaximumPercent": {
     "auth_ref": [
      "r39"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Transaction Fees Basis, Maximum [Percent]"
       }
      }
     },
     "localname": "OtherTransactionFeesBasisMaximumPercent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_OtherTransactionFeesBasisNoteTextBlock": {
     "auth_ref": [
      "r39"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Transaction Fees Basis, Note [Text Block]"
       }
      }
     },
     "localname": "OtherTransactionFeesBasisNoteTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_OtherTransactionFeesNoteTextBlock": {
     "auth_ref": [
      "r39"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Transaction Fees, Note [Text Block]"
       }
      }
     },
     "localname": "OtherTransactionFeesNoteTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_OutstandingSecuritiesTableTextBlock": {
     "auth_ref": [
      "r25"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Securities [Table Text Block]"
       }
      }
     },
     "localname": "OutstandingSecuritiesTableTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_OutstandingSecurityAuthorizedShares": {
     "auth_ref": [
      "r27"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Security, Authorized [Shares]"
       }
      }
     },
     "localname": "OutstandingSecurityAuthorizedShares",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "sharesItemType"
    },
    "cef_OutstandingSecurityHeldShares": {
     "auth_ref": [
      "r28"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Security, Held [Shares]"
       }
      }
     },
     "localname": "OutstandingSecurityHeldShares",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "sharesItemType"
    },
    "cef_OutstandingSecurityNotHeldShares": {
     "auth_ref": [
      "r29"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Security, Not Held [Shares]"
       }
      }
     },
     "localname": "OutstandingSecurityNotHeldShares",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "sharesItemType"
    },
    "cef_OutstandingSecurityTitleTextBlock": {
     "auth_ref": [
      "r26"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Security, Title [Text Block]"
       }
      }
     },
     "localname": "OutstandingSecurityTitleTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_PreferredStockRestrictionsArrearageTextBlock": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred Stock Restrictions, Arrearage [Text Block]"
       }
      }
     },
     "localname": "PreferredStockRestrictionsArrearageTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_PreferredStockRestrictionsOtherTextBlock": {
     "auth_ref": [
      "r16"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred Stock Restrictions, Other [Text Block]"
       }
      }
     },
     "localname": "PreferredStockRestrictionsOtherTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_PrimaryShelfFlag": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Primary Shelf [Flag]"
       }
      }
     },
     "localname": "PrimaryShelfFlag",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "booleanItemType"
    },
    "cef_PrimaryShelfQualifiedFlag": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Primary Shelf Qualified [Flag]"
       }
      }
     },
     "localname": "PrimaryShelfQualifiedFlag",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "booleanItemType"
    },
    "cef_ProspectusLineItems": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prospectus [Line Items]"
       }
      }
     },
     "localname": "ProspectusLineItems",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "xbrltype": "stringItemType"
    },
    "cef_ProspectusTable": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prospectus:"
       }
      }
     },
     "localname": "ProspectusTable",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "stringItemType"
    },
    "cef_PurposeOfFeeTableNoteTextBlock": {
     "auth_ref": [
      "r31"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Purpose of Fee Table , Note [Text Block]"
       }
      }
     },
     "localname": "PurposeOfFeeTableNoteTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_RegisteredClosedEndFundFlag": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Registered Closed-End Fund [Flag]"
       }
      }
     },
     "localname": "RegisteredClosedEndFundFlag",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "booleanItemType"
    },
    "cef_ReturnAtMinusFivePercent": {
     "auth_ref": [
      "r63"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Return at Minus Five [Percent]"
       }
      }
     },
     "localname": "ReturnAtMinusFivePercent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_ReturnAtMinusTenPercent": {
     "auth_ref": [
      "r63"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Return at Minus Ten [Percent]"
       }
      }
     },
     "localname": "ReturnAtMinusTenPercent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_ReturnAtPlusFivePercent": {
     "auth_ref": [
      "r63"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Return at Plus Five [Percent]"
       }
      }
     },
     "localname": "ReturnAtPlusFivePercent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_ReturnAtPlusTenPercent": {
     "auth_ref": [
      "r63"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Return at Plus Ten [Percent]"
       }
      }
     },
     "localname": "ReturnAtPlusTenPercent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_ReturnAtZeroPercent": {
     "auth_ref": [
      "r63"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Return at Zero [Percent]"
       }
      }
     },
     "localname": "ReturnAtZeroPercent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_RightsLimitedByOtherSecuritiesTextBlock": {
     "auth_ref": [
      "r18"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rights Limited by Other Securities [Text Block]"
       }
      }
     },
     "localname": "RightsLimitedByOtherSecuritiesTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_RightsSubjectToOtherThanMajorityVoteTextBlock": {
     "auth_ref": [
      "r17"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rights Subject to Other than Majority Vote [Text Block]"
       }
      }
     },
     "localname": "RightsSubjectToOtherThanMajorityVoteTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_RiskAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Risk [Axis]"
       }
      }
     },
     "localname": "RiskAxis",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "stringItemType"
    },
    "cef_RiskFactorsTableTextBlock": {
     "auth_ref": [
      "r59"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Risk Factors [Table Text Block]"
       }
      }
     },
     "localname": "RiskFactorsTableTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_RiskTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Risk [Text Block]"
       }
      }
     },
     "localname": "RiskTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_SalesLoadPercent": {
     "auth_ref": [
      "r30"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sales Load [Percent]"
       }
      }
     },
     "localname": "SalesLoadPercent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_SecurityAxis": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security [Axis]"
       }
      }
     },
     "localname": "SecurityAxis",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "stringItemType"
    },
    "cef_SecurityDividendsTextBlock": {
     "auth_ref": [
      "r8"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Dividends [Text Block]"
       }
      }
     },
     "localname": "SecurityDividendsTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_SecurityLiabilitiesTextBlock": {
     "auth_ref": [
      "r11"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Liabilities [Text Block]"
       }
      }
     },
     "localname": "SecurityLiabilitiesTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_SecurityLiquidationRightsTextBlock": {
     "auth_ref": [
      "r10"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Liquidation Rights [Text Block]"
       }
      }
     },
     "localname": "SecurityLiquidationRightsTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_SecurityObligationsOfOwnershipTextBlock": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Obligations of Ownership [Text Block]"
       }
      }
     },
     "localname": "SecurityObligationsOfOwnershipTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_SecurityPreemptiveAndOtherRightsTextBlock": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Preemptive and Other Rights [Text Block]"
       }
      }
     },
     "localname": "SecurityPreemptiveAndOtherRightsTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_SecurityTitleTextBlock": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Title [Text Block]"
       }
      }
     },
     "localname": "SecurityTitleTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_SecurityVotingRightsTextBlock": {
     "auth_ref": [
      "r9"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Voting Rights [Text Block]"
       }
      }
     },
     "localname": "SecurityVotingRightsTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_SeniorSecuritiesAmount": {
     "auth_ref": [
      "r50"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities Amount"
       }
      }
     },
     "localname": "SeniorSecuritiesAmount",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cef_SeniorSecuritiesAverageMarketValuePerUnit": {
     "auth_ref": [
      "r53"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities Average Market Value per Unit"
       }
      }
     },
     "localname": "SeniorSecuritiesAverageMarketValuePerUnit",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "perShareItemType"
    },
    "cef_SeniorSecuritiesAveragingMethodNoteTextBlock": {
     "auth_ref": [
      "r55"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities Averaging Method, Note [Text Block]"
       }
      }
     },
     "localname": "SeniorSecuritiesAveragingMethodNoteTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_SeniorSecuritiesCoveragePerUnit": {
     "auth_ref": [
      "r51"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities Coverage per Unit"
       }
      }
     },
     "localname": "SeniorSecuritiesCoveragePerUnit",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "perShareItemType"
    },
    "cef_SeniorSecuritiesHeadingsNoteTextBlock": {
     "auth_ref": [
      "r56"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities Headings, Note [Text Block]"
       }
      }
     },
     "localname": "SeniorSecuritiesHeadingsNoteTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_SeniorSecuritiesHighlightsAnnualizedNoteTextBlock": {
     "auth_ref": [
      "r47",
      "r54"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities Highlights Annualized, Note [Text Block]"
       }
      }
     },
     "localname": "SeniorSecuritiesHighlightsAnnualizedNoteTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_SeniorSecuritiesHighlightsAuditedNoteTextBlock": {
     "auth_ref": [
      "r48",
      "r54"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities Highlights Audited, Note [Text Block]"
       }
      }
     },
     "localname": "SeniorSecuritiesHighlightsAuditedNoteTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_SeniorSecuritiesInvoluntaryLiquidatingPreferencePerUnit": {
     "auth_ref": [
      "r52"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities Involuntary Liquidating Preference per Unit"
       }
      }
     },
     "localname": "SeniorSecuritiesInvoluntaryLiquidatingPreferencePerUnit",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "perShareItemType"
    },
    "cef_SeniorSecuritiesNoteTextBlock": {
     "auth_ref": [
      "r46",
      "r54"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities, Note [Text Block]"
       }
      }
     },
     "localname": "SeniorSecuritiesNoteTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_SeniorSecuritiesTableTextBlock": {
     "auth_ref": [
      "r49"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities [Table Text Block]"
       }
      }
     },
     "localname": "SeniorSecuritiesTableTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_SharePriceTableTextBlock": {
     "auth_ref": [
      "r65"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share Price [Table Text Block]"
       }
      }
     },
     "localname": "SharePriceTableTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_SharePricesNotActualTransactionsTextBlock": {
     "auth_ref": [
      "r66"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share Prices Not Actual Transactions [Text Block]"
       }
      }
     },
     "localname": "SharePricesNotActualTransactionsTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_ShareholderTransactionExpensesTableTextBlock": {
     "auth_ref": [
      "r30"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shareholder Transaction Expenses [Table Text Block]"
       }
      }
     },
     "localname": "ShareholderTransactionExpensesTableTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_TotalAnnualExpensesPercent": {
     "auth_ref": [
      "r43"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Annual Expenses [Percent]"
       }
      }
     },
     "localname": "TotalAnnualExpensesPercent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_UnderwritersCompensationPercent": {
     "auth_ref": [
      "r39"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Underwriters Compensation [Percent]"
       }
      }
     },
     "localname": "UnderwritersCompensationPercent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_WaiversAndReimbursementsOfFeesPercent": {
     "auth_ref": [
      "r44"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Waivers and Reimbursements of Fees [Percent]"
       }
      }
     },
     "localname": "WaiversAndReimbursementsOfFeesPercent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_WarrantsOrRightsCalledAmount": {
     "auth_ref": [
      "r24"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants or Rights, Called Amount"
       }
      }
     },
     "localname": "WarrantsOrRightsCalledAmount",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cef_WarrantsOrRightsCalledPeriodDate": {
     "auth_ref": [
      "r24"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants or Rights, Called Period [Date]"
       }
      }
     },
     "localname": "WarrantsOrRightsCalledPeriodDate",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "dateItemType"
    },
    "cef_WarrantsOrRightsCalledTitleTextBlock": {
     "auth_ref": [
      "r24"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants or Rights, Called Title"
       }
      }
     },
     "localname": "WarrantsOrRightsCalledTitleTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_WarrantsOrRightsExercisePrice": {
     "auth_ref": [
      "r24"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants or Rights, Exercise Price"
       }
      }
     },
     "localname": "WarrantsOrRightsExercisePrice",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "perShareItemType"
    },
    "ck0001285650_CommonSharesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for Common Shares.",
        "label": "Common Shares [Member]"
       }
      }
     },
     "localname": "CommonSharesMember",
     "nsuri": "http://www.calamos.com/20220930",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "domainItemType"
    },
    "ck0001285650_MandatoryRedeemablePreferredSharesSeriesBMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for Mandatory Redeemable Preferred Shares Series B.",
        "label": "Mandatory Redeemable Preferred Shares Series B [Member]"
       }
      }
     },
     "localname": "MandatoryRedeemablePreferredSharesSeriesBMember",
     "nsuri": "http://www.calamos.com/20220930",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "domainItemType"
    },
    "ck0001285650_MandatoryRedeemablePreferredSharesSeriesCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for Mandatory Redeemable Preferred Shares Series C.",
        "label": "Mandatory Redeemable Preferred Shares Series C [Member]"
       }
      }
     },
     "localname": "MandatoryRedeemablePreferredSharesSeriesCMember",
     "nsuri": "http://www.calamos.com/20220930",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "domainItemType"
    },
    "ck0001285650_MandatoryRedeemablePreferredSharesSeriesDMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for Mandatory Redeemable Preferred Shares Series D.",
        "label": "Mandatory Redeemable Preferred Shares Series D [Member]"
       }
      }
     },
     "localname": "MandatoryRedeemablePreferredSharesSeriesDMember",
     "nsuri": "http://www.calamos.com/20220930",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "domainItemType"
    },
    "ck0001285650_MandatoryRedeemablePreferredSharesSeriesEMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for Mandatory Redeemable Preferred Shares Series E.",
        "label": "Mandatory Redeemable Preferred Shares Series E [Member]"
       }
      }
     },
     "localname": "MandatoryRedeemablePreferredSharesSeriesEMember",
     "nsuri": "http://www.calamos.com/20220930",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AdditionalSecurities462b": {
     "auth_ref": [
      "r80"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Securities. 462(b)"
       }
      }
     },
     "localname": "AdditionalSecurities462b",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AdditionalSecurities462bFileNumber": {
     "auth_ref": [
      "r80"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Securities, 462(b), File Number"
       }
      }
     },
     "localname": "AdditionalSecurities462bFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_AdditionalSecuritiesEffective413b": {
     "auth_ref": [
      "r79"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Securities Effective, 413(b)"
       }
      }
     },
     "localname": "AdditionalSecuritiesEffective413b",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AddressTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An entity may have several addresses for different purposes and this domain represents all such types.",
        "label": "Address Type [Domain]"
       }
      }
     },
     "localname": "AddressTypeDomain",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of changes contained within amended document.",
        "label": "Amendment Description"
       }
      }
     },
     "localname": "AmendmentDescription",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_ApproximateDateOfCommencementOfProposedSaleToThePublic": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The approximate date of a commencement of a proposed sale of securities to the public. This element is disclosed in S-1, S-3, S-4, S-11, F-1, F-3 and F-10 filings.",
        "label": "Approximate Date of Commencement of Proposed Sale to Public"
       }
      }
     },
     "localname": "ApproximateDateOfCommencementOfProposedSaleToThePublic",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "dateOrAsapItemType"
    },
    "dei_BusinessContactMember": {
     "auth_ref": [
      "r2",
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business contact for the entity",
        "label": "Business Contact [Member]"
       }
      }
     },
     "localname": "BusinessContactMember",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_ContactPersonnelName": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of contact personnel",
        "label": "Contact Personnel Name"
       }
      }
     },
     "localname": "ContactPersonnelName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_DelayedOrContinuousOffering": {
     "auth_ref": [
      "r4",
      "r5",
      "r75"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Delayed or Continuous Offering"
       }
      }
     },
     "localname": "DelayedOrContinuousOffering",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DividendOrInterestReinvestmentPlanOnly": {
     "auth_ref": [
      "r4",
      "r5",
      "r75"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividend or Interest Reinvestment Plan Only"
       }
      }
     },
     "localname": "DividendOrInterestReinvestmentPlanOnly",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentRegistrationStatement": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a registration statement.",
        "label": "Document Registration Statement"
       }
      }
     },
     "localname": "DocumentRegistrationStatement",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EffectiveAfter60Days486a": {
     "auth_ref": [
      "r84"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective after 60 Days, 486(a)"
       }
      }
     },
     "localname": "EffectiveAfter60Days486a",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EffectiveOnDate486a": {
     "auth_ref": [
      "r84"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Date, 486(a)"
       }
      }
     },
     "localname": "EffectiveOnDate486a",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_EffectiveOnDate486b": {
     "auth_ref": [
      "r85"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Date, 486(b)"
       }
      }
     },
     "localname": "EffectiveOnDate486b",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_EffectiveOnSetDate486a": {
     "auth_ref": [
      "r84"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Set Date, 486(a)"
       }
      }
     },
     "localname": "EffectiveOnSetDate486a",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EffectiveOnSetDate486b": {
     "auth_ref": [
      "r85"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Set Date, 486(b)"
       }
      }
     },
     "localname": "EffectiveOnSetDate486b",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EffectiveUponFiling462e": {
     "auth_ref": [
      "r83"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective Upon Filing, 462(e)"
       }
      }
     },
     "localname": "EffectiveUponFiling462e",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EffectiveUponFiling486b": {
     "auth_ref": [
      "r85"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective upon Filing, 486(b)"
       }
      }
     },
     "localname": "EffectiveUponFiling486b",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EffectiveWhenDeclaredSection8c": {
     "auth_ref": [
      "r87"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective when Declared, Section 8(c)"
       }
      }
     },
     "localname": "EffectiveWhenDeclaredSection8c",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine3": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 3 such as an Office Park",
        "label": "Entity Address, Address Line Three"
       }
      }
     },
     "localname": "EntityAddressAddressLine3",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityAddressesAddressTypeAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table.",
        "label": "Entity Addresses, Address Type [Axis]"
       }
      }
     },
     "localname": "EntityAddressesAddressTypeAxis",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r86"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Entity Ex Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Securities Act File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityInvCompanyType": {
     "auth_ref": [
      "r77"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "One of: N-1A (Mutual Fund), N-1 (Open-End Separate Account with No Variable Annuities), N-2 (Closed-End Investment Company), N-3 (Separate Account Registered as Open-End Management Investment Company), N-4 (Variable Annuity UIT Separate Account), N-5 (Small Business Investment Company), N-6 (Variable Life UIT Separate Account), S-1 or S-3 (Face Amount Certificate Company), S-6 (UIT, Non-Insurance Product).",
        "label": "Entity Inv Company Type"
       }
      }
     },
     "localname": "EntityInvCompanyType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "invCompanyType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [
      "r78"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_ExhibitsOnly462d": {
     "auth_ref": [
      "r82"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exhibits Only, 462(d)"
       }
      }
     },
     "localname": "ExhibitsOnly462d",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_ExhibitsOnly462dFileNumber": {
     "auth_ref": [
      "r82"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exhibits Only, 462(d), File Number"
       }
      }
     },
     "localname": "ExhibitsOnly462dFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_InvestmentCompanyActFileNumber": {
     "auth_ref": [
      "r5",
      "r72",
      "r73",
      "r74"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Act File Number"
       }
      }
     },
     "localname": "InvestmentCompanyActFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_InvestmentCompanyActRegistration": {
     "auth_ref": [
      "r76"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Act Registration"
       }
      }
     },
     "localname": "InvestmentCompanyActRegistration",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_InvestmentCompanyRegistrationAmendment": {
     "auth_ref": [
      "r76"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Registration Amendment"
       }
      }
     },
     "localname": "InvestmentCompanyRegistrationAmendment",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_InvestmentCompanyRegistrationAmendmentNumber": {
     "auth_ref": [
      "r76"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Registration Amendment Number"
       }
      }
     },
     "localname": "InvestmentCompanyRegistrationAmendmentNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "sequenceNumberItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_NewEffectiveDateForPreviousFiling": {
     "auth_ref": [
      "r5",
      "r72",
      "r73",
      "r74"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "New Effective Date for Previous Filing"
       }
      }
     },
     "localname": "NewEffectiveDateForPreviousFiling",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_NoSubstantiveChanges462c": {
     "auth_ref": [
      "r81"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Substantive Changes, 462(c)"
       }
      }
     },
     "localname": "NoSubstantiveChanges462c",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_NoSubstantiveChanges462cFileNumber": {
     "auth_ref": [
      "r81"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Substantive Changes, 462(c), File Number"
       }
      }
     },
     "localname": "NoSubstantiveChanges462cFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_PostEffectiveAmendment": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Post-Effective Amendment"
       }
      }
     },
     "localname": "PostEffectiveAmendment",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PostEffectiveAmendmentNumber": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amendment number to registration statement under the Securities Act of 1933 after the registration becomes effective.",
        "label": "Post-Effective Amendment Number"
       }
      }
     },
     "localname": "PostEffectiveAmendmentNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "sequenceNumberItemType"
    },
    "dei_PreEffectiveAmendment": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-Effective Amendment"
       }
      }
     },
     "localname": "PreEffectiveAmendment",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreEffectiveAmendmentNumber": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amendment number to registration statement under the Securities Act of 1933 before the registration becomes effective.",
        "label": "Pre-Effective Amendment Number"
       }
      }
     },
     "localname": "PreEffectiveAmendmentNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "sequenceNumberItemType"
    }
   },
   "unitCount": 3
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r10": {
   "Name": "Form N-2",
   "Paragraph": "a",
   "Publisher": "SEC",
   "Section": "Item 10",
   "Subparagraph": "3",
   "Subsection": "1"
  },
  "r11": {
   "Name": "Form N-2",
   "Paragraph": "a",
   "Publisher": "SEC",
   "Section": "Item 10",
   "Subparagraph": "4",
   "Subsection": "1"
  },
  "r12": {
   "Name": "Form N-2",
   "Paragraph": "a",
   "Publisher": "SEC",
   "Section": "Item 10",
   "Subparagraph": "5",
   "Subsection": "1"
  },
  "r13": {
   "Name": "Form N-2",
   "Paragraph": "a",
   "Publisher": "SEC",
   "Section": "Item 10",
   "Subparagraph": "6",
   "Subsection": "1"
  },
  "r14": {
   "Name": "Form N-2",
   "Paragraph": "a",
   "Publisher": "SEC",
   "Section": "Item 10",
   "Subparagraph": "Instruction 2",
   "Subsection": "1"
  },
  "r15": {
   "Name": "Form N-2",
   "Paragraph": "b",
   "Publisher": "SEC",
   "Section": "Item 10",
   "Subparagraph": "1",
   "Subsection": "1"
  },
  "r16": {
   "Name": "Form N-2",
   "Paragraph": "b",
   "Publisher": "SEC",
   "Section": "Item 10",
   "Subparagraph": "2",
   "Subsection": "1"
  },
  "r17": {
   "Name": "Form N-2",
   "Paragraph": "c",
   "Publisher": "SEC",
   "Section": "Item 10",
   "Subsection": "1"
  },
  "r18": {
   "Name": "Form N-2",
   "Paragraph": "d",
   "Publisher": "SEC",
   "Section": "Item 10",
   "Subsection": "1"
  },
  "r19": {
   "Name": "Form N-2",
   "Publisher": "SEC",
   "Section": "Item 10",
   "Subsection": "2"
  },
  "r2": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f"
  },
  "r20": {
   "Name": "Form N-2",
   "Paragraph": "a",
   "Publisher": "SEC",
   "Section": "Item 10",
   "Subsection": "2"
  },
  "r21": {
   "Name": "Form N-2",
   "Paragraph": "b",
   "Publisher": "SEC",
   "Section": "Item 10",
   "Subsection": "2"
  },
  "r22": {
   "Name": "Form N-2",
   "Paragraph": "c",
   "Publisher": "SEC",
   "Section": "Item 10",
   "Subsection": "2"
  },
  "r23": {
   "Name": "Form N-2",
   "Paragraph": "e",
   "Publisher": "SEC",
   "Section": "Item 10",
   "Subsection": "2"
  },
  "r24": {
   "Name": "Form N-2",
   "Publisher": "SEC",
   "Section": "Item 10",
   "Subsection": "3"
  },
  "r25": {
   "Name": "Form N-2",
   "Publisher": "SEC",
   "Section": "Item 10",
   "Subsection": "5"
  },
  "r26": {
   "Name": "Form N-2",
   "Paragraph": "1",
   "Publisher": "SEC",
   "Section": "Item 10",
   "Subsection": "5"
  },
  "r27": {
   "Name": "Form N-2",
   "Paragraph": "2",
   "Publisher": "SEC",
   "Section": "Item 10",
   "Subsection": "5"
  },
  "r28": {
   "Name": "Form N-2",
   "Paragraph": "3",
   "Publisher": "SEC",
   "Section": "Item 10",
   "Subsection": "5"
  },
  "r29": {
   "Name": "Form N-2",
   "Paragraph": "4",
   "Publisher": "SEC",
   "Section": "Item 10",
   "Subsection": "5"
  },
  "r3": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f"
  },
  "r30": {
   "Name": "Form N-2",
   "Publisher": "SEC",
   "Section": "Item 3",
   "Subsection": "1"
  },
  "r31": {
   "Name": "Form N-2",
   "Paragraph": "Instruction 1",
   "Publisher": "SEC",
   "Section": "Item 3",
   "Subsection": "1"
  },
  "r32": {
   "Name": "Form N-2",
   "Paragraph": "Instruction 10",
   "Publisher": "SEC",
   "Section": "Item 3",
   "Subparagraph": "a",
   "Subsection": "1"
  },
  "r33": {
   "Name": "Form N-2",
   "Paragraph": "Instruction 10",
   "Publisher": "SEC",
   "Section": "Item 3",
   "Subparagraph": "a, g, h",
   "Subsection": "1"
  },
  "r34": {
   "Name": "Form N-2",
   "Paragraph": "Instruction 10",
   "Publisher": "SEC",
   "Section": "Item 3",
   "Subparagraph": "f",
   "Subsection": "1"
  },
  "r35": {
   "Name": "Form N-2",
   "Paragraph": "Instruction 10",
   "Publisher": "SEC",
   "Section": "Item 3",
   "Subparagraph": "g",
   "Subsection": "1"
  },
  "r36": {
   "Name": "Form N-2",
   "Paragraph": "Instruction 10",
   "Publisher": "SEC",
   "Section": "Item 3",
   "Subparagraph": "i",
   "Subsection": "1"
  },
  "r37": {
   "Name": "Form N-2",
   "Paragraph": "Instruction 11",
   "Publisher": "SEC",
   "Section": "Item 3",
   "Subsection": "1"
  },
  "r38": {
   "Name": "Form N-2",
   "Paragraph": "Instruction 4",
   "Publisher": "SEC",
   "Section": "Item 3",
   "Subsection": "1"
  },
  "r39": {
   "Name": "Form N-2",
   "Paragraph": "Instruction 5",
   "Publisher": "SEC",
   "Section": "Item 3",
   "Subsection": "1"
  },
  "r4": {
   "Name": "Form F-3",
   "Publisher": "SEC"
  },
  "r40": {
   "Name": "Form N-2",
   "Paragraph": "Instruction 6",
   "Publisher": "SEC",
   "Section": "Item 3",
   "Subsection": "1"
  },
  "r41": {
   "Name": "Form N-2",
   "Paragraph": "Instruction 7",
   "Publisher": "SEC",
   "Section": "Item 3",
   "Subparagraph": "a",
   "Subsection": "1"
  },
  "r42": {
   "Name": "Form N-2",
   "Paragraph": "Instruction 7",
   "Publisher": "SEC",
   "Section": "Item 3",
   "Subparagraph": "b",
   "Subsection": "1"
  },
  "r43": {
   "Name": "Form N-2",
   "Paragraph": "Instruction 8",
   "Publisher": "SEC",
   "Section": "Item 3",
   "Subsection": "1"
  },
  "r44": {
   "Name": "Form N-2",
   "Paragraph": "Instruction 9",
   "Publisher": "SEC",
   "Section": "Item 3",
   "Subsection": "1"
  },
  "r45": {
   "Name": "Form N-2",
   "Publisher": "SEC",
   "Section": "Item 4"
  },
  "r46": {
   "Name": "Form N-2",
   "Paragraph": "Instruction 2",
   "Publisher": "SEC",
   "Section": "Item 4",
   "Subsection": "1"
  },
  "r47": {
   "Name": "Form N-2",
   "Paragraph": "Instruction 3",
   "Publisher": "SEC",
   "Section": "Item 4",
   "Subsection": "1"
  },
  "r48": {
   "Name": "Form N-2",
   "Paragraph": "Instruction 8",
   "Publisher": "SEC",
   "Section": "Item 4",
   "Subsection": "1"
  },
  "r49": {
   "Name": "Form N-2",
   "Publisher": "SEC",
   "Section": "Item 4",
   "Subsection": "3"
  },
  "r5": {
   "Name": "Form N-2",
   "Publisher": "SEC"
  },
  "r50": {
   "Name": "Form N-2",
   "Paragraph": "2",
   "Publisher": "SEC",
   "Section": "Item 4",
   "Subsection": "3"
  },
  "r51": {
   "Name": "Form N-2",
   "Paragraph": "3",
   "Publisher": "SEC",
   "Section": "Item 4",
   "Subparagraph": "Instruction 2",
   "Subsection": "3"
  },
  "r52": {
   "Name": "Form N-2",
   "Paragraph": "4",
   "Publisher": "SEC",
   "Section": "Item 4",
   "Subparagraph": "Instruction 3",
   "Subsection": "3"
  },
  "r53": {
   "Name": "Form N-2",
   "Paragraph": "5",
   "Publisher": "SEC",
   "Section": "Item 4",
   "Subsection": "3"
  },
  "r54": {
   "Name": "Form N-2",
   "Paragraph": "Instruction 1",
   "Publisher": "SEC",
   "Section": "Item 4",
   "Subsection": "3"
  },
  "r55": {
   "Name": "Form N-2",
   "Paragraph": "Instruction 4",
   "Publisher": "SEC",
   "Section": "Item 4",
   "Subsection": "3"
  },
  "r56": {
   "Name": "Form N-2",
   "Paragraph": "Instruction 5",
   "Publisher": "SEC",
   "Section": "Item 4",
   "Subsection": "3"
  },
  "r57": {
   "Name": "Form N-2",
   "Publisher": "SEC",
   "Section": "Item 8"
  },
  "r58": {
   "Name": "Form N-2",
   "Paragraph": "b, d",
   "Publisher": "SEC",
   "Section": "Item 8",
   "Subsection": "2"
  },
  "r59": {
   "Name": "Form N-2",
   "Paragraph": "a",
   "Publisher": "SEC",
   "Section": "Item 8",
   "Subsection": "3"
  },
  "r6": {
   "Name": "Form N-2",
   "Publisher": "SEC",
   "Section": "Item 10"
  },
  "r60": {
   "Name": "Form N-2",
   "Paragraph": "b",
   "Publisher": "SEC",
   "Section": "Item 8",
   "Subsection": "3"
  },
  "r61": {
   "Name": "Form N-2",
   "Paragraph": "b",
   "Publisher": "SEC",
   "Section": "Item 8",
   "Subparagraph": "1",
   "Subsection": "3"
  },
  "r62": {
   "Name": "Form N-2",
   "Paragraph": "b",
   "Publisher": "SEC",
   "Section": "Item 8",
   "Subparagraph": "2",
   "Subsection": "3"
  },
  "r63": {
   "Name": "Form N-2",
   "Paragraph": "b",
   "Publisher": "SEC",
   "Section": "Item 8",
   "Subparagraph": "3",
   "Subsection": "3"
  },
  "r64": {
   "Name": "Form N-2",
   "Paragraph": "b",
   "Publisher": "SEC",
   "Section": "Item 8",
   "Subsection": "5"
  },
  "r65": {
   "Name": "Form N-2",
   "Paragraph": "b",
   "Publisher": "SEC",
   "Section": "Item 8",
   "Subparagraph": "4",
   "Subsection": "5"
  },
  "r66": {
   "Name": "Form N-2",
   "Paragraph": "b",
   "Publisher": "SEC",
   "Section": "Item 8",
   "Subparagraph": "Instruction 2",
   "Subsection": "5"
  },
  "r67": {
   "Name": "Form N-2",
   "Paragraph": "b",
   "Publisher": "SEC",
   "Section": "Item 8",
   "Subparagraph": "Instruction 3",
   "Subsection": "5"
  },
  "r68": {
   "Name": "Form N-2",
   "Paragraph": "b",
   "Publisher": "SEC",
   "Section": "Item 8",
   "Subparagraph": "Instruction 4",
   "Subsection": "5"
  },
  "r69": {
   "Name": "Form N-2",
   "Paragraph": "b",
   "Publisher": "SEC",
   "Section": "Item 8",
   "Subparagraph": "Instructions 4, 5",
   "Subsection": "5"
  },
  "r7": {
   "Name": "Form N-2",
   "Paragraph": "a",
   "Publisher": "SEC",
   "Section": "Item 10",
   "Subsection": "1"
  },
  "r70": {
   "Name": "Form N-2",
   "Paragraph": "c",
   "Publisher": "SEC",
   "Section": "Item 8",
   "Subsection": "5"
  },
  "r71": {
   "Name": "Form N-2",
   "Paragraph": "e",
   "Publisher": "SEC",
   "Section": "Item 8",
   "Subsection": "5"
  },
  "r72": {
   "Name": "Form N-3",
   "Publisher": "SEC"
  },
  "r73": {
   "Name": "Form N-4",
   "Publisher": "SEC"
  },
  "r74": {
   "Name": "Form N-6",
   "Publisher": "SEC"
  },
  "r75": {
   "Name": "Form S-3",
   "Publisher": "SEC"
  },
  "r76": {
   "Name": "Investment Company Act",
   "Number": "270",
   "Publisher": "SEC"
  },
  "r77": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "313"
  },
  "r78": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r79": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "413",
   "Subsection": "b"
  },
  "r8": {
   "Name": "Form N-2",
   "Paragraph": "a",
   "Publisher": "SEC",
   "Section": "Item 10",
   "Subparagraph": "1",
   "Subsection": "1"
  },
  "r80": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "462",
   "Subsection": "b"
  },
  "r81": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "462",
   "Subsection": "c"
  },
  "r82": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "462",
   "Subsection": "d"
  },
  "r83": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "462",
   "Subsection": "e"
  },
  "r84": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "486",
   "Subsection": "a"
  },
  "r85": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "486",
   "Subsection": "b"
  },
  "r86": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2"
  },
  "r87": {
   "Name": "Securities Act",
   "Publisher": "SEC",
   "Section": "8",
   "Subsection": "c"
  },
  "r9": {
   "Name": "Form N-2",
   "Paragraph": "a",
   "Publisher": "SEC",
   "Section": "Item 10",
   "Subparagraph": "2",
   "Subsection": "1"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>13
<FILENAME>0001104659-22-104691-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001104659-22-104691-xbrl.zip
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M7YPKB:2O2_;% 90(>K-FV2^=5(G$S\+/]F#LM[+N27OQ9X+N7U!+ P04
M" #(C#Y5:NK7SB<"   <#   '0   &-K,# P,3(X-38U,"TR,#(R,#DS,%]P
M<F4N>&ULW59=;]HP%'WOK_"R9^-\E*D@H&H[-"'1:H)-XBU*G M8.#:RTP+[
M];5# D3] "8F-%X2QS[WW'.LY,2MVV7*T0LHS:1H.U[-=1 (*A,F)FWG.1OC
M&^>V<]7B3,R:]A)'&I"I$;KM3+-LWB1DL5C4EK'B-:DFQ'?=@)1 9XW,"X^
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M-%HD8(N\>]0SAWQ2.>5W7@%02P,$%     @ R(P^5;RI'DWC0@  GQ@" !4
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M*,,)B5+&=A Y/6>,4L%8'9PO$I>=,$AC!0EJP!R]. @4<F7D70(H,#8?CNA
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M@:!Q 9!Y$4.]!BG=4."7(L\FR,..-4,6\I_V"!1]U)_<N(_RGNXHKF\+$DO
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M64N [3CRC;).J9K(2Y6H7&/KP^?M,WB':AUBT*4+S'^YG.IGZ?\XL]K::^L
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M_^XE@E,LAZ1GO6-(3^SK)&@"V^(Z#U0=&NE -:?-J_A[D2HM.Z,LL%D_N<8
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M8Q,,+![TGS6,K;O4VXQB09O9Z"W5JLD0[*YLMFF)7*N;^ G&4UG;L?'V.>A
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MK;&+ "]\CQPK*7!,4;0-^I[&7^F\F,5%4HKXW&8X\!)-.L#;L5"^\@:ILJ_
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M#I+0NK2[ =L3I+Y.NQ>PAGKJZVF' M9]3CVRK!>A1."%".R+Z/@TXU3%.U5
M^F(1O9>88"I>'A>EZHC9 #Y3?1)-BBDN3//703H87^DX6B%(ROBI:4#&^SV'
M^'5N)I3FD4)J87X?T1E^-$>/1-N3'T1 4(XO(U,\:9[&O0+D],BA*7DXK!'T
M/-*:&K4.*"1[LH+D/0 ,6R3GE&_#3D\#/I6*4"C]L$3X10BO+FK4=8\A)JI8
MH8CWAI[S[U@XT0$-\93M/L8HBD! <6;D=<#3#6<5^]17:!+-/3L.>2K,"P/7
M40I(RRH^-++O/4?ZJQ5""LT''@ZQ,^J=,)K A1+)35!KCXK18<CIV,%.W=A(
M'&/7A),8UJ[O#P81J1!4B6<8.Q]F;AOZ=H+!FKPO;,\]7\3QJR]3Q"'Q76F3
MJ9P1QV@8CM<*4?J,>]3\'&\#GMQB"BLNL#*",1)6C!FKHCND6!J<,\YHQ U&
M)L_++HLT:L/Z"[!@;HT"1!Q'U4"#E*U8;4!2HW/NZJN*DP6"/5"8F+QGI'K=
MIP+&\M&.Q'DJ&&,ZR#SQ*((DC]$H@P%K?B1J[Z+2X3J4 <0+Q?.4W*:H?BCV
M':1451H\IX^/GM!*'T4]VH&(DD0<57F24ES0I81,NCX]8DA2&=U)A"3;Q@IT
M\.Y]?(.R[KFGHC&7R6ZC2-QN9!!>C=TBJ>5 *$81.#V$VS$/Y$5<7_("W299
M4S2R2LGXB(039J,-PC#)(=*H6AI-+;95ZR_RF:EBY#.VH3"NK^*^S0[P=!=N
M03>NJ&>Q>7OB*R'52^GEBB9CF?B2D)0(H4-L-1V80*&4-&I$?8%8\2B4!"T#
MTM*I=.0,9?D4/F-0<2I5M9I,3SJKB.W0*BB&?F- O'#O),%S(E;9\--I@+1-
MQM!CI/!69E@  I.8TD(D+3XH3C_A76*=<N,<#XUS/1XF+ELQH1O*G( DW&T,
M=V+4P83&SD66$D4?<H^X88YEI3?[@#(S=GE>UCERAL#IZ84DD?0P'6ZG<, G
M27F"$_6-313W%R.'S^%)#_$I9RWEL,"1'5#\'C%.W*- NL.2_,*4$Q;.V@ A
M/3\U4R!0,^@BY/A"[" D0+O$"+4-W [O7JB35'<7QS5V8EG/;,EC%O&8"RYN
M S*(XC<SFR,C'.EZ C=++"Q*!SS'I%U-!L17E8XGI6Y*FPVU2!51O/)%\8X(
MO$+*P%GI3D242]ABWP,C"T-JV0 O:J4V05[0Y$/,]T7SE>&",:=!!*99^HZ2
MYTIH$\VK''0RFPY%@!_>F+*3_19J:_XYZ H&QY,:A'[#("^I75$N4T!F5(\_
M5LV7R9HN>I7T%?\>V#UDCS)_,*55Y6A/TC@@J8[N+?X#C#PSLF?)$/JMTMAB
MEVBK:<'OS;DNT6N1@+6J9_3E4OV=Z?.6=;N!W  !A!&*-.3)&*]K5.7/,$D9
MUTQ4$63 9(89I"6R_"ZYSW9EC >@8!R*+A+:(YIG]=H7TE3ES=%X6 Y P!U*
M7074 C;Q8^UCT(ZYQ(01FH1(/AL*^Z!Q0# ^PB%I*'48I2; ,+/XW#L3!F(E
M<D\^[*"Q#L6?9%4I:T3NG9\4'9XSKPZ&S9O$X_?"<H3UZU--.;(3B!T=./<Q
M6>;'8[C:"=YG; G*Y10:D"[7BQ)[8JBT&[6BS,2D%^0.7IBU'*9H?A<Y3J/1
MZ'06!&'@DM?";]99T+YN%:]H;\"@:]DKD-98%50-F2EFW'Q:G699)537#\?2
MCJ>-6CN?BZZW."&(9$PWOM9D>B/(= ]=ND")GZ198HDJ]C,V9]6RVRL/6ZS,
MZ*QIENBJL/6RHWMUJV8M47ET UNYX17N%ZY$6N+?,^!?NT2_$OV>L0/!Z\:^
M$OEV&/E>.^LKD6^'D>_5ZWU+8I_9!D(M=M5^+%.;]K)N>)=^@(%COC RI:J&
MBZO>^S >PPT"+WCPRPK(M%XBWRQM[RQ%[TE3SN= EB7+M>6T6U:S<63:<L19
MGD=?'2\.[[AW+3P@16PXL>>(KZ_C@%=8B 7&/U0.&A4T[3DCVPT_5%H5)O+B
M/E2<G]&I%X\.^CX57,4'X"78(7BG<E8_KG6.E#5,+6(+6/6RK@0EJ6R+5-JM
M=K-N=6:2RF?G@3\;K5BU=DDK):WL#*VT&^WF43N/5OZ7!_YSD4FCUBRII*22
M+5!),2)I6\U6(X](KMWGD"=G[=IQZU>@CY(\7@)Y=*QFLYDK0Y \MGXS.:NW
M:E9)'HM-)7\QOE#=^\2?&XAL8/B3[!^YW3+7'+6X8+:-.V?WV96(Z0]7R!2L
M)D5$HTQ*\H)L/'3C%R#=IE6'FQ*274*ZYY25I_+H,2U_R]2+">93Q/NV*B.L
M,UD*4R7@BT7O)&7;IE%]A_I7;AQ1L>;X( XH=M0L@V1WL?J[#,FBRA4A5BJ[
M<<(?[#,<B1^$U/BYWG@GPD7QF^0CG=2'']<J!8ZDK$(T6P*K*D2^#!".ADZ
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M#U!+ 0(4 Q0    ( ,B,/E5L?/U:M ,  'T3   9              "  0
M  !C:S P,#$R.#4V-3 M,C R,C Y,S N>'-D4$L! A0#%     @ R(P^5;\A
M47=: @  Y0T  !T              ( !ZP,  &-K,# P,3(X-38U,"TR,#(R
M,#DS,%]D968N>&UL4$L! A0#%     @ R(P^57SUG:@5 P  /R$  !T
M         ( !@ 8  &-K,# P,3(X-38U,"TR,#(R,#DS,%]L86(N>&UL4$L!
M A0#%     @ R(P^56KJU\XG @  ' P  !T              ( !T D  &-K
M,# P,3(X-38U,"TR,#(R,#DS,%]P<F4N>&UL4$L! A0#%     @ R(P^5;RI
M'DWC0@  GQ@" !4              ( !,@P  '1M,C(R-C@P.&0T7S0R-&(S
:+FAT;5!+!08     !0 % &L!  !(3P     !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
